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Message of the Vice-Dean for Research 
 
Dear Friends and Colleagues, 
On behalf of the Organizing Committee I would like to welcome you to the ninth 
edition of the CHUV Research Day, which will be dedicated to cardiology and 
metabolism. Clinical and research development in both fields  has been given 
high priority at the CHUV and UNIL, and the coming years should see significant 
progress toward the establishment of corresponding clinical and research 
centres.  
Growing evidence indicates that inflammation is causally related to obesity and 
diabetes. Thus, obesity is associated with low grade systemic inflammation that 
constitutes one of the mechanisms underlying obesity-associated morbidity. 
Moreover, chronic inflammation is a significant risk factor for the development of 
cardiovascular and metabolic disease and continuous secretion of factors such as 
TNFα and IL-6 is associated with increased risk for numerous chronic diseases 
including insulin resistance, atherosclerosis and type 2 diabetes. 
Given that obesity is a complex disorder, a mutidisciplinary approach is 
necessary to unravel its pathogenesis and underlying mechanisms. The use of 
numerous « omic » technologies including genomics, proteomics and 
metabolomics is becoming essential in order to identify inflammatory biomarkers 
that may be implicated in the pathogenesis of obesity and the mechanisms that 
link the increase in adipose mass to morbidity. Once identified, elucidation of the 
role of the relevant inflammatory factors in the various disorders related to 
obesity will be essential.  
Among cardiovascular diseases, atherosclerosis is linked not only to inflammation 
but to an adaptive immune response as well. However, whereas the role of Th1 
lymphocytes in atherogenesis is well established, less is known about the role of 
othee T cell subsets, including Th2 and Th17. Elucidation of the full repretoire of 
mechanisms whereby adaptive immunity enhances atherogenesis will no doubt 
be important. 
The program to which you have been invited will cover a variety of aspects of the 
implication of inflammation and immunity in obesity and atherogenesis with a 
view as to possible novel therapeutic approaches down the line.   
I would like to thank the Scientific Committee for putting together a high quality 
program with a superb panel of guest speakers and hope that you will find the 
event to be both stimulating and enjoyable. 
 
Ivan Stamenkovic 
Vice-Doyen for Research 
Message du Vice-Doyen de la Recherche 
 
Cher(e)s Collègues, Cher(e)s Ami(e)s, 
Je vous souhaite la bienvenue à la neuvième édition de la Journée de Recherche 
CHUV dont les thématiques sont la cardiologie et le métabolisme. Ces 
thématiques représentent des domaines de développement prioritaires du CHUV 
et de l’UNIL et prennent une importance croissante dans notre Faculté. 
Les développements récents dans le domaine du métabolisme indiquent que 
l’inflammation joue un rôle important dans l’obésité et dans le diabète. Ainsi, 
l’obésité est associée à un état inflammatoire systémique chronique de bas grade 
qui constitue l’un des mécanismes potentiels impliqué dans les complications de 
l’obésité. L’inflammation chronique de bas grade est un facteur de risque 
significatif pour les maladies cardiovasculaires et métaboliques, et la sécrétion 
continue des médiateurs tels que le TNFα et l’IL-6 est associée à un risque 
augmenté pour de nombreuses maladies chroniques y compris la résistance à 
l’insuline, l’artériosclérose et le diabète de type II.   
La physiologie de l’obésité étant complexe, il est évident qu’une approche 
multidisciplinaire est nécessaire pour comprendre son processus et les 
mécanismes qui y conduisent. L’utilisation de nouvelles technologies, y compris 
la génomique, la protéomique et la métabolomique devient indispensable afin 
d’identifier les biomarqueurs inflammatoires qui pourraient être impliqués dans la 
pathogénèse de l’obésité ainsi que dans les mécanismes moléculaires qui lient 
l’augmentation la masse du tissu adipeux aux dysfonctions de l’organisme. Il est 
de ce fait essentiel de comprendre le rôle des différents facteurs inflammatoires 
dans les affections liées à l’obésité. 
Parmi les maladies cardiovasculaires, la pathogénèse de ’artériosclérose est 
intimement liée à la réponse immune adaptative. Toutefois, alors que le rôle 
athérogène des lymphocytes Th1 est bien établi, celui des autres sous groupes 
lymphocytaires T, y compris Th2 et Th 17 l’est moins mais de plus en plus de 
données suggèrent que ces lymphocytes participent à la régulation de 
l’artériosclérose et l’élucidation de leur mécanisme d’action sera d’importance.  
Le programme auquel vous êtes conviés fait le point sur les approches actuelles 
de l’analyse de la réponse inflammatoire et immune dans l’obésité et dans 
l’artériosclérose et examine les voies thérapeutiques possibles.  
Je tiens à remercier les membres du comité scientifique pour avoir établi un 
programme stimulant et de très haute qualité et je vous souhaite de passer une 
journée agréable.  
 
Ivan Stamenkovic 
Vice-Doyen de la Recherche 
 Faculty of Biology and Medicine 
FBM RESEARCH DAY 2011 
Thursday, January 27th, 2011 
César-Roux Auditorium, CHUV, Lausanne 
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University of Cambridge, Cambridge, UK 
Adaptive Immunity in Atherosclerosis 
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Short talks 
 
 
 
Schedule 
 
 
Names & Departments 
 
 
Titles 
 
 
Morning 
 
10h15 - 10h30 Stefan KOHLER 
PACTT – UNIL/CHUV 
From the lab to the market: 
Commercialisation of research results 
10h30 – 10h45 Cécile JACOVETTI 
Department of Cellular Biology  
and Morphology - UNIL 
The role of micro-RNAs in beta-cell mass 
expansion during pregnancy 
10h45 – 11h00 Pedro MARQUES-VIDAL 
Social and Preventive Medicine 
CHUV 
Prevalence and management of 
cardiovascular risk factors among 
migrants in Switzerland 
11h00 – 11h15 Francesca AMATI 
Department of Physiology - UNIL and 
Service of Endocrinology, Diabetology 
and Metabolism - CHUV 
Skeletal muscle mitochondrial content 
and electron transport chain activity in 
older adults at risk for type 2 diabetes: 
relationship to insulin sensitivity, 
metabolic flexibility and fatty acid 
oxidation 
11h15 – 11h30 Evrim JACCARD 
Departement of Physiology 
UNIL 
Involvement of the RasGAP-derived 
fragment N in the resistance of 
pancreatic beta cells towards apoptosis 
11h30 – 11h45 Luca CARIOLATO 
Institute of Pharmacology and 
Toxicology - UNIL  
Characterization of novel hypertrophic 
pathways activated by the AKAP-Lbc 
signalling complex in cardiomyocytes  
 
Afternoon 
14h15 – 14h30 
 
Sasha HUGENTHOBLER 
Euresearch 
 
European funding opportunities for health 
and health related research 
14h30 – 14h45 Mohammed NEMIR 
Experimental Cardiology Unit 
CHUV 
Cardiac-specific overexpression of the 
Notch ligand Jagged1 reduces cardiac 
hypertrophy and fibrosis in response to 
hemodynamic stress 
14h45 – 15h00 Hoshang FARHRAD 
Service of Nuclear Medicine 
CHUV 
Myocardial Blood Flow Quantification with 
Rubidium-82 Cardiac PET has 
Incremental Prognostic Value in Patients 
with Known or Suspected Coronary 
Artery Disease 
15h00 - 15h15 Muriel AUBERSON 
Department of Pharmacology and 
Toxicology - UNIL 
GLUT9 and uric acid handling by the 
kidney 
 
15h15 - 15h30 Fabienne MAURER 
Service of Medical Genetics 
CHUV 
Mapping genetic variants associated to 
beta-adrenergic responses in inbred mice 
15h30 – 15h45 
 
Maxime PELLEGRIN 
Service of Angiology 
CHUV 
Critical role of Angiotensin II type 1 
receptor on bone marrow-derived cells in 
the development of vulnerable 
atherosclerotic plaque in 2-Kidney, 1-Clip 
ApoE-/- mice 
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« Je sais pas si vous avez des plans pour l’avenir » ou les énoncés déclaratifs 
à valeur questionnante dans les entretiens oncologiques  
 
 
1Bourquin C., 1Stiefel F., 1Singy P.  
 
 
Psychiatric Liaison Service, DP-CHUV1  
 
 
Si l’enseignement postgradué des compétences communicationnelles (communication skills) en médecine 
– et spécialement en oncologie – fait déjà l’objet d’un certain nombre d’évaluations, l’impact global de ce 
type d’enseignement au niveau prégradué reste encore largement à déterminer. Un fonds d’innovation 
pédagogique (FIP) visant à éclairer la portée d’un enseignement individualisé (en 1ère année de master), 
comparativement à un enseignement en petits groupes, consistant en une simulation de situation complexe 
(annonce de diagnostic d’une maladie oncologique – pouvant bénéficier d’une chimiothérapie soit curative, 
soit palliative – lors d’un entretien filmé avec un patient simulé) a constitué le cadre d’une première 
évaluation scientifique de la formation à la communication médecin/patient reçue par les étudiants en 
médecine de Lausanne.  
 
Les compétences communicationnelles des étudiants ont été mesurées notamment au moyen du RIAS 
(Roter Interaction Analysis System), une méthode de codage qui permet d’associer l’ensemble des 
énoncés produits lors d’un entretien clinique à 42 catégories « de contenu » mutuellement exclusives. Les 
questions, « supercatégorie » qui nous intéresse ici, sont catégorisées sur la base de leur forme, ouverte 
vs fermée, et de leur contenu – en lien avec la condition médicale, le plan de traitement, le style de vie ou 
le psychosocial.  
 
L’analyse des entretiens filmés menés par les étudiants (N=63) avec un patient simulé a fait ressortir 
l’usage récurrent d’énoncés de type je sais pas si - vous avez déjà entendu parler des chimiothérapies / 
vous avez des plans pour l’avenir / … ou je sais pas comment - vous vous sentez aujourd’hui après cette 
opération / vous aimeriez que ça se passe / … (26 étudiants (41%) recourent de 1 à 7 fois à ces énoncés 
durant leurs entretiens). Ces énoncés font question, pour ainsi dire, et sont l’objet d’une étude exploratoire 
en cours. Etude qui interroge notamment la particularité de ces énoncés interrogatifs (indirects) se 
présentant sous une forme déclarative, leur intentionnalité – spécifique (question fermée) vs exploratoire 
(question ouverte) – et la possible spécificité des contenus qu’ils véhiculent. Une comparaison de 
l’échantillon des étudiants avec un échantillon d’oncologues (N=31) ayant conduit de semblables entretiens 
montre que ce type d’énoncés est atypique chez ces derniers (4 oncologues y recourent de 1 à 2 fois au 
cours de leurs entretiens). Il s’agit donc aussi de tenter de saisir les raisons de la récurrence de ces 
formulations en je sais pas parmi les étudiants : expression d’un sentiment d’insécurité relativement au 
sujet discuté, marqueur d’atténuation ou générationnel, mécanisme de défense ? 
 
 
Human Environment/EHU-2 
 
 
Exposition au virus de l’hépatite E dans les STEP 
 
 
1Masclaux F., 2Duquenne P., 3Hotz P., 1Oppliger A.  
 
 
Institut universitaire romand de Santé au Travail (IST)1, INRS Nancy, France2, Département de médecine du travail, 
Université de Zürich3  
 
 
L’hépatite E est une inflammation du foie provoquée par un virus à ARN appelé VHE. L'hépatite E est très 
répandue dans la plupart des pays en développement et fréquente dans tous les pays au climat chaud. Elle se 
propage principalement par le biais de la contamination fécale de l'approvisionnement en eau ou en nourriture. Dans 
les pays développés comme la Suisse ou la France, il y a peu de personnes touchées par une hépatite E. Cependant, 
les statistiques montrent que les cas sont en forte augmentation dans ces pays, sans qu’il soit pour le moment 
possible d’expliquer cette augmentation. 
  
En Suisse, une étude longitudinale montre une incidence non négligeable de séroconversion pour le VHE 
chez des travailleurs avec 26 nouveaux cas apparus en 5 ans dans une cohorte de 667 travailleurs (Tschopp et al 
2008). L’eau contaminée par les matières fécales est un vecteur de transmission de beaucoup de maladies virales, 
bactériennes ou parasitaires. La recherche du VHE dans ce type d’eau peut permettre de mesurer le niveau de 
circulation du virus tout en identifiant les différentes souches en circulation. De plus, travailler à proximité des eaux 
usées pourrait être une situation de risque pour les employés des STEP. Les voies possibles de contamination dans 
ces STEP n’ont pas encore été identifiées : la contamination peut se produire par contact direct avec l’eau, par 
contact avec des surfaces contaminées (transfert au niveau de lésion cutanées ou par ingestion) ou par inhalation ou 
déglutition d’aérosols contaminés. 
 
Une méthode de détection du VHE a été développée : c’est une méthode moléculaire de type RT-PCR en 
temps réel TaqMan (RTi RT-PCR - TaqMan). Des STEP suisses ont été sélectionnées afin d’avoir un échantillonnage 
représentatif de leur grande variété d’environnements (urbain, rural,). La recherche du VHE a été entreprise dans ces 
STEP en analysant les eaux et l’air environnant, prélevés à différents niveaux de traitement. Ce travail permettra 
d’évaluer l’exposition professionnelle aux VHE dans les STEP. Il permettra aussi de fournir des informations sur les 
réservoirs du virus et sur les voies de propagation. 
 
Human Environment/EHU-3 
 
 
Good implementation of a smoking ban in public places in the Seychelles 
 
 
1Plumettaz C., 2Viswanathan B., 2Shamlaye C., 2Gedeon J., 1Bovet P.  
 
 
Institute of Social and Preventive Medicine - CHUV1, Ministry of Health, Republic of Seychelles2  
 
 
 
Background Following two decades of continued tobacco control activities, a smoking ban in all 
enclosed public places was initiated in August 2009 in the Seychelles (African region), as part of a 
comprehensive tobacco control legislation. After nine months of a “grace period” (penalties were 
not issued against for offenders), we assessed the level of implementation of the ban. 
Methods Seven survey officers visited, during a two-week period, 38 most popular hospitality 
venues in the country, including all bars and discotheques. In each venue, a survey officer 
observed compliance with the smoking ban for 15 minutes and subsequently administered a 
structured questionnaire to two customers, two workers and one manager. 
Results In the 38 venues, information was gathered from 63 patrons, 66 workers and 34 
managers. Survey officers witnessed virtually no smoking in the indoor premises. 88% of 
managers but only 65% of workers “often” or “always” requested customers to stop smoking. 88% 
of workers and 98% of managers reported that smoking customers “generally agree smoothly” to 
stop smoking when requested. The smoking ban was supported by approximately 90% of the 
patrons, workers and managers. Health improvement was reported by 20% of workers. 
Respectively 21% of managers and 9% of workers reported a decrease in business but 17% of 
managers reported new customers since the smoking ban took effect. 
Conclusion We found good compliance with the smoking ban in hospitality venues in the 
Seychelles. Despite a few weaknesses in the implementation processes, suggesting the need for 
further training of workers and application of enforcement measures, our findings suggest that a 
smoking ban has a large potential for self-implementation, conditional on favorable circumstances, 
i.e. previous tobacco control activities likely to mould social support to clean air policy. This study 
also provides an example of a simple and inexpensive methodology to evaluate the 
implementation and impact of clean air policy. 
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Aménagement d'un laboratoire de production cellulaire selon les GMP au 
CHUV 
 
 
CALMET G. 
 
 
CHUV 
 
 
Le Centre Universitaire Vaudois souhaite créer un laboratoire de production cellulaire, appelé 
Centre de Production Cellulaire du CHUV ou CPC2. 
Ce centre sera un laboratoire destiné à la production de cellules selon les réglementations GMP, 
dans des domaines variés tels que la production de peau pour le Centre Romand des Grands 
Brûlés, et des applications liées à la recherche clinique (production de cellules neurales, 
mésenchymateuses, …). 
La réglementation suisse impose aux laboratoires qui souhaitent se lancer dans le développement 
technique de la thérapie cellulaire, de respecter les « Good Manufacturing Practice for medicinal 
Products » (GMP). Cela implique des contraintes relativement sévères dans différents domaines. 
Pour respecter ces recommandations, l’équipe d’ingénierie biomédicale du CHUV ainsi que les 
responsables du projet CPC2 ont travaillé sur plusieurs concepts, puis à l’élaboration d’un cahier 
des charges techniques pour une étude de marché. Plusieurs solutions techniques ont été 
envisagées, mais après mûres réflexions, il s’avère que l’installation d’isolateurs « ultra-propres » 
semble la meilleure, tant au niveau des contraintes techniques que financières. Un appel d’offres 
fut envoyé pour l’acquisition de tels modules. 
En parallèle, d’autres outils sont mis en places afin de faciliter la certification du laboratoire, telle 
qu’un logiciel LIMS (pour Laboratory Information Management System). 
 
Mots clés : thérapie cellulaire ; production cellulaire ; classe de propreté ; CHUV ; 
grands brûlés ; peau ; monitoring, air, réglementation suisse. 
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De novo sequencing of the genome of the human pathogenic fungus 
Pneumocystis jirovecii from lung microbiome 
 
 
1-2Cissé O., 1Hauser P., 2Pagni M.  
 
 
Institute of Microbiology -CHUV1, Vital-IT group - SIB2  
 
 
Pneumocystis jirovecii is an opportunistic fungus, which causes life-threatening pneumonia in 
immunocompromised patients. The lack of a culture method in vitro has hampered progress in the 
understanding of its biology. Sequencing P. jirovecii genome is complicated by the fact that its 
DNA can be isolated only from bronchoalveolar lavage specimens, which implies small amounts 
and contamination from other organisms. These difficulties can now be overcome using the new 
techniques of random DNA amplification and high throughput sequencing, as well as appropriate 
bioinformatics strategy. The main problem in this approach is the reconstruction of the whole 
genome out of a mixture of DNA sequences from diverse organisms. We are using the following 
procedure in order to obtain a high-quality genome assembly. First, we performed an enrichment 
of the BAL in P. jirovecii cells using immuno-precipitation. Multiple displacement amplification was 
then used to obtain large amounts of DNA. 1’192’988 sequence reads were analysed by 
comparison to other relevant genomes, including the Pneumocystis species infecting rats. 
Currently, 20% of reads had a high homology with P. carinii and were considered as being from P. 
jirovecii. Remaining reads considered, as non-Pneumocystis using rigorous control will be 
removed before assembly of P. jirovecii genome. Recent updates will be presented. 
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Gender and communicative competence in medical setting: a case study 
 
 
1SULSTAROVA B., 1SINGY P.  
 
 
Liaison Psychiatry Service1  
 
 
 
Background: Although we can observe a rise in number of women in medical profession, they are 
still less present in the high ranking positions. Some researches have shown the impact of 
physician gender on medical communication with patients. They revealed that female physicians 
engage in more patient-centered communication than do their male peers. Few researches, 
however, have examined how the gender affect the backstage communication, where the health 
care professionals learn to gain communicative competences through discourse and to present 
themselves as future candidate for professional careers.  
 
Aims: An ongoing Ph.D. study in sociolinguistics attempts to show the linguistic practices used by 
health care providers when they discuss amongst themselves in a formal setting. The study aims 
mainly to find gender differences in these linguistics practices and to investigate the perceptions of 
health care providers on the importance of backstage communication and on the gender linguistic 
patterns in this context.   
 
Methods: Data are collected in the Liaison Psychiatry Service (CHUV) in two phases. In the first 
phase, eight meetings with several male and female physicians, psychologists, nurses and social 
workers supervised by an expert psychiatrist, were filmed. In the second phase, 25 semi-directive 
interviews were conducted with members of all professions in this service. All the data are 
transcribed and submitted to quantitative and qualitative discourse analyses. 
 
Results and discussion: The preliminary results reveal the impact of gender in gaining 
communicative competence in medical settings. The evaluation of speaking time in the recorded 
meetings shows an evident asymmetry between male and female health care professionals. The 
male dominate the verbal exchange independently of their professional status.  Gender 
differences are also observed in linguistic practices used by male and female health care 
professionals during medical communication. It seems that the participants in the meetings choose 
strategically the linguistics practices according to the norms of a particular community and 
according to the linguistic behaviors considered appropriate to women and men. When asked 
about their experiences and linguistic behavior in medical settings, some physician women insist 
on the barriers they are facing as speakers in institutional settings. They are more likely to 
experience “anxiety” when speaking in such formal settings than their male colleagues.  
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Influence of individual factors on occupational solar UV exposure - for a 
targeted prevention 
 
 
1Milon A., 1Vernez D., 2Bulliard J.-L., 3Bonneau J.  
 
 
Institute for Work and Health, DUMSC1, Institute of Social and Preventive Medicine, DUMSC2, EHESP School of 
Public Health3  
 
 
BACKGROUND 
UV is a carcinogenic agent involved in both the initiation and promotion of skin cancers. Over the last 
decades, skin cancer rates have markedly increased in Caucasian populations worldwide. And Switzerland 
has one of the highest rates of melanoma and non-melanoma skin cancers in Europe. Outdoor workers, 
such as agricultural workers, are at increased risk of skin cancer. The lag time between sun exposure and 
severe cutaneous damage, along with the positive social perception of tanning, render compliance with sun 
protection messages challenging. Specific educational messages and prevention strategies focusing on the 
work place and occupational exposure appear to be a key reinforcement to reach this highly sun-exposed 
subgroup. 
MATERIAL AND METHODS 
A questionnaire has been used to obtain information on sun-related behaviour during occupational and 
leisure activities (use of sun protective measures, history of skin cancers, sun sensitivity, knowledge and 
understanding of UV Index). Through the collaboration with professional farmers’ associations, 4000 
questionnaires were sent to farmers in Vaud, Valais, Neuchâtel and Jura cantons,. 
In addition, field measurements using biological film dosimeters were performed to estimate the daily UV 
dose associated to several agricultural activities (vineyard, arboriculture, cereal and agriculture). 
RESULTS 
This study (answer rate = 29%) indicated a better knowledge of UV risk in this specific population 
compared to the general population. However, this awareness did not translate into a systematic use of 
sun-protective measures and showed an under-estimation of the personal UV risk, especially at work. If 
farmers knew the UV index and could describe it better than the general population, it was scarcely used to 
plan outdoor activities. Surprisingly, significant differences between vineyard/arboriculture workers and 
farmers were evidenced on risk perception and protective measures used at work. 
Personal solar UV exposure measurements indicated an elevated acute and chronic exposure associated 
to agricultural activities. Combined with postural activity recordings, these results confirmed a risk of 
over-exposing specific anatomical parts where cutaneous carcinomas tend to appear. 
CONCLUSION 
This study was the first broad-scaled description of the knowledge and UV risk perception, and use of sun 
protective measures in an occupational activity in Switzerland. The differences in sun exposure modalities 
between leisure and occupational activities reinforce the need for specific prevention messages on 
occupational solar UV exposure for outdoor workers. 
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Incidence of colorectal cancers and polyps in Vaud, 1983-2007:  
Trends and determinants 
 
F. Bruchez1, F. Levi2,3, J-L. Bulliard2 
1 Faculty of Biology and Medicine (FBM), Lausanne, Switzerland 
2 Cancer Epidemiology Unit, University Institute of Social and Preventive Medicine (IUMSP), Centre Hospitalier 
Universitaire Vaudois (CHUV) and University of Lausanne, Switzerland 
3 Vaud Cancer Registry, Lausanne, Switzerland 
 
Background:   
Colorectal cancer is the second most lethal cancer and third most common neoplasm in Switzerland, with 
about 1600 deaths and 4000 new cases per year, respectively. A prior study in the canton of Vaud showed 
an increase in rates of polyps but a stable incidence of colorectal cancer between 1979 and 1996 with 
however diverging trends according to subsite. 
Objectives:   
To examine recent trends (1983-2007) in colorectal polyps and cancers, and explore determinants of these 
trends in a rare population-based series on polyps in the world. 
Methods: 
16,308 first polyps and 7063 primary cancers of the colon and rectum registered between 1983 and 2007 
were extracted from the Vaud Cancer Registry. Standardised (European population) rates as well as sex, 
age- and site-specific incidence rates were computed. 
Results: 
A fourfold increase was observed in the detection rate of polyps (from 46/100,000 in 1985-89 to 
188/100,000 in 2003-07) while colorectal cancer incidence remained constant (35-40/100,000) over the 
25-year period studied. Rates of polyps increased exponentially since the late 1980s. The proportion of 
polyps in the right side of colon doubled (17% to 35%) whereas a commensurate decrease was seen in the 
percentage of polyps in the rectum. No statistically significant change occurred in the sex, grade or site 
distribution of colorectal cancer over time, and trends by stage at diagnosis were inconsistent. However, a 
concomitant shift to younger age at diagnosis was found both for polyps and cancers, with a higher risk of 
polyp and cancer in males than females. 
Conclusion: 
The large increase in detection rate of polyps, along with shifts to right-sided adenomas and younger age at 
diagnosis support the effect of an increasing use of colonoscopy as a screening and diagnostic tool. In a 
multifactorial and evolving context, the stable incidence of colorectal cancer can be explained by several 
concomitant and antagonistic factors which may mask the impact of the increasing practice of opportunistic 
screening in the Vaud population.
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Exposure to microorganisms and endotoxins in crop workers 
 
 
1Niculita-Hirzel H., 1Oppliger A.  
 
 
Institute for Work and Health 1  
 
 
 
Microorganisms are biotic factors that may strongly affect farmers’ health. They may be present at a 
particularly high concentration in the air when they are mechanically aerosolized during harvesting and 
post-harvesting operations. Regular inhalation of these microorganisms and of their constituents (e.g. 
endotoxins, β-glucans, mycotoxins) has been proposed to be responsible of the high prevalence of 
respiratory syndromes among farmers. For this raison, general preventive strategies are needed in order to 
decrease farmer exposure to these bioaerosols. This study aims to identify the factors that reduce the 
growth of fungi and bacteria in crops. 
 
In agroecosystem, the composition of soil fungal and bacteria communities is greatly influenced by 
agriculture practices such as the usage or not of tilling, of nutritional additives or of different fungicides. A 
change in soil microbial community composition may directly affect the concentration in bacteria, fungal 
particles and mycotoxins deliver in air. In order to test this hypothesis, we sampled soil, plant, grain and air 
during harvesting from 100 sites randomly distributed through Vaud canton representative of the different 
agriculture practices. Genomic DNA has been extracted from these samples and fungal and bacteria 
concentration has been evaluated by Q-PCR on the ITS2 and 16S respectively. The results are interpreted 
by taking in account the agriculture practice, the Phosphorus : Carbon : Nitrogen ratio of the soil, the 
altitude and the average of rainy days per year. 
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Estrella lausannensis, a new species within the Chlamydiales order 
 
 
1LIENARD J., 1CROXATTO A., 1GREUB G.  
 
 
Institute of Microbiology - CHUV1  
 
 
 
Originally, the Chlamydiales order was represented by a single family, the Chlamydiaceae, 
composed of several pathogens, such as Chlamydia trachomatis, C. pneumoniae, C. psittaci and 
C. abortus. Recently, 4 new families have been added to the order. Chlamydia-related bacteria are 
strict intracellular bacteria, able for the most to replicate in free-living amoebae. Amoebal 
co-culture that selectively isolates amoeba-resisting bacteria allowed the discovery of the strain 
CRIB 30, from an environmental water sample. Based on the 16S ribosomal RNA gene sequence 
similarity, strain CRIB 30 was affiliated as a new genus in the Criblamydiaceae family. 
Morphologic analyses revealed peculiar star-shaped elementary bodies similar to that of 
Criblamydia sequanensis and we proposed to call this new strain “Estrella lausannensis”. 
Phylogenetic analyses of the genes gyrA, gyrB, topA, rpoA, rpoB and 23S rRNA and MALDI TOF 
assay confirmed the taxonomic affiliation of E. lausannensis.  Furthermore, E. lausannensis 
showed a large amoebal host range and a very efficient replication rate in Acanthamoeba species. 
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A Numeric Model to Simulate Solar Individual Ultraviolet Exposure 
 
 
1Milon A., 1Vernez D., 2Francioli L., 3Bulliard J.-L., 4Moccozet L., 5Vuilleumier L.  
 
 
Institute for Work and Health, DUMSC1, ZOOM Créations2, University Institute of Social and Preventive Medicine, 
DUMSC3, Faculty of Social and Economic Sciences, UniGe4, Federal Office of Meteorology and Climatology 
MeteoSwiss5  
 
 
 
Exposure to solar Ultra-Violet (UV) light is the main causative factor for skin cancer. UV exposure 
depends on environmental and individual factors. Individual exposure data remain scarce and 
development of alternative assessment methods is greatly needed. We developed a model 
simulating human exposure to solar UV. The model predicts the dose and distribution of UV 
exposure received on the basis of groud irradiation and morphological data. A 3D rendering 
visualisation tool illustrates UV exposure over the body surface. Computer graphic techniques (3D 
rendering) were adapted to reflect solar exposure conditions. A virtual manikin, depicted as a 3D 
triangular mesh, represented the body skin. The amount of solar energy received by each triangle 
was calculated, taking into account reflected, direct and diffuse radiation, and shading from other 
body parts. Dosimetric measurements (n=54) were conducted in field conditions using a foam 
manikin as surrogate for an exposed individual. Dosimetric results were compared to the model 
predictions. The model predicted exposure to solar UV adequately. The symmetric mean absolute 
percentage error was 13%. Half of the predictions were within 17% range of the measurements. 
This model provides a tool to assess outdoor occupational and recreational UV exposures, without 
necessitating time-consuming individual dosimetry, with numerous potential uses in skin cancer 
prevention and research. 
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Variant within the promoter region of the CHRNA3 gene associated with 
nicotine dependence is not related to willingness to quit smoking 
 
 
1Marques-Vidal P., 2Kutalik Z., 1Paccaud F., 2Bergmann S., 3Waeber G., 3Vollenweider P., 
4Cornuz J.  
 
 
CHUV and University of Lausanne1, Department of Medical Genetics, University of Lausanne2, Department of 
Medicine, CHUV3, Department of Ambulatory Care and Community Medicine, University of Lausanne4  
 
 
 
Introduction: Common variation in the CHRNA5-CHRNA3-CHRNB4 gene region is robustly 
associated with smoking quantity. Conversely, the association between one of the most significant 
SNPs (rs1051730 within the CHRNA3 gene) with difficulty or willingness to quit smoking is 
unknown. 
Methods: cross-sectional study including current smokers, 502 women and 552 men. Heaviness 
of smoking index (HSI), difficulty, attempting and intention to quit smoking were assessed by 
questionnaire. 
Results: the rs1051730 SNP was associated with increased HSI (age, gender and 
education-adjusted mean ± standard error: 2.6 ± 0.1, 2.2 ± 0.1 and 2.0 ± 0.1 for AA, AG and GG 
genotypes, respectively, p<0.01). Multivariate logistic regression adjusting for gender, age, 
education, leisure-time physical activity and personal history of cardiovascular or lung disease 
showed rs1051730 to be associated with higher smoking dependence (OR and 95% confidence 
interval for each additional A-allele: 1.38 [1.11-1.72] for smoking over 20 cigarette equivalents per 
day; 1.31 [1.00-1.71] for a HSI≥5 and 1.32 [1.05-1.65] for smoking 5 minutes after waking up) and 
borderline associated with difficulty to quit (OR=1.29 [0.98-1.70]), but this relationship was no 
longer significant after adjusting for nicotine dependence. Also, no relationship was found with 
willingness (OR=1.03 [0.85-1.26]), attempt (OR=1.00 [0.83-1.20]) or preparation (OR=0.95 
[0.38-2.38]) to quit. 
Conclusions: these data confirm the effect of rs1051730 on nicotine dependence but failed to find 
any relationship with difficulty, willingness and motivation to quit. 
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The nuclear hormone receptor PPARβ and microRNA as a regulators of skin 
carcinogenesis 
 
 
1Degueurce G., 2Schütz F., 2Ibberson M., 1Wahli W., 2Xenarios I., 1Michalik L.  
 
 
UNIL1, SIB2  
 
 
 
The three isotypes of peroxisome proliferator-activated receptors (PPARs), PPARα, β and γ, are 
ligand-inducible transcription factors that belong to the nuclear hormone receptor family. 
While they are best known as transcriptional regulator of lipid and glucose metabolism, PPARs are 
also implicated in the control of inflammatory responses. 
We have described a number of roles for PPARβ in skin homeostasis. We showed that the 
activation of PPARβ triggers keratinocyte survival, directional sensing and migration, and 
proliferation. Our ongoing work demonstrates that PPARβ is involved in skin tumor development 
after UV irradiation, through the control of c-Src expression and downstream signaling pathways. 
Interestingly, microRNA (miRNA) were shown to be involved in the UV stress response. Based on 
these observations, we explore the interaction between miRNAs and PPARβ in the development 
of UV-induced skin cancer. PPARβ wt and null mice were exposed to UV during a maximal period 
of 30 weeks, and mRNA and miRNA expression was analysed in UV-exposed skin at various time 
points using microarrays. Our data suggests that miRNAs are indeed involved in the PPARβ 
response to UV in dorsal skin. We are currently validating some of the miRNA/mRNA interactions 
and their involvement in PPARβ-mediated UV-stress response pathways. 
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Understanding the mechanism of RasGAP cleavage by caspase-3 derived 
fragment N on Survivin induction. 
 
 
Peltze N. 
 
 
Department of Physiology 
 
 
 
RasGAP, a regulator of the Ras and Rho small G proteins, is cleaved by caspase-3 into two 
fragments in low stress conditions. The N-terminal fragment, called fragment N, displays potent 
anti-apoptotic properties, protecting a variety of cell types against many death stimuli. Fragment N 
protects cells by activating the Ras-PI3K-Akt pathway. Which of the many Akt effectors is 
participating in fragment N-induced protection is unclearly defined at the moment, although we 
have recently observed that survivin, a member of the inhibitor of apoptosis (IAP) family, is 
induced by fragment N in an Akt-dependent manner. 
Moreover we observed that when survivin is silenced, even though fragment –N is produced in the 
cell under a mild stress, cells are no longer protected against apoptosis suggesting that indeed 
survivin is a key mediator in fragment N - mediated protection. 
Survivin is an antiapoptotic protein but also a chromosomal passenger and so it is highly regulated 
at different levels, suffering from transcriptional to post-translational modifications. In this study we 
would like to characterize the mechanism of activation of survivin by fragment N and try to 
understand better this antiapoptotic pathway as a whole. 
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Transgenic Animal Facility (TAF) of the Faculty of Biology and Medicine and 
the University Hospitals, UNIL/CHUV 
 
 
1Dénéréaz M.-L., 1Maison D., 1Merillat A.-M., 1Hummler E.  
 
 
Institut de Pharmacologie et Toxicologie1  
 
 
 
The Transgenic Animal Facility (TAF) is now in its 6th year of activity. The platform generates 
genetically-engineered mouse models for biomedical research. In principle, the Platform generates 
transgenic mice using BACs and mini-genes, knock-out and Knock-in mice and performs 
rederivation of established mouse strains. Additionally, we offer thawing of frozen embryos. The 
TAF actively participates in the continued formation and offers thereby a platforme open to the 
local scientific community in order to answer questions concerning the generation and analysis of 
these mice. 
Since August 2010, the Transgenic Animal Facility is part of the technical platforms of the NCCR 
Kidney :CH (Kidney Control of Homeostasis) and will develop complex engineered rat and mouse 
animal models using novel techniques like zinc finger nuclease technology. 
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DNA topology alterations induced by a bacterial volatile excreted molecule 
promote antibiotic tolerance in prokaryotes 
 
 
1Que Y., Hazan R., He J., Zhang J., Kesarwani M., Giddey M., Rahme L.  
 
 
Service de Médecine Intensive Adulte1  
 
 
Bacterial persistence, observed in a broad range of microbial species, is the capacity of bacteria 
sub-populations to tolerate exposure to normally lethal concentrations of bactericidal antibiotic. 
This ability, which is not due to antibiotic-resistant mutants, has been implicated in antibiotic 
treatment failures and may account for latent, chronic and relapsing infections that can be 
suppressed, but not eradicated. Drugs that target such infections are lacking, as the phenomenon 
of antibiotic tolerance remains poorly understood. The low frequency and transience of the 
persister trait has complicated the elucidation of the mechanism that controls persister cell 
formation. We show that 2’ amino-acetophenone (2-AA), a small, volatile odorant molecule 
produced by the recalcitrant Gram-negative human pathogen Pseudomonas aeruginosa promotes 
persister production in response to quorum-sensing (QS) signalling in an epigenetic manner. 2-AA 
modulates DNA topology via its effects on topoisomerase I (TopA) activity, leading to persister 
accumulation in an SOS response-independent manner. Our findings provide a new perspective 
on the functions of QS regulated small molecules and the first demonstration of a natural topology 
auto-altering molecule being involved in the promotion of antibiotic tolerant cells formation. As QS 
and TopA are evolutionarily conserved among bacteria, our findings suggest that QS 
auto-regulated molecules altering DNA topology may be a universal mechanism by which 
prokaryotes produce persisters. 
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Pancreatic Stone Protein (PSP): an Acurate Biomarker of Sepsis 
 
 
 
1Eggimann P., 2Liaudet L., 2Que Y.-A., 3Lajaunias F., 4Graf R., 4Bain M., 5Moreillon P., 6Roger T., 
6Calandra T., 2Eggimann P.  
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Geneva3, Visceral and Transplant Surgery, Univ. Hosp. Zürich4, Institut de microbiologie fondamentale, Université de 
Lausanne5, Service des maladies infectieuses, CHUV, Lausanne6  
 
 
BACKGROUND: Serum levels of pancreatic stone protein/regenerating protein (PSP) increased transiently in septic 
polytrauma patients without pancreatic injury (Crit Care Med 2009; 37:1642). PSP acts as an activator of neutrophils 
suggesting that it may be a biomarker of sepsis.  
 
METHODS: Serum levels of PSP (ELISA) and other sepsis biomarkers (procalcitonin [PCT], IL-8, IL-6, TNF-alpha) 
were measured in samples collected prospectively at admission, day 3, day 7, and weekly thereafter until discharge or 
death in ICU in a cohort of 108  patients with severe sepsis (n=33) and septic shock (n=75). 
 
RESULTS: Median age was 63 years (19-85). Respiratory tract (n=37) and abdomen (n=38) were the most common 
sources of infection, which were microbiologically documented in 91 cases (82%). Overall, 2 (6%) and 17 (25%) 
patients with severe sepsis and septic shock died, respectively. At admission IL-6, IL-8, IL-10, PSP, and PCT were 
significantly more elevated in septic shock. At admission, PSP and IL-8 were significantly more elevated in non 
survival (Table) 
 
Median values  
at entry (IQR)  
Survival  
(n=87)  
Death  
(n=21) 
 
P values  
Cytokines     
 TNF-alpha 
 IL-1beta 
 IL-6 
 IL-8 
 IL-10 
2.35(6.7) 
7.32(20.4) 
737(6483) 
412(1616) 
135(500)  
2.1(10.3) 
1.59(34) 
2901(15801) 
818(10358) 
570(1390)  
0.67 
0.44 
0.056 
0.046 
0.06 
Acute phase protein     
 PCT 
 PSP  
4.22(22) 
211(397)  
6.2(28.8) 
398(1627) 
0.92 
0.007 
 
To predict survival at entry areas under the ROC curves, were 0.68 (95% CI: 0.56-0.81), 0.64 (0.49-0.79) and 0.49 
(0.34-0.64), for PSP, IL-8, and PCT, respectively. The evolution of PSP and PCT differed significantly over time in 
patients with severe sepsis and septic shock. 
 
These data suggests that PSP serum levels is an accurate biological marker of the clinical severity of infections 
requiring ICU admission. Moreover, it predicts outcome and then may potentially allow early stratification of septic 
patients.  
 
CONCLUSIONS: We conclude that Pancreatic Stone Protein (PSP), an acute phase protein, is an early and accurate 
biomarker reflecting severity and outcome in patients with severe sepsis and septic shock requiring ICU admission. 
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Rapid detection of Staphylococcus aureus strains with reduced susceptibility 
to vancomycin by isothermal microcalorimetry 
 
 
1Bizzini A., 2Kasas S., 3Trampuz A.  
 
 
Institute of Microbiology - CHUV1, Laboratory of Physics of Living Matter - EPFL2, Department of Infectious diseases - 
CHUV3  
 
 
 
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is an increasing cause of 
morbidity and mortality. Vancomycin (VAN) is the first-line antibiotic for serious and invasive 
MRSA infections. MRSA can be either vancomycin-susceptible (VSSA) or exhibit reduced 
susceptibility to VAN. The latter can be expressed as a heterogeneous-intermediate (hVISA), 
homogeneous-intermediate (VISA) or resistant (VRSA) phenotype. Current microbiological 
detection techniques are either inaccurate (e.g. macrobroth, Etest) or laborious and 
time-consuming (e.g. population analysis profile). We investigated the potential of microcalorimetry 
to detect subpopulations of reduced susceptibility to VAN by detection of growth-related heat 
production in the presence of VAN. 
Methods: Representative strains were used for VSSA (ATCC 29213, ATCC 43300), hVISA (Mu3, 
PC1), VISA (Mu50, PC3) and VRSA (SA510) phenotypes. Microcalorimetry was performed by 
inoculating 5x107 CFU of overnight cultures into vials containing 3 ml of brain heart infusion broth 
with serial dilutions of VAN. Heat production was measured at 37°C and time to detection was 
determined. 
Results: No heat production was detected in the VSSA strains at VAN concentration >3 µg/mL 
during the 72 hours of incubation. hVISA and VISA strains showed heat production with a 
dose-proportional delay up to 6 µg/mL in 48h and up to 12 µg/mL in 72h, respectively. The VRSA 
strain showed heat production up to 16 µg/mL in 12h. 
Conclusions: Microcalorimetry was able to detect strains with reduced susceptibility to VAN and 
distinguish hVISA, VISA and VRSA strains in less than 12 h. Measuring of bacterial heat 
production might represent a simple and rapid method for detection of heteroresistant bacterial 
phenotypes. 
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Monitoring of 1,3-Beta-D-Glucan (BDG) for Early Diagnosis of Abdominal 
Candidiasis (AC) in High-Risk Surgical ICU Patients  
 
 
1Tissot F., 2Hauser P., 3Lamoth F., 4Eggiman P., 5Flueckiger U., 6Siegemund M., 5Orasch C., 
7Zimmerli S., 3Calandra T., 3Marchetti O.  
 
 
Infectious Diseases Service1, Institute of Microbiology, CHUV2, Infectious Diseases Service, CHUV3, Intensive Care 
Unit, CHUV4, Infectious Diseases Service, Basel University Hospital5, Intensive Care Unit, Basel University Hospital6, 
Infectious Diseases Institute, Bern University Hospital7  
 
 
Background : The aim of study was to assess the utility of monitoring serum 1,3-beta-D-glucan 
(BDG) for early diagnosis of abdominal candidiasis (AC) in high-risk surgical ICU patients. 
Methods : serum BDG (Fungitell®) was monitored 3x/week in a 3-year prospective observational 
cohort of surgical ICU patients at high-risk for AC (recurrent abdominal perforation/leakage, acute 
necrotizing pancreatitis). The Candida score (CS) was assessed during the first week after 
inclusion and the Candida colonization index (CI) monitored 2x/week. Endpoint was the 
occurrence of microbiologically documented AC. The diagnostic performance of BDG cut-offs 
ranging from 60 to 500 pg/ml for diagnosis of AC was compared to that of CS and CI. 
Results : 89 patients (67% males; median age 62y, range 22-86) with recurrent abdominal 
perforation/leakage (68) and acute necrotizing pancreatitis (21) were followed during 19d (3-63): 
87 were colonized during the first week (IC ≥ 0.5 in 51) and the CS was ≥ 3 in 44. AC occurred in 
29 cases (76% C. albicans). 9 (2-28) blood samples were collected per patient. Median BDG 
values at inclusion were significantly higher in AC (n=29) vs. colonized patients who received 
antifungal therapy (n=18) vs. colonized patients who were not treated (n=40): 176 pg/ml 
(11.85-3866), 78.87 (18.19-439.77) and 70.95 (7.81-240.66), respectively. A BDG cut-off ≥ 80 at 
inclusion as well as at the time of microbiological diagnosis of AC had the best sensitivity / 
specificity (76% / 59% and 76% / 78%, respectively) for differentiating infected from colonized 
patients. Sensitivity / specificity of a CI ≥ 0.5 and a CS ≥ 3 were 79% / 34% and 62% / 64%, 
respectively. The first BDG value ≥ 80 preceded by a median of 5 days the microbiological 
documentation of AC. 
Conclusion : 1,3-beta-D-glucan early differentiates abdominal candidiasis from colonization in 
high-risk surgical ICU patients and may be used for guiding pre-emptive antifungal therapy. 
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Impact of chlorhexidine-impregnated sponges on catheter-related infections 
rate  
 
 
1Joseph C., 2Thévenin M.-J., 3Voirol P., 2Bellini C., 2Zanetti G., 1Pagani J.-L., 1Revelly J.-P., 
1Eggimann P.  
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Pharmacie, CHUV, Lausanne3  
 
INTRODUCTION 
Multimodal strategy targeted at prevention of catheter-related infection combine education to general measures of hygiene with 
specific guidelines for catheter insertion and dressing 1.  
OBJECTIVES 
In this context, we tested the introduction of chlorhexidine(CHX)-impregnated sponges 2.  
METHODS 
In our 32-beds mixed ICU, prospective surveillance of primary bacteremia and of microbiologically documented catheter-related 
bloodstream infections (CRBSI) is performed according to standardized definitions. New guidelines for central venous catheter 
(CVC) dressing combined a CHX-impregnated sponge (BioPatch®) with a transparent occlusive dressing (Tegaderm®) and 
planning for refection every 7 days. To contain costs, Biopatch® was used only for internal jugular and femoral sites. Other 
elements of the prevention were not modified (overall compliance to hand hygiene 65 to 68%; non coated catheters except for 
burned patients [173 out of 9542 patients]; maximal sterile barriers for insertion; alcoholic solution of CHX for skin disinfection).  
 
RESULTS 
Median monthly CVC-days increased from 710, to 749, 855 and 965 in 2006, 2007, 2008 and 2009, respectively (p<0.01). 
Following introduction of the new guidelines (4Q2007), the average monthly rate of infections decreased from 3.7 (95%CI: 2.6-4.8) 
episodes/1000 CVC-days over the 24 preceding months to 2.2 (95%CI: 1.5-2.8) over the 24 following months (p=0.031). Dressings 
needed to be changed every 3 to 4 days 
 
 
 
The decrease of catheter-related infections we observed in all consecutive admitted patients is comparable to that recently showed 
in a placebo- randomized trial 2. Further generalization to all CVC and arterial catheters access may be justified. 
 
CONCLUSIONS 
Our data strongly suggest that combined with occlusive dressings, CHX-impregnated sponges for dressing of all CVC catheters 
inserted in internal jugular and/or femoral sites, significantly reduces the rate of primary bacteremia and CRBSI.  
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Cambinol, an inhibitor of Sirtuin 1 and Sirtuin 2, inhibits innate immune 
responses 
 
 
1Lugrin J., 1Grandmaison G., 1LeRoy D., 1KnaupReymond M., 1Calandra T., 1Roger T.  
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Background: The mammalian family of histone deacetylases (HDACs) is composed of 
HDAC1-11 and sirtuins (Sirt) 1-7. Sirt1-7 display deacetylase and/or ADP-ribosyl transferase 
activities, and have been involved in the control of cell metabolism, proliferation and survival. 
Pharmacological inhibitors and activators of sirtuins are currently been evaluated for the treatment 
of metabolic, neurogenerative and oncologic disorders. We have recently shown that inhibitors of 
HDAC1-11 strongly inhibit innate immune responses and protect from mice from septic shock. The 
aim of this study was to analyze the impact of cambinol, an inhibitor of Sirt1-2 that exhibits 
antitumor activity, on innate immune responses in vitro and in vivo. 
 
Methods: Bone marrow-derived macrophages (BMDMs), RAW 264.7 macrophages and human 
whole blood were incubated for 1 h with cambinol and stimulated with microbial products (LPS, 
Pam3CSK4, CpG DNA, and heat-killed E. coli and S. aureus). TNF, IL-6 and IL-12p40 mRNA and 
protein levels were quantified by RT-PCR, bioassay and ELISA. The activation of intracellular 
signalling pathways was analyzed by Western blotting. Mice were injected with LPS (LPS 17.5 
mg/kg i.p.) and treated with cambinol (10 mg/kg). Blood was collected after 3 h, and mouse 
survival followed over 6 days. 
 
Results: Cambinol dose-dependently inhibited the secretion of TNF, IL-6 and IL-12p40 by 
macrophages and whole blood stimulated with microbial products. In agreement, cambinol 
inhibited LPS- and Pam3CSK4-induced cytokine mRNA expression in macrophages. Yet, cambinol 
did not affect the activation of the NF-kB and MAPKs intracellular signaling pathways. Finally, 
cambinol reduced TNF blood levels (P = 0.05) and increased survival (from 0% to 42%; P = 0.03) 
of mice injected with LPS.  
 
Conclusion: Cambinol has potent anti-inflammatory activity in vitro and in vivo. Although the 
molecular mechanisms by which cambinol interferes with innate immune responses remain to be 
identified, our data suggest that drugs targeting sirtuin activity could represent promising 
adjunctive therapy for the treatment of acute or chronic inflammatory disorders. 
 
Research supported by Swiss National Science Foundation. 
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Histone deacetylase inhibitors impair innate immune responses through the 
induction of the Mi-2/NuRD transcriptional repressor 
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Background: Histone deacetylase (HDAC) inhibitors are potent anticancer agents. Several HDAC 
inhibitors are currently being tested in phase II-III clinical trials in cancer patients, and two drugs of 
this class have recently been introduced in the clinic. We have previously shown that HDAC 
inhibitors impair innate immune responses in vitro and in vivo. The aim of this study was to identify 
the molecular mechanisms underlying these effects. 
 
Methods: Mouse bone marrow-derived macrophages and RAW 264.7 macrophage (in selected 
experiments transfected with Mi-2b siRNAs) were incubated for 1 h with the HDAC inhibitors 
trichostatin A (TSA) or valproate (VPA), and then stimulated for 15 min to 24 h with bacterial 
products (lipopolysaccharide and Pam3CSK4 lipopetide). The expression of cytokines, the 
activation of intracellular signalling pathways and the binding of transcription regulatory factors to 
DNA were analyzed by RT-PCR, ELISA, luminex, Western blotting and chromatin 
immunoprecipitation. 
 
Results: TSA and VPA inhibited cytokine (TNF, IL-6, IL-12p40, and IL-10) and chemokine (CCL2, 
CCL5, CCL8, CXCL2, CXCL10) mRNA and protein expression induced by microbial products in 
macrophages. Although TSA did not interfere with the activation of the intracellular signal 
transduction pathways (NF-kB, ERK1/2 and p38 MAPKs, IRF3 and STAT-1), it strongly impaired 
the recruitment of RNA polymerase II and NF-kB p65 to the promoter region of TSA-repressed 
repressed genes. TSA enhanced the expression and DNA binding activity of Mi-2b, the catalytic 
subunit of the Mi-2/NuRD complex which acts as a transcriptional repressor of pro-inflammatory 
gene expression. Moreover, siRNA-mediated silencing of Mi-2beta increased LPS-induced IL-6 
mRNA expression in RAW 264.7 macrophage. 
 
Conclusions: We describe a new molecular mechanism by which HDAC inhibitors impair 
cytokine production in macrophages through an increased expression and DNA-binding activity of 
the transcriptional repressor Mi-2b. Overall, our data identify an essential role for HDACs inhibitors 
in the regulation of the expression of innate immune genes and host defenses against microbial 
pathogens. 
 
Research supported by Swiss National Science Foundation. 
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IDENTIFICATION IN SITU 
 
 
1Verrier J., 1Bontems O., 1Fratti M., 1Monod M.  
 
 
Service of Dermatology and Venereology - CHUV1  
 
 
 
Background: Dermatophytes are the main cause of superficial mycoses. These fungi have the 
capacity to invade keratinized tissue of humans or animals to produce infections that are generally 
restricted to the corneocytes of the skin, hair, and nails. 
Statement of the problem: It is common to obtain negative results from fungal cultures of 
dermatological specimens where direct mycological examination showed fungal elements 
(≈30-40%). However, correct identification of the isolated dermatophytes from Tinea is important 
to choose the appropriate treatment. 
Objectives: To develop a rapid polymerase chain reaction – restriction fragment length 
polymorphism (PCR-RFLP) assay based on 28S rDNA that is able to identify dermatophytes 
species in positive dermatological samples.  
Results:  PCR-RFLP identification of dermatophytes in skin or hair allowed validation of the 
results obtained in culture. It was also possible to identify the infectious dermatophytes when 
direct hair/skin mycological examination showed fungal elements, but negative results were 
obtained from fungal culture. 
Conclusion: PCR methods may provide significant benefits in the rapid diagnosis of Tinea. First, 
there is an increase in sensitivity of dermatophytes identification when enough material is 
available. Secondly, identification of the infecting agent can be obtained in 24h with PCR-RFLP or 
sequencing, whereas results from fungal cultures can take 3–4 weeks.  
Keywords: dermatophytes, identification in situ, PCR-RFLP assay 
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Background: We previously reported that myeloid cells can induce mucosal healing in a mouse 
model of acute colitis. Promotion of mucosal repair is becoming a major goal in the treatment of 
Crohn’s disease. Our aim in this study is to investigate the pro-repair function of myeloid cells in 
healthy donor (HD) and Crohn’s disease patients (CD).  
 
Methods: Peripheral blood mononuclear cells (PBMC) from HD and CD patients were isolated 
from blood samples by Ficoll density gradient. Monocytic CD14+ cells were positively selected by 
Macs procedure and then differentiated ex-vivo into macrophages (Mφ). The repair function of 
PBMC, CD14+ monocytic cells and macrophages were evaluated in an in vitro wound healing 
assay.  
 
Results: PBMC and CD14+ myeloid cells from HD and CD were not able to repair at any tested 
cell concentration. Remarkably, HD Mφ were able to induce wound healing only at high 
concentration (105 added Mφ), but, if activated with heat killed bacteria, they were able to repair 
even at very low concentration. On the contrary, not activated CD Mφ were not able to promote 
healing at any rate, but this function was restored upon activation.  
 
Conclusion: We showed that CD Mφ in their steady state, unlike HD Mφ, are defective in 
promoting wound healing. Our results are in keeping with the current theory of CD as an innate 
immunodeficiency. Defective Mφ may be responsible to the mucosal repair defects in CD patients 
and to the subsequent chronic activation of the adaptive immune response. 
 
 
 
 
Immunity and Infectiology/IMI-24 
 
 
Immunotherapeutic strategies to induce vaccine-specific cytotoxic T 
lymphocytes (CTL) in mice bladder and tumor regression 
 
 
1Domingos-Pereira S., 1Decrausaz L., 1Bobst M., 1Jichlinski P., 1Nardelli-Haefliger D.  
 
 
Service d'urologie - CHUV1  
 
 
Introduction: Non musculo-invasive bladder cancer (NMIBC) can respond to immunomodulation as 
demonstrated by intravesical (ives) treatments with Bacillus Calmette-Guerin (BCG) after transurethral 
resections. Although quite effective, about one-third of patients fail to respond and/or suffer from side 
effects. Vaccines against tumor associated antigens (TAA) are able to eradicate tumors growing 
subcutaneously in animal models. However, it is yet unclear how to target vaccine-specific cell mediated 
immune responses to the bladder. Here we are investigating in mice a novel immunotherapeutic approaches 
that combines vaccines against TAA and local application of immunomodulators to increase local CTL 
responses. As the bladder is part of the immune mucosal network, we have examined whether mucosal 
immunization routes may better target vaccine-specific cell mediated immune responses to the bladder and 
induce local tumor protection. In parallel, we will examine how the local instillation of different 
immunostimulants may increase the vaccine-specific CD8 T cells responses locally in the bladder.  
Methods: Mice were immunized by different routes with an adjuvanted synthetic polypeptide vaccine 
encoding for a human papillomavirus oncogene (E7), as a model antigen. The specific immune response 
was investigated by tetramer staining (TetE7) and ex-vivo IFN-gamma ELISPOT. Bladder tumor regression 
was evaluated in an orthotopic murine model where tumor cells co-expressing E7 and luciferase (TC-1-luc) 
were instilled intravesically (ives) and followed with a Xenogen in vivo imaging system. Synthetic (CpG, 
Poly I:C) or bacterial (Ty21a or BCG) immunostimulants were used ives in combination with subcutaneous 
(s.c.) vaccination route, in order to increase vaccine-specific immune responses in bladder. 
Results: Comparison of s.c., intranasal (i.n.) and intravaginal (ivag) vaccinations showed that both sc and 
ivag routes were able to induce similar number of TetE7 CD8 T cells in the bladder mucosa, while s.c. 
immunization induced higher responses in the spleen. Interestingly, i.n. immunization did not induce 
detectable responses in the bladder. Orthotopic bladder cancer model with ives TC-1-luc instillation resulted 
in 85% tumor-take. Tumor protection assay in a prophylactic setting shows that a single vaccination by all 
three routes was able to efficiently protect the mice against a tumor challenge 8 days later, as well as at long 
term. In a therapeutic setting ivag vaccination route efficiently regressed established tumors (7/9), whereas 
s.c. vaccination route transiently regressed 8/9 tumors, though only 3 remained tumor free at long term. All 
the immunostimulants tested increased 5-30 fold the number of vaccine induced E7-specific CD8 T cells 
locally in the bladder, highest responses being obtained with live Ty21a bacteria. The effect of the 
immunostimulant was only local as it did not affect the vaccine-specific response in draining lymph nodes 
and in the spleen.   
Conclusion: Our results shows that both s.c. and ivag vaccination routes can efficiently induced 
vaccine-specific CD8 T cells able to both prevent and regress at least small established tumor in the 
bladder. S.c. vaccinaton in combination with ives application of immunostimulants significantly increase 
vaccine-specific CD8 T cells in the murine bladder. We anticipate that this will result in regression of larger 
bladder tumors, as we have shown in the case of genital tumors in mice. This represents a valuable 
immunotherapeutic strategy to investigate in NMIBC patients. 
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Background. Enterovirus (EV) is the most frequent cause of aseptic meningitis (AM). Lack of 
differentiation of self-limited EV AM from bacterial meningitis results in unnecessary antimicrobial 
therapy and prolonged hospitalisation. We assessed the impact of rapid PCR for detecting EV in 
cerebrospinal fluid (CSF) (GeneXpert EV assay, [GXEA]) on management of patients with 
suspected AM.  
Methods. Observational study in adult patients with AM defined by all of the followings: 1) 
headache plus fever and/or meningeal signs, 2) CSF pleocytosis and 3) negative bacterial 
cultures. Three periods were analyzed according to the use of EV PCR in addition to standard 
CSF tests: Period A = no PCR, Period B = home-made real-time PCR (a two-step reverse 
transcriptase TaqMan PCR using the ABI 7900 Detection system), and Period C = GXEA. 
Demographics, clinical and laboratory data were compared.  
Results. Eighteen AM patients in Period A, 25 in Period B and 22 in Period C were studied. 
Demographics, clinical presentation, and CSF parameters were similar in the 3 groups. EV was 
identified in CSF in 0/18 cases (0%) of Period A, 20/25 cases (80%) of Period B, and in 22/35 
cases (63%) of Period C. Median time to PCR result was 58h (15.5-118.5) in period B vs. 5.3h 
(3.5-20) in period C (p<0.001). Aciclovir was empirically administered in 50%, 36%, and 0% of 
patients in Period A, B, and C, respectively (p=0.001) and antibacterial therapy was started in 
67%, 60%, and 54% of cases. Duration of antibiotics was 3d (1-12), 1d (1-3), and 0.5d (single 
dose in all patients) in period A, B, and C, respectively (p<0.001). Median length of hospital stay 
was 96h (24-288) in period A, 48h (18-624) in period B, and 11h (5-28) in period C (p<0.001). 
Conclusions. Routine detection of enterovirus by PCR in cerebrospinal fluid of patients with 
suspected aseptic meningitis significantly reduces the use of empirical antimicrobial therapy and 
length of hospital stay. 
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Introduction: Oseltamivir phosphate (OP), the prodrug of oseltamivir carboxylate (OC; active 
metabolite), is marketed since 10 years for the treatment of seasonal influenza flu. It has recently 
received renewed attention because of the threat of avian flu H5N1 in 2006-7 and 2009-10 
A/H1N1 pandemics. However, relatively few studies have been published on OP and OC clinical 
pharmacokinetics. The disposition of OC and the dosage adaptation of OP in specific populations, 
such as young children or patients undergoing extrarenal epuration, have also received poor 
attention. An analytical method was thus developed to assess OP and OC plasma concentrations 
in patients receiving OP and presenting with comorbidities or requiring intensive care. 
Methods: A high performance liquid chromatography coupled to tandem mass spectrometry 
method (HPLC-MS/MS) requiring 100-µL aliquot of plasma for quantification within 6 min of OP 
and OC was developed. A combination of protein precipitation with acetonitrile, followed by dilution 
of supernant in suitable buffered solvent was used as an extraction procedure. After reverse 
phase chromatographic separation, quantification was performed by electro-spray ionization–triple 
quadrupole mass spectrometry. Deuterated isotopic compounds of OP and OC were used as 
internal standards. 
Results: The method is sensitive (lower limit of quantification: 5 ng/mL for OP and OC), accurate 
(intra-/inter-assay bias for OP and OC: 8.5%/5.5% and 3.7/0.7%, respectively) and precise 
(intra-/inter-assay CV%: 5.2%/6.5% and 6.3%/9.2%, respectively) over the clinically relevant 
concentration range (upper limits of quantification 5000 ng/mL). Of importance, OP, as in other 
previous reports, was found not to be stable ex vivo in plasma on standard anticoagulants (i.e. 
EDTA, heparin or citrate). This poor stability of OP has been prevented by collecting blood 
samples on commercial fluoride/oxalate tubes. 
Conclusions: This new simple, rapid and robust HPLC-MS/MS assay for quantification of OP and 
OC plasma concentrations offers an efficient tool for concentration monitoring of OC. Its exposure 
can probably be controlled with sufficient accuracy by thorough dosage adjustment according to 
patient characteristics (e.g. renal clearance). The usefulness of systematic therapeutic drug 
monitoring in patients appears therefore questionable. However, pharmacokinetic studies are still 
needed to extend knowledge to particular subgroups of patients or dosage regimens. 
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Objectives: Propionibacterium acnes is a low-virulent, facultative anaerobe organism, which is part of the normal skin 
flora. P. acnes typically causes infections associated with implants on which they grow in biofilms and manifest 
delayed (3-24 months after surgery). P. acnes is difficult to eradicate because of decreased antimicrobial susceptibility 
in the biofilm state. We tested antimicrobial activity against P. acnes biofilms on large-surface beads by measuring 
growth-related heat production (microcalorimetry). 
Methods: P. acnes (ATCC 11827) was used. The minimal inhibitory concentration (MIC) for daptomycin, rifampicin, 
levofloxacin and clindamycin was determined by Etest. P. acnes biofilm was formed on porous sintered glass beads 
(diameter 2mm, surface ~2.65m2) in reduced Brain Heart Infusion supplemented with 0.5% glucose (rBHI+g) at 37°C 
under anaerobic conditions without agitation. After 72 h, beads were washed in sterile normal saline trice and 
incubated in rBHI+g containing serial dilution of antimicrobials (or combinations) for 24 h. Beads were then washed as 
before and placed in 4ml rBHI+g. Recovering bacteria were detected by measuring heat production at 37°C for 5 
days. The minimal biofilm inhibition concentration (MBIC) was defined as the lowest antimicrobial concentration 
inhibiting heat production during 72 h. The minimal biofilm eradication concentration (MBEC) was determined as the 
lowest concentration showing no heat production during 5 days and absent growth on subsequently plated on blood 
agar plates. Experiments were repeated twice. 
Results: The MIC, MBIC and MBEC of tested antimicrobials are shown in Table 1. Rifampicin and clindamycin were 
most active against planktonic bacteria (MIC <0.5 µg/ml). In biofilm, 256x (for daptomycin) to 16,384x higher 
concentration (for clindamycin) were needed to inhibit growth of P. acnes. For eradication of P. acnes biofilms, 
rifampin was the most effective (MBEC 128 µg/ml). In combination at sub-MBIC concentrations, daptomycin and 
rifampin showed improved activity against biofilms (Figure 1).  
Conclusions: The activity of antibiotics was significantly decreased in P. acnes biofilms, especially for clindamycin. In 
combination, daptomycin and rifampicin showed an improved activity against biofilms. Microcalorimetry allowed the 
investigation of most promising antimicrobial combinations for in vivo experiments in a foreign-body infection animal 
model.  
Table 1. MIC, MBIC, MBEC and MBIC/MIC ratio of antimicrobials  
tested against  P. acnes biofilm 
Antibiotic MIC 
(µg/ml) 
MBIC 
(µg/ml) 
MBEC 
(µg/ml) 
MBIC/ MIC 
ratio 
Daptomycin 1 256-512 > 1024 256-512 
Levofloxacin 0.75 512-1024 >1024 341-682 
Clindamycin 0.125 > 1024 > 1024 >8192 
Rifampin 0.004 16-32 128  4000-8000 
 
 
 
 
 
Figure 1. Activity of daptomycin (DAP) and rifampin (RIF)  
alone and in combination against P. acnes biofilms  
on sintered beads evaluated by microcalorimetry. 
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Background. The optimal antimicrobial regimen enterococcal implant-associated infections has 
not been defined. We investigated the activity of daptomycin (DAP), vancomycin (VAN) and 
gentamicin (GEN) against E. faecalis in a foreign-body infection model. 
Methods. A guinea pig model with subcutaneously implanted cages was used. Infection was 
established by injection of 104 E. faecalis (ATCC 19433) in the cage. Treatment for 4 days with 
intraperitoneal DAP (1 x 40 mg/kg) or VAN (2 x 15 mg/kg), alone or combined with GEN (2 x 10 
mg/kg) was started 3 h (early biofilm) or 24 h (established biofilm) after infection. Animals were 
sacrificed 5 days after end of treatment, cages were removed and cultured in TSB for 48 h to 
determine the cure rate (%). 
Results. The MIC and MBC (broth macrodilution) was for DAP 1.25 and 5 µg/ml, for VAN 1 and 
>64 µg/ml, and 16 and 32 µg/ml, respectively. Figure shows cure rates of treatment regimens. 
DAP cured 33% of early (3 h) and 0% of established (24 h) biofilms, which was improved in 
combinations with GEN to 58% and 8%, respectively (p <0.05). 
Conclusion. DAP was more active against E. faecalis foreign-body infection than VAN, which was 
further improved by GEN. Delaying treatment from 3 h to 24 h, the cure rate was significantly 
reduced, highlighting the importance of early treatment of implant-associated infections.  
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Background: Aspergillus fumigatus (A. fumigatus) is an opportunistic pathogen that causes 
invasive aspergillosis (IA), a potentially fatal infection in onco-hematological patients. Toll-like 
receptors (TLRs) are key detectors of pathogens, which interact with adaptor proteins such as 
MyD88 or TRIF to trigger innate immune response.  While TLR2 and TLR4 were shown to 
influence innate immune response to A. fumigatus, the role of TLR1 and TLR6 has not been 
established. The aim of this study was to determine the role of TLR1 and TLR6 in the immune 
response to A. fumigatus in mice and in human. 
Methods: Bone marrow derived macrophages (BMDMs) from wild type (WT), TLR1, TLR2, TLR4, 
TLR6, MyD88 and TRIF-deficient mice were stimulated with two strains of 2% PFA inactivated A. 
fumigatus, a wild-type strain (CBS144-89) and a strain deficient in the RodA protein, known to be 
highly immunogenic (ΔrodA-47). CXCL-2 and IL-12p40 expression and secretion were measured 
after 4h by RT-PCR and after 24h by ELISA. In vivo expression of cytokines in response to 107 
CFU of A. fumigatus ΔrodA-47 and fungal burden in lungs of intranasally injected WT and 
TLRs-deficient mice were assessed by RT-PCR and lungs plating, respectively. HEK293T cells 
were transiently transfected with 50 ng of ELAM-1 plasmid, together with 5 ng of a pRL-TK 
plasmid and 10 ng of human or murine MD2 and TLR4 or CD14 together with TLR2 and TLR1 or 
TLR6. Twenty-four hours after transfection, cells were stimulated with 107 CFU of A. fumigatus WT 
and Δrod A and appropriate controls. Luciferase and Renilla Luciferase activities were measured 4 
hours latter using the Dual-LuciferaseTM Reporter Assay System (Promega Corporation, Madison 
USA). Results were expressed as relative Luciferase activity (the ratio of Luciferase to Renilla 
Luciferase activity). 
Results: The expression and secretion of CXCL-2 and IL-12p40 by BMDMs in response to both 
strains of A. fumigatus were strongly reduced in cells from mice deficient in TLR1, TLR2, TLR4, 
TLR6 and MyD88, but not in TRIF, as compared to cells from WT mice. In vivo expression of 
CXCL-2 and CXCL-1 in response to A. fumigatus ΔrodA-47 was abolished in lungs from TLR1, 
TLR2, TLR4, TLR6 and MyD88-deficient mice compared to WT mice. In vivo fungal burden was 
higher in lungs collected from TLR1, TLR2, TLR4, TLR6 and MyD88-deficient mice, but not from 
TRIF KO mice, compared to WT mice. A. fumigatus induced NF-κB activation in cells transfected 
with TLR4 from both mice and human, TLR2/TLR1 combinations from both mice (mTLR2/mTLR1) 
and humans (hTLR2/hTLR1), as well as TLR2/TLR6 combination from mouse (mTLR2/mTLR6), 
but not human (hTLR2/hTLR6). 
Conclusion: These data suggest that TLR1 is involved in the innate immune detection of A. 
fumigatus in human and mouse, while TLR6 seems to play a role in mouse but not in human. They 
confirm the role of TLR2 and TLR4, and show a role for MyD88, but not TRIF, both in human and 
mice, in this detection. 
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Introduction: Myelin oligodendrocyte glycoprotein (MOG) is a serious potential target antigen in 
MS, as MOG-specific antibodies and T cell responses were detected in the blood of MS patients. 
Another myelin protein, the myelin-associated oligodendrocyte basic protein (MOBP), was 
reported to cause experimental autoimmune encephalomyelitis (EAE) in susceptible mice and 
MOBP-specific cellular T cells were found in MS patients. On the other hand, EBV has been 
repeatedly associated with MS. We and others have shown that humoral and cellular immune 
responses are increased in patients with MS as compared to control subjects. Furthermore, recent 
studies demonstrated the existence of T cells in MS patients which recognize both EBV and 
myelin proteins, revealing a role for viral-specific T cells in the autoimmunity processes. Thus, we 
analysed the MOG- and MOBP-specific T cell responses in a large population of MS patients and 
controls and study the putative cross-reactivity between myelin proteins and EBV. 
 
Methods: We enrolled 78 patients with MS, 24 patients with other neurological diseases (OND) 
and 20 healthy controls (HC) and analysed their MOG-, MOBP- and EBV-specific T cell responses 
by proliferation and ELISPOT assays. Cross-reactivity between MOG and EBV peptides was 
tested with a crossed functional CFSE Cytotoxic T Lymphocyte (CTL) assay in a subset of study 
subjects. 
 
Results: We found that a fraction of the subjects have a myelin-specific cellular immune response 
(36% for MOG and 14% for MOBP) with no difference between the different groups of subjects. 
There was no correlation between myelin- and EBV-specific T cell responses in the proliferation or 
ELISPOT assay. However, by crossed CTL assay, we found that 2/16 MS patients and 0/4 control 
subjects who had EBV-specific T cells that recognized MOG-specific targets. 
 
Conclusions: Myelin-specific T cells are not increased in MS patients as compared to controls. 
However, there may be a molecular mimicry between EBV and MOG in some MS patients.  
 
This work supported by the Swiss National Foundation, the Biaggi Foundation and the Swiss 
Society for MS. 
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The glucocorticoid-induced leucine zipper (GILZ) is a X-linked transcription factor and was 
originally described as a dexamethasone-induced transcript in murine thymocytes. It is a member 
of the transforming growth factor b1-stimulated clone 22 domain (TSC22D) family. GILZ is known 
as TSC22D3 and described as 4 isoforms. GILZ is widely expressed and an important role in 
immunity, adipogenesis, renal sodium handling has been proposed. 
Using the Cre-Lox recombination technique, we generated mice constitutively lacking the vital 
region of the GILZ gene, thus abolishing the function of this gene in mice. The expression of GILZ 
mRNA transcripts and protein is completely abolished in all the tissues tested from knockout mice. 
Knockout mice are viable, but the males are sterile and present a severe testis hypoplasia. 
Although different processes in inflammation and immune system have been tested, only minor 
defects were observed. Changes in fat metabolism and adipogenesis are observed with age. 
Following sodium and water deprivation experiments, water and salt homeostasis is conserved. 
Sterility of knockout males is associated with a severe testis dysplasia. Generally, seminiferous 
tubules are smaller and the number of Sertoli and germ cells is reduced while apoptosis is 
increased as evidenced by TUNEL staining. The interstitial Leydig cell population is augmented, 
and higher plasma FSH and testosterone levels are found. 
In summary, these new GILZ-deficient mice allow to proof in vivo its implication in various 
glucocorticoid-dependent and -independent biological processes. 
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The various species of the Chlamydiales order differ in their ability to infect phagocytic cells. 
Waddlia chondrophila infects macrophages and replicates within them. Parachlamydia 
acanthamoebae infects macrophages and causes a rapid apoptosis of the host cell without 
productive infection. Macrophages are refractory to Chlamydia pneumoniae infection. Since D. 
discoideum is used as a model amoebae to determine basal functions of the phagocytic 
machinery, we wanted to investigate the role of the Nox genes in the outcome of various 
chlamydial infections.  The model organism D. discoideum encodes three members of the 
NADPH oxidase (Nox) family. NoxA and NoxB are homologous to Nox2, an enzyme responsible 
for the respiratory burst in phagocytic cells. NoxC is homologous to Nox5 that contains two 
EF-hand domains. D. discoideum does not encode for any homologues to DUOX the third 
member of the Nox family. So far the role of these Nox proteins has only been studied in the 
development of the multicellular structure of D. discoideum, the fruiting body.  Preliminary results 
with W. chondrophila show a resistance to infection independent on the presence of Nox genes. 
Upon infection of both the wild-type and Nox mutants the bacteria enter the cell, but rapidly the 
number of infected cells decreases. Even though the infected cells were observed over an extend 
period of time the replication of W. chondrophila was very low. Immunofluorescence observations 
showed that the bacteria differentiate from elementary bodies to reticulate bodies, but then their 
replication stops. Some reticulate bodies even become large aberrant bodies. So far the absence 
of Nox genes seems not to influence the resistance of D. discoideum to infection. Further 
investigations with the other members of the Chlamydiales will allow to better understand the role 
of Nox genes in the phagocytic cells. 
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Background: It has long been considered that the progression rate of liver fibrosis among chronic 
HCV patients is not influenced by the viral genotype. However, recent studies suggested an 
association between viral genotypes 3 and rapid progression. We performed a systematic review 
and meta-analysis of published studies evaluating the association between HCV genotypes and 
fibrosis progression. 
 
Methods: We searched PubMed, Embase and ISI Web of Knowledge databases for studies on 
treatment naïve HCV infected-adults with an estimated date of HCV infection, at least one liver 
biopsy, and an estimated fibrosis progression rate (FPR). A random-effect model was used to 
derive FPR among the different HCV genotypes. 
  
Results: Eight single biopsy studies (3182 patients, mean/median duration of infection ranging 
from 9-21 years) and 8 paired biopsies studies (678 patients, mean interval between biopsies 2-12 
years) met the selection criteria. Most patients included in the studies were males (62%), the most 
frequent ethnicity was Caucasian (95%, data available in 5 studies) and the mean age was 42 
years. The most frequent routes of infection were intravenous drug use (41%) and blood 
transfusion (31%). The odds ratio for the association of genotype 3 with accelerated fibrosis 
progression was 1.52 (95% CI 1.12-2.07, P=0.007) in single biopsy studies. The odds ratio for the 
association of genotype 3 with fibrosis progression was 1.37 (95% CI 0.87-2.17, P=0.17) in paired 
biopsy studies.  
Conclusion: Viral genotype 3 was significantly associated with faster fibrosis progression when 
analyzing single biopsy studies. There was a trend toward the same direction when analyzing 
paired biopsy studies. Paired biopsies studies may have reduced power to detect such 
associations, due to an important indication bias, small sample size and use of arbitrary 
dichotomization criteria to assess progression. This observation may have important 
consequences for the decision to start therapy among genotype 3-infected patients. 
 
Contact Information:  
Pierre-Yves Bochud, Infectious Disease Service, Department of Medicine, Rue du Bugnon 46, 
1011 Lausanne, Switzerland, mail: pierre-yves.bochud@chuv.ch, Phone: +41213144379 
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The properties of CD8 T-cells required for protection from infectious disease and cancer are only 
partially characterized, and only limited data is available regarding T-cell clonotypes. It has been 
proposed that dominant T-cell clonotypes may have higher protective potential than their 
non-dominant counterparts. Our objectives were to assess memory and effector functions, stage 
of differentiation and clonotype selection of tumor-reactive T lymphocytes following peptide 
vaccination in melanoma patients. We also characterized dominant versus non-dominant 
clonotypes to further understand the in vivo function of these T-cells based on their prevalence. 
Using a novel single-cell approach for simultaneous ex vivo molecular and functional analysis, we 
report the preferential selection and expansion of several tumor-specific co-dominant clonotypes 
of intermediate to high frequencies, irrespective of whether native or analog peptide was used for 
vaccination. These clonotypes made up 40 to 95% of the differentiated “effector-like” T-cells, but 
only 25% of the less-differentiated “effector-memory” cells. Both subsets also contained 
non-dominant T-cell clonotypes, but these were significantly more frequent in the 
less-differentiated cells. Thus, cell differentiation was clonotype-dependent. Surprisingly however, 
the acquisition of memory and effector T-cell properties was clonotype independent, as we found 
similar functional profiles in dominant and low/non-dominant T-cell clonotypes. In contrast to 
analog peptide vaccination, native peptide vaccination induced T-cell functions that were more 
comprehensive, with more pronounced effecter functions combined with memory cell properties. In 
summary, this study reveals that T-cell functions are determined primarily by the antigen and the 
stage of T-cell differentiation, but are similar in dominant and non-dominant clonotypes 
participating in a CD8 T-cell response. The identified clonotypic basis of T-cell responses 
contributes to the rational development of vaccines. 
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Objectives : The postantibiotic effect (PAE) and the postantibiotic sub-minimal inhibitory 
concentration effect (PA-SME) represent important pharmacodynamic parameters for the 
establishement of an optimal antibiotic dosing regimen. The current gold standard for the 
determination of PAE and PA-SME is the viable counts method, which is laborious and time 
consuming. We developed a new method based on the measurement of bacterial growth-related 
heat production to determine the PAE and the PA-SME. 
Methods : All experiments were performed with either a methicillin-sensitive (SA1) or 
methicillin-resistant (SA3) Staphylococcus aureus. Exponential growth cultures (OD600 = 0.3) were 
exposed to 10 times the minimal inhibitory concentration (MIC) of daptomycin for 1 hour. At the 
end of exposure, antibiotic was removed by dilution. Microcalorimetry was performed on a 
48-channel isothermal microcalorimeter (TAM III, TA Instruments, USA) by adding 30 μl of the 
antibiotic-exposed cultures into ampoules containing 3 ml of Mueller Hinton broth. For PA-SME 
determination, subinhibitory concentrations of the drug were added to the ampoules after antibiotic 
removal. Heat production (in μW) was followed at 37 °C. Duration of the PAE and PA-SME was 
defined as the time required for cultures to reach a 10 μW heat flow threshold. All experiments 
were performed in triplicate. 
Results : The PAE and PA-SME (in hours) of the tested strains towards daptomycin determined 
either by microcalorimetry (present work) or by conventional method (Pankuch et al. AAC, 2007) 
are shown in the Table 1. 
Conclusion : Microcalorimetry is a new method that allows a simple and precise determination of 
the PAE and the PA-SME. In comparison with the gold standard, this method is less labor-and 
time-consuming. Further experiments will aim at determining the PAE and PA-SME of various 
drug/pathogen combinations. 
 
Table 1. PAE and PA-SME of daptomycin against S. aureus strains  
   Determination by microcalorimetry    Determination by conventional method 
                   
 
PAE    PA‐SME 
(0.2x MIC) 
PA‐SME
(0.3x MIC)
PA‐SME 
(0.4x MIC) 
  PAE    PA‐SME 
(0.2x MIC) 
PA‐SME
(0.3x MIC)
PA‐SME 
(0.4x MIC)
                   
S. aureus strain                   
SA1 (MSSA)  4.27 ± 0.87  5.16 ± 1.19  8.46 ± 4.98 18.71 ± 8.48    1.2‐4.2 1.2‐4.3  10.1‐>12 10.6‐>12 
SA3 (MRSA)  5.28 ± 0.69  6.2 ± 1.02  8.63 ± 2.44 18.29 ± 12.37   4.8‐7.6 >12  >12  >12 
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Background: Recurring low-grade bacteremia following tooth brushing, or even mastication, is 
likely to cause infective endocarditis (IE) in patients at risk. This was recently confirmed in a new 
animal model of IE, in which prolonged low-grade inoculation of S. aureus was as infective as 
bolus injection of large bacterial numbers (> 104 CFU; Entenza et al. ICAAC 2009). Since this 
model mimics more closely the human situation, it is relevant to use it to reassess the role of S. 
aureus virulence factors involved in IE. Here used it to study the role of FnBPA, which was 
expressed individually in surrogate Lactococcus lactis. 
Methods: Rats with sterile aortic vegetations (Veg) were inoculated with 106 or 107 CFU of L. 
lactis WT (lacking surface adhesins) or recombinant L. lactis expressing FnBPA (Que et al. IAI 
2001; Que et al. JEM 2005). Identical inoculum sizes of each strain were given by continuous i.v. 
infusion, at a rate of 0.0017 ml/min over 10 h. Bacteremia levels 2 h after inoculation [expressed 
as mean (range) CFU/ml of blood] and Veg infection 24 h later were determined. 
Results:  
Inoculum Strain Bacteremia 
(CFU/ml) 
Infected veg/total 
(%) 
106 CFU L. lactis WT 7 (2-18) 4/14 (28,5) 
 L. lactis FnBPA 12 (0-40) 9/12 (75) * 
107 CFU L. lactis WT 267 (1-360) 9/18 (50) 
 L. lactis FnBPA 39 (0-100) 18/19 (95)* 
* P<0.05 vs L. lactis WT 
 
Conclusions: Recombinant L. lactis expressing FnBPA were more infective parent L. lactis WT in 
this realistic low-grade inoculation model. This confirms FnBPA as a critical virulence factor in IE, 
and as potential target for andi-adhesin strategies. Reassessing the role of other virulence factors, 
such as that of fibrinogen-binding protein (ClfA), is currently in progress. 
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Background: Hepatitis B infection among HIV-infected patients is more frequent than in the 
general population, and associated with an increased severity, making vaccination particularly 
important. We assessed the impact of a nurse intervention over a 3.5-year period (2007-2010) on 
hepatitis B (HBV) immunity in patients from the Lausanne center of the Swiss HIV Cohort Study 
(SHCS). 
Methods: All participants from the SHCS in the Lausanne center with a negative AgHbs and 
anti-HBc followed between 2007 and 2010 were included. Non immune patients (anti-HBs < 10 
IU/L) and patients with unknown immunity were eligible for nurse intervention, consisting of (1) 
documenting HBV serostatus in all patients with previously missing information, (2) providing 
vaccination (3 doses with a minimal interval of 1 and 6 months) to all non-immune patients, (3) 
measuring vaccination effectiveness ≥ 1 month after the 3rd dose and (4) providing a second 
course of vaccination to non-responders (anti-HBs < 10 IU/L). 
Results: The study included 245 patients, of whom 169 were included in the intervention. The 
number of patients with undocumented HBV serostatus before intervention declined from 40 
(16%) to 1 (1%) (P<0.001), the number of patients with immunity increased from 76 (31%) to 178 
(73%) (P<0.001), and 2 patients categorized as non-immune before intervention acquired HBV 
infection.   
Conclusions: HBV immunity in the HIV population is insufficient in Switzerland and can be 
significantly improved by nurse intervention. 
 
 
 
 
 
Immunity and Infectiology/IMI-38 
 
 
Subversion of the host cell’s innate immune defense by human pathogenic 
arenaviruses 
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A hallmark of fatal arenavirus infections in humans is the inability of the patient’s innate immune 
system to contain the virus resulting in uncontrolled infection, shock and death. The nucleoprotein 
(NP) of the prototypic arenavirus lymphocytic choriomenengitis virus (LCMV) was shown to 
counteract the host type I interferon (IFN) response by inhibiting activation of the IFN regulatory 
factor 3 (IRF3). In this study we show that the NPs of different arenaviruses (LCMV, Lassa virus, 
Junin virus, and Tacaribe virus) block signaling via the RNA-sensing retinoic acid-inducible gene 
(RIG-I) helicase. Arenavirus NPs intercept signal transduction leading to IRF3 activation 
downstream of the mitochondrial-bound CARD protein Cardif (IPS-1/MAVS/VISA). Using a 
co-immunoprecipitation approach, our preliminary experiments show that arenavirus NPs interact 
with one of the kinases involved in RIG-I/Cardif-mediated activation of IRF3, IKKε, but not with the 
closely related kinase TBK1. The interaction of NP with IKKε may interfere with the 
phosphorylation of IRF3, which is an essential step in IRF3 activation and type-I IFN induction. 
Moreover, the specific interaction with IKKε, but not TBK1, is striking and suggests selective 
perturbation of some, but not other pathways involved in innate anti-viral defense by arenaviruses. 
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Lymphodepletion by short-term chemotherapy does not alter the highly stable 
and persistent EBV specific CD8 T cell repertoire 
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Protective T cell responses against persistent viruses like Epstein-Barr virus in healthy individuals are 
characterized by a remarkable stability of the T cell receptor (TCR) clonotypic repertoire, with highly 
preserved clonotype selection and persistence over time. Here, we extended recent work to the study of 
EBV-specific CD8 T cell responses in melanoma patients treated by short-term chemotherapy for transient 
lymphodepletion, followed by adoptive cell transfer (ACT) and immune reconstitution for cancer therapy. 
After this treatment, we observed increased proportions of virus-specific T cells in 3/5 patients, 
accompanied by a more differentiated phenotype (EMRA/CD28neg), compared to specific cells of healthy 
individuals. Yet, similarly to healthy donors, clonotype selection and composition of virus-specific T cells 
varied along the pathway of cell differentiation, with some clonotypes that were selected with late 
differentiation, while others were not. After treatment, we did not observe novel dominant clonotypes, likely 
related to absence of EBV reactivation measured as viral load levels by quantitative PCR in PBMCs and 
antibody levels in plasma samples. Furthermore, public TCR BV signatures were frequently found within T 
cell clonotypes that dominated the repertoires of patients, in line with those observed in healthy individuals. 
Our findings indicate that even in situations where the immune system is strongly challenged such as 
following lymphodepletion and homeostatic repopulation, cytotoxic T cells specific for EBV remain strikingly 
stable in terms of clonotype selection and composition along T cell differentiation. We are currently 
characterizing the clonotype selection and gene expression profiles of single EBV-specific CD8 T 
lymphocytes sorted ex-vivo in one patient who underwent two cycles of lymphodepletion with escalading 
doses of chemotherapy over one-year interval. Observations made from this setting will provide additional 
insight into the degree of stability of virus specific T cells, and changes in the expression levels of genes 
important for cytolytic function and long-term survival of T cells. 
This work is supported by the Swiss National Center of Competence in Research (NCCR) Molecular 
Oncology, and the Swiss National Science Foundation. 
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Aim 
The aim of this study was to determine the seroprevalence of Hepatitis E virus (HEV) among blood 
donors in Switzerland. 
Background 
HEV has emerged as a food-borne disease in various developed countries, transmitted mainly 
through pork meat. Cases of transmission through blood transfusion have been reported. Recent 
studies revealed seroprevalence rates of 13.5%, 16.6% and 20.6% among blood donors in 
England, France and Denmark, respectively.  
Methods / Materials 
We analyzed 550 consecutive blood donor samples collected in the canton of Vaud in Switzerland 
for the presence of anti-HEV IgG (MP Diagnostics HEV ELISA). For each donor, we obtained the 
following variables: age, sex and alanine aminotransferase (ALT) values. 
Results 
The study panel was composed of 332 men (60.4 %) and 218 women (39.6%). Overall, anti-HEV 
IgG was found in 27 of 550 samples (4.9%). The seroprevalence was 5.4% (18/332) in men and 
4.1% (9/218) in women. The presence of anti-HEV IgG was not correlated with age, gender or 
ALT values.  
Conclusions 
Compared with other European countries, the HEV seroprevalence among blood donors in 
Switzerland is low. Possible explanations include 1) the strict regulation of animal and meat 
imports and 2) the sensitivity of commercial tests used. 
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Milk fat globule-EGF factor 8 (MFG-E8) is a secreted glycoprotein that is expressed in breast 
carcinomas and is present in the serum of patients with aggressive breast cancer. By performing a 
meta-analysis of publicly available gene expression data of breast cancer biopsies we have found 
that MFG-E8 is highly expressed in breast cancer and its expression is significantly associated 
with low levels of ErbB2 and of Estrogen receptor. We have then confirmed MFG-E8 expression in 
a series of breast cancer biopsies by immunohistochemistry analysis. To investigate the function 
of MFG-E8 we have overexpressed it in non-transformed mouse mammary epithelial cells 
NMuMG. We have observed that MFG-E8 increases in vitro proliferation and 
anchorage-independent growth of NMuMG cells and it promotes their proliferation and branching 
in Collagen I gels. Moreover, overexpression of of MFG-E8 in mouse mammary carcinoma cells 
that have low endogenous levels of the protein promotes their in vivo growth when injected 
orthotopically in immunosuppressed mice. In line with these results, we have also found that 
MFG-E8 downregulation enhances the epithelial phenotype of mammary carcinoma and 
Ras-transformed mammary cells, and decreases the in vivo growth of the latter. In addition, 
expression of a mutated version of MFG-E8 unable to bind integrins decreases in vivo 
tumorigenicity of mammary carcinoma cells. These results demonstrate that MFGE8 promotes 
mammary gland carcinoma growth in vivo and and identify this molecule as a potential therapeutic 
target in breast cancer. 
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Background: Susceptibility testing of mycobacteria is time-consuming and not well standardized. 
We evaluated a new method for rapid detection and susceptibility testing of mycobacteria by 
real-time measurement of their growth-related heat production in comparison with the standard 
microbroth dilution method. 
Methods: A clinical isolate of M. abscessus was used. MIC was determined by microbroth dilution 
method after 120 h-incubation. Microcalorimetry was performed by adding 50 µl containing 2 ± 0.7 
x107 CFU/ml (= 1 ± 0.5 x 106 CFU/ampoule) M. abscessus on Middlebrook 7H10 agar 
supplemented with 10% OADC. For susceptibility testing, serial two-fold antibiotic dilutions were 
added to agar. Heat production was measured at 37°C and defined positive at 5 µW. The minimal 
heat inhibition concentration (MHIC) was defined as the lowest concentration delaying the heat 
detection (compared to growth control) for 24 h. Experiments were performed in duplicate. 
Results: The mean detection time of M. abscessus without antibiotics was 12.8 h (range, 
10.4-15.2 h), reaching a peak of 109 µW (range, 104.8-114.1 µW) after 62.9 h (range, 60.8-65.0 
h). With antibiotics, the heat production was delayed proportionally to antibiotic concentration. The 
MHIC / MIC were (µg/ml): 2 / 4 (clarithromycin), 4-8 / 8 (amikacin), 12 / 8 (linezolid) and 2 / >4 
(ciprofloxacin). 
Conclusion: Microcalorimetry allowed rapid detection (within 1 day) and susceptibility testing 
(within 2 days) of M. abscessus. The MHIC correlated with MIC values within one two-fold dilution, 
except for ciprofloxacin. Microcalorimetry might be extended to other mycobacteria, including 
slow-growing such as M. tuberculosis. This method has the potential to accelerate the current 
diagnosis and antibiotics susceptibility testing of mycobacteria. 
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Serine proteases are involved in the regulation of many biological processes. Their activities are 
controlled by different specific inhibitors. Any alteration of this balance may result diseases. 
CAP1/Prss8 is a serine protease involved in the physiology of several organs including the skin. In 
our study, we have used an in vitro Xenopus oocyte assay where we can test the effect of 
potential inhibitory candidates on CAP1/Prss8 induced ENaC-mediated sodium currents. Using 
this technique, a specific CAP1/Prss8 inhibitor has been identified. To verify whether this inhibition 
can occur also in vivo, we have generated mice transgenic for CAP1/Prss8 and mice transgenic 
for this inhibitor in the skin. Animals transgenic for CAP1/Prss8 exhibit a scaly skin phenotype, an 
increase in epidermal thickness and an excessive loss of water through the skin. Strikingly, this 
phenotype can be prevented in double transgenic mice that over-express both CAP1/Prss8 and its 
inhibitor. Therefore, we show that skin abnormalities caused by CAP1/Prss8 over-expression can 
be abolished when its inhibitor is also co-expressed. In conclusion, CAP1/Prss8 inhibition could be 
confirmed in an in vivo model as well showing the importance of a controlled CAP1/Prss8 balance 
expression for the normal skin physiology. 
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Sunburn, an acute inflammatory response to UVB-induced epithelial skin injury represents a 
clinical marker for non-melanoma skin cancer (NMSC) risk. Here we investigated the role of CD1d, 
a MHC class-1-like receptor for lipid antigen, in sunburn development. We show that sunburn, 
signified by cutaneous tissue injury and inflammation, is abolished in CD1d-/- mice compare to wt 
mice. In epidermal tissues, the activation of NKT cells by CD1d-lipids has an important role in the 
regulation of innate and adaptive immune responses. We thus investigated if CD1d has an NKT 
cell-independent signaling role in human and mouse keratinocyte in response to UVB. We 
analyzed the release of pro-inflammatory cytokines in normal and CD1d-deficient keratinocyte 
after different doses of UVB radiation and indentify cell signaling pathways regulated by CD1d in 
an UVB-time and –dose dependent manner. In mouse and human epithelial cells, CD1d is critical 
for the expression of many genes that promote inflammation and skin tumor development. In 
summary, our findings identify an NKT cell-independent signaling role for CD1d in regulating the 
response of keratinocyte to UVB. 
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Introduction : Immunity in the reproductive tissues of postmenopausal women is poorly 
understood. SLPI (Secretory leukocyte protease inhibitor), a multifunctional antimicrobial protein 
expressed at mucosal surfaces, is thought to play a key role in infectious and inflammatory 
contexts. The  aim of this study was to measure SLPI production along the female reproductive 
tract in postmenopausal women with and without hormonal treatment. We additionally examined 
ER alpha expression in these tissues as it is the main receptor through which oestrogen is thought 
to signal in this environment. 
Methods : SLPI and estrogen receptor alpha mRNA expression was quantified using realtime 
PCR and protein was quantified using an ELISA or Western blot. SLPI cellular localisation was 
shown using Immunohistochemistry. 
Results : SLPI tissue expression was highest in the endocervix and lowest in the vagina. SLPI is 
prominently expressed by epithelial cells. 
SLPI expression was decreased in the ectocervix of women under hormonal treatment and 
increased in the vagina, while production in the endocervix and endometrium remained 
unchanged. ER alpha expression correlated with SLPI expression in general, with a differential 
regulation being observed in vaginal tissue. 
Conclusion : We demonstrate a compartmentalised expression of this antimicrobial protein and 
hormone receptor along the female reproductive tract in postmenopausal women and that 
expression is altered after hormonal administration. 
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CD4 T cell help is required for the generation and maintenance of long-lasting, robust cytolytic T 
lymphocyte (CTL) responses for many antigens. Here, patients were vaccinated with a virus like 
particle (VLP) linked, long Melan-A peptide containing the immunodominant Melan-A26-35 epitope 
with an introduced amino acid exchange for improved HLA-class I binding. We previously reported 
on the vaccination-driven CTL response in five of six patients based on ex vivo analysis of 
Melan-A-multimer specific CD8 T cells. Now, we found that four of these five patients also elicited 
a CD4 T cell response to the vaccine peptide, but the amino acid exchange greatly reduced or 
impeded recognition of the natural counterpart. So far, one of those responses was characterized 
in detail and revealed that repeated vaccinations induced a Th1 dominated response to the 
vaccine peptide and, to an even higher extent, to the VLP derived peptides. Vaccination also 
drove the expansion of CD4 T cells specific for the natural Melan-A peptide, but their functional 
profile was Th2 biased. These results may already suggest that peptide vaccination protocols 
should include strong, natural CD4 T cell epitopes that maximally support sustained polyfunctional 
CD8 T cell responses. 
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Non-invasive assessment of coronary artery disease progression using 
magnetic resonance imaging (MRI) 
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Cardiovascular disease is still the 
leading cause of death in industrialized 
nations. According to the AHA statistical 
update in 2010, more than 50% if these 
deaths are attributable to coronary heart 
disease in the United States. The 
current gold standard for the 
assessment of coronary artery disease 
is x-ray angiography. However, early 
atherosclerosis progression that 
precedes luminal narrowing cannot 
easily be identified with this test, and 
repeated studies aimed at guiding and 
monitoring therapy in a low risk 
population cannot ethically be justified 
due to invasiveness and x-ray exposure. 
For these reasons, a non-invasive, safe 
and repeatable means that provides 
information about both early 
atherosclerosis progression and luminal 
disease would not only significantly 
advance diagnosis but also therapy. In 
theory, magnetic resonance imaging (MRI) fits that profile perfectly since a high soft tissue 
contrast can be obtained without ionizing radiation and with relatively high spatial and temporal 
resolution. While significant technical challenges exist for imaging the small and constantly moving 
coronary arteries, advanced methods still permit the assessment of coronary endothelial 
dysfunction, the quantification of positive arterial remodeling of the coronary vessel wall, 
characterization of plaque components using targeted contrast agents, and the identification of 
proximal luminal coronary artery disease. Therefore, MRI does not only have the ability to 
characterize different stages of the atherosclerotic cascade, but it also offers novel biological 
insights in the local progression of coronary disease. 
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Only few cases of classical phenylketonuria (PKU) in premature infants have been reported. 
Treatment of these patients is challenging due to the lack of a phenylalanine-free amino acid 
solution for parenteral infusion. The boy was born at 27 weeks of gestation with a weight of 1000 g 
(P10). He received parenteral nutrition with a protein intake of 3 g/kg/day. On day 7 he was 
diagnosed with classical PKU (genotype IVS10-11G>A/IVS12+1G>A) due to highly elevated 
phenylalanine (Phe) level in newborn screening (2800 micromol/L). His maximum plasma Phe 
level reached 3696 micromol/L. Phe intake was stopped for 4 days. During this time the boy 
received intravenous glucose and lipids as well as little amounts of Phe-free formula by a 
nasogastric tube. Due to a deficit of essential amino acids and insufficient growth, a parenteral 
nutrition rich in branched-chain amino-acids and relatively poor in Phe was added, in order to 
promote protein synthesis without overloading in Phe. Under this regimen, Phe plasma levels 
normalized on day 19 when intake of natural protein was started. The boy has now a corrected 
age of 2 years. He shows normal growth parameters and psychomotor development. Despite a 
long period of highly elevated Phe levels in the postnatal period our patient shows good 
psychomotor development. The management of premature infants with PKU depends on the 
child’s tolerance to enteral nutrition. It demands an intensive follow-up by an experienced team 
and dedicated dietician. Appropriate Phe-free parenteral nutrition would be necessary especially in 
case of gastro-intestinal complications of prematurity. 
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Glutaryl-CoA dehydrogenase (GCDH, EC 1.3.99.7) deficiency, known as glutaric acidemia type I, 
is one of the more common organic acidurias. To investigate the role of this pathway in different 
organs we studied the tissue-specific expression pattern of rat Gcdh. The open reading frame 
cDNA of the rat Gcdh gene was cloned from rat brain mRNA by RT-PCR, allowing the synthesis of 
digoxigenin-labeled in situ hybridization (ISH) riboprobes. Gcdh mRNA expression was analyzed 
by ISH on cryosections of adult rat brain, kidney, liver, spleen and heart muscle, as well as on E15 
and E18 rat embryos. Gcdh was found expressed in the whole rat brain, almost exclusively in 
neurons. Gcdh was absent from astrocytes but expressed in rare oligodendrocytes. Strong Gcdh 
expression was found in liver and spleen, where expression appears predominant to lymphatic 
nodules. In kidney, the highest Gcdh expression is found in the juxtamedullar cortex (but not in 
glomerula), and at lower levels in medulla. Heart muscle was negative. During embryonic 
development, Gcdh was found well expressed in liver, intestinal mucosa and skin, as well as at 
lower levels in CNS. Further studies are ongoing to provide evidence on the presence of the entire 
pathway in CNS in order to understand the mechanisms leading to neurotoxicity in glutaric 
aciduria. The high expression of Gcdh in kidney may explain why certain patients with residual 
enzyme activity are low excretors at the urine metabolite level.  
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Malonate, methylmalonate and propionate are potentially neurotoxic metabolites in 
branched-chain organic acidurias. Their effects were tested on cultured 3D rat brain cell 
aggregates, using dosages of 0.1, 1.0 and 10.0 mM with a short but intense (twice a day over 3 
days) and a longer but less intense treatment (every 3rd day over 9 days). CNS cell-specific 
immunohistochemical stainings allowed the follow-up of neurons (axons, phosphorylated 
medium-weight neurofilament), astrocytes (glial fibrillary acidic protein) and oligodendrocytes 
(myelin basic protein). Methylmalonate and malonate were quantified by tandem mass 
spectrometry. Tandem mass spectrometry analysis of harvested brain cell aggregates revealed 
clear intracellular accumulation of methylmalonate and malonate. In immunohistochemical 
stainings oligodendrocytes appeared the most affected brain cells. The MBP signal disappeared 
already at 0.1 mM treatment with each metabolite. Mature astrocytes were not affected by 
propionate, while immature astrocytes on intense treatment with propionate developed cell 
swelling. 1 mM methylmalonate induced cell swelling of both immature and mature astrocytes , 
while 1 mM malonate only affected mature astrocytes. Neurons were not affected by 
methylmalonate, but 10.0 mM malonate on less intense treatment and 0.1, 1.0 and 10.0 mM 
propionate on intense treatment affected axonal growth. Our study shows significant uptake and 
deleterious effects of these metabolites on brain cells, principally on astrocytes and 
oligodendrocytes. This may be explained by the absence of the pathway in glial cells, which thus 
are not able to degrade these metabolites. Further studies are ongoing to elucidate the underlying 
mechanisms of the observed neurotoxic effects. 
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In the adult organism, the ability to form new blood vessels via angiogenesis or 
vasculogenesis is essential to wound healing. Endothelial progenitor cells (EPCs) have the 
capacity to differentiate into mature endothelial cells and to secrete angiogenic factors in vitro and 
in vivo. Thus, their therapeutic potential may be important, notably in the management of skin 
wounds or ischemic myocardial injury.  
 
The aim of our study was to determine whether EPCs can be isolated in large number from 
peripheral blood of healthy or burned patients and expanded in vitro. In a second step, we 
characterized these cells and tested their capacity to induce angiogenesis in a mouse model of 
ischemic limb in vivo.  
 
Mononuclear cells were isolated from peripheral blood samples obtained from either healthy 
donors (100 ml) or severly burned patients (45 ml)and cultured in specific medium. EPC colonies 
appeared after 2 weeks and could be cultured up to 10 passages. They formed tubelike structures 
on matrigel, took up acetylated low-density lipoprotein and bound Ulex lectin. They expressed the 
surface antigens CD34, VEGFR-2, CD31, and E-cadherin, as well as the von Willbrand factor and 
the endothelial isoform of nitric oxide synthase (eNOS). After 5 passages of a single clone, cells 
were generated in sufficient number to allow 5x105 of them to be injected to nude mice. The 
evaluation of the angiogenic properties of these cells in vivo is ongoing. 
 
           In conclusion, it is possible to isolate endothelial precursor cells from a limited amount 
of peripheral blood from healthy donors or burned patients. These cells can be obtained in large 
number after culture expansion. If their angiogenic potential is valuated in vivo, these cells could 
be re-injected in patients in order to treat ischemic damages by cellular therapy. 
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In the western world, cardiovascular disease remains a leading cause of mortality and morbidity. 
Heart failure is a progressive disorder that is initiated by a loss of functional cardiomyocytes 
leading to the weakening of the pumping capacity of the heart. In this context, cell replacement 
therapies to induce myocardial regeneration represent attractive alternatives to classical drug 
approaches for maintaining cardiac function. In a first study, we isolated cardiac precursor cells 
(CPCs) from human fetal ventricles. These mesenchymal cells can proliferate in vitro and express 
early cardiac markers (Nkx2.5 and Gata4) but no cardiac proteins expressed in functional 
cardiomyocytes, such as contractile proteins of the sarcomere. In appropriate conditions, these 
cells can differentiate into functional cardiomyocytes and smooth muscle cells (SMC). In order to 
identify a suitable source of cardiomyocyte precursors that could be used in autologous cell 
replacement therapy in humans, we established the conditions to isolate a mesenchymal 
non-myocyte fraction from human adult atrial appendages. Biopsies were obtained from adult 
patients undergoing right atrial appendage resection during surgery. Minced tissue was subjected 
to enzymatic digestion (protease XXIV and Collagenase V), and the non-myocyte fraction 
(containing putative precursor cells) was isolated and expanded in vitro. These cells are adherent, 
can be expanded for several passages and stored frozen. Flow cytometry analysis of cells in 
expansion showed no expression of hematopoietic markers (c-kit and CD45) and low or no 
expression of the endothelial stem cell markers CD34 (<10%) and CD31 (0%). In contrast, 100% 
of the cells expressed the mesenchymal stem cell markers CD73, CD90 and CD105. Cells under 
expansion conditions expressed early cardiac markers such as Mef2c, GATA4, and Nkx2.5 but no 
contractile proteins of the sarcomere and no SMC markers. This pattern of expression is 
consistent with a CPCs phenotype. Induction of differentiation in vitro stimulated the expression of 
β-MHC and sm-MHC in CPCs. When injected into the temporal vein of new born SCID mice, cells 
were able to home back to the heart, to engraft and to differentiate into cardiomyocytes 12 days 
after transfer. Taken together, these data demonstrate that we successfully isolated mesenchymal 
CPCs from human atrial appendages. These cells are able to proliferate and differentiate into 
cardiomyocytes in vitro and in vivo, and might, therefore, represent a suitable source of precursors 
for autologous cell replacement therapy. 
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Generation of Nedd4-2 total knockout (KO) mice revealed that Nedd4-2 inactivation leads to Na+ 
retention and hypertension. To determine the role of renal Nedd4-2 in mediating salt-sensitive 
hypertension in vivo, inducible renal tubule-specific Nedd4-2 KO mice were generated by 
combining the TetOn and CreLoxP systems. Pax8-rtTA transgenic mice expressing the reverse 
tetracycline (Tet)-dependent transactivator (rtTA) along all renal tubules were bred with TRE-LC1 
transgenic mice expressing the Cre recombinase under the control of an rtTA-response element 
(TRE). Double transgenic Pax8-rtTA/TRE-LC1 mice (Pax8/LC1) allowing Tet-inducible renal 
tubule-specific Cre-mediated recombination were bred with mice homozygous for the Nedd4-2 
floxed allele to obtain mutants (Nedd4-2fl/fl/Pax8/LC1). Controls (Nedd4-2fl/fl/Pax8 or 
Nedd4-2fl/fl/LC1) and mutants were treated with doxycyclin (Dox, 2mg/ml) for 11d and fed with 
high-Na+ diet for 8d. Western-blot on total kidney lysates revealed complete loss of Nedd4-2 in 
Dox-treated mutants. Daily urine volume was increased in mutants, whereas plasma aldosterone, 
urine Na+ and absolute urinary Na+ excretion were decreased. Interestingly, mutants showed 
impaired urinary K+ excretion, paralleled with hyperkalemia. Western blot on kidneys showed 
increased α-, β-, γ-ENaC, and NCC protein abundance in mutants. In addition, 
immunofluorescence revealed increased ROMK protein expression in distal convoluted tubules 
and connecting tubules in mutants, which might be secondary to the hyperkalemia. Taken 
together, these data suggest that inducible Nedd4-2 ablation in renal tubules of adult mice leads to 
Na+ retention, likewise via ENaC and NCC over-activation. The impaired K+ excretion in mutants 
suggests that Nedd4-2 is important for maintaining K+ balance. The mechanisms behind this 
regulation remain to be elucidated. 
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Objective: to assess the relationships between body mass index (BMI), body fat (BF), and fitness 
on blood pressure (BP) levels. 
Methods: cross-sectional study in 2041 boys and 1995 girls aged 10-18 living in the Lisbon area, 
Portugal. BMI and BP were measured as recommended. BF was assessed by bioimpedance. 
Fitness was assessed by the 20-meter shuttle run and the participants were classified as fit/ unfit. 
Obesity and high blood pressure were defined according to international criteria. 
Results: in both genders, BMI and BF were positively related with systolic (BMI only) and diastolic 
BP z-scores. No interaction was found between being fit and BMI categories regarding BP levels, 
while for BF a significant interaction (lower BP levels among fit participants) was found. Being fit 
reduced the BF-induced increase in the Odds ratio (OR) of presenting with high BP: OR (95% 
confidence interval) 1.01 (0.73-1.40) and 0.99 (0.70-1.38) for overweight and obese fit boys, 
respectively, the corresponding values for unfit overweight and obese boys being 1.33 (0.94-1.90) 
and 1.75 (1.34-2.28), respectively. The values were 0.88 (0.57-1.35) and 1.66 (0.98-2.80) for 
overweight and obese fit girls, respectively, the corresponding values for unfit overweight and 
obese being 1.63 (1.12-2.37) and 1.90 (1.32-2.73) respectively. Conversely, no interaction was 
found between fitness and BMI-defined overweight and obesity. 
Conclusion: Being fit reduces the negative impact of BF on BP levels in both genders. This 
protective effect was not found with BMI. Our results emphasize the importance of fitness in the 
paediatric age. 
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Background: in industrialized countries, migrants tend to present higher cardiovascular risk factor 
(CVRF) levels than nationals. Whether these differences are due to inadequate management of 
CVRFs among migrants has seldom been studied. Hence, we assessed CVRF (hypertension, 
dyslipidaemia and diabetes) management according to nationality in Switzerland. 
Methods: four cross-sectional studies: three nationwide interview surveys (Swiss Health Surveys 
– SHS) from 1997, 2002 and 2007 (N=49,245) and one local examination (CoLaus study, 
2004-2006, N=6,710). Subjects were separated into Swiss, French, German, Italian, Portuguese, 
Spanish, former Republic of Yugoslavia, other European and other countries. 
Results: most CVRFs were unevenly distributed between migrants and Swiss nationals. Among 
hypertensive subjects, lower treatment rates were found in participants from Portugal and Spain 
and to a lesser degree from the former Republic of Yugoslavia, Germany and other countries in 
the SHS. Multivariate analysis adjusting for sex, age, educational level, body mass index and 
leisure-time physical activity showed lower treatment rates among Italian and Spanish participants. 
In CoLaus, lower treatment rates were found for participants from France and Portugal, but the 
differences were not significant after multivariate adjustment. Among dyslipidamic subjects, lower 
treatment rates were found in participants from Italy, Portugal and Spain in the SHS. In CoLaus, 
lower treatment rates were found for participants from Germany, Portugal and other countries; in 
both settings the differences were not significant after multivariate adjustment. No differences 
were found regarding treatment of diabetes.  
Conclusion: most CVRFs are unevenly distributed among migrants in Switzerland, but these 
differences are mainly due to disparities in age, leisure-time physical activity, overweight/obesity 
and education. Screening and management of CVRFs in Switzerland do not appear to differ 
significantly between Swiss nationals and migrants, suggesting that there is no need to specifically 
target migrant populations regarding CVRFs. 
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Background/Introduction: Obesity increases the risk for cardiovascular risk factors 
(hypertension, dyslipidemia and type 2 diabetes). The contribution of overweight and obesity to 
those risk factors at the population level should be assessed using data from the same population. 
Methods: The number of cases of cardiovascular risk factors that could have been prevented if 
the increase in overweight and obesity in Switzerland had been contained were estimated using 
gender-specific, age and smoking-adjusted PAFs for overweight and obesity. PAFs were 
estimated from the Swiss Health Survey 2007 (self-reported) and the CoLaus study (measured) 
data. 
Results: PAFs calculated using self-reported data were lower than using measured data. Using 
measured data, overweight and obesity contributed to 38% of hypertension cases in men (32% in 
women). In men, being overweight contributed more to hypertension than obesity (22.2% and 
15.6%, respectively), while the opposite was observed for women (13.6% and 18.1%, 
respectively). Also, 36% of dyslipidemia in men (30% in women) could be attributed to overweight 
and obesity. In both genders, being overweight had a higher contribution than being obese (21.2% 
and 15.2% in men; 15.9% and 14.3% in women, respectively). Lastly, 57% of type 2 diabetes in 
men (62% in women) was attributable to overweight and obesity, with obesity having a larger 
impact than overweight in both sexes (39.2% and 17.7% in men; 48.0% and 14.1% in women, 
respectively). Circa 61,500 cases of hypertension, 37,500 cases of dyslipidemia and 26,500 cases 
of type 2 diabetes could have been prevented if overweight and obesity levels were maintained at 
1992 levels. 
Conclusion: In Switzerland, a large proportion of cardiovascular risk factors is attributable to 
overweight and/or obesity. A substantial amount of them could have been prevented by containing 
the overweight/obesity epidemic. 
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Background: several authors have suggested that watching football matches might increase the 
risk of developing coronary heart disease (CHD). 
Objective: to assess the relationship between football matches and CHD mortality in Switzerland. 
Methods: Swiss mortality data was collected for the periods of European cups 1980 to 2004 and 
World cups 1982 to 2006 (385,238 deaths). CHD was assessed using the following ICD 
definitions: acute myocardial infarction (AMI) + unstable angina + acute ischaemic heart disease, 
unspecified + cardiac arrest + other cardiac arrhythmias. Matches carrying a potential extra stress, 
i.e. where the Swiss national team played or with over time or penalties, where flagged. 
Results: after adjusting for year, age and gender, no increase in the risk of dying from CHD was 
found in days when matches occurred (table). Similarly, no increase in the risk of dying from CHD 
was found for matches with extra time or with penalties, or after stratification on gender (table). 
Restricting deaths to AMI only also did not change the results (not shown). 
Conclusion: no relationship was found between Euro or World cup football matches and CHD 
mortality in Switzerland. Matches with extra time or with penalties do not carry any additional risk. 
Table 1: risk of dying of CHD according to football matches 
 All (n=385,238) Men (n=196,023) Women (n= 189,215) 
Year 0.995 (0.993 – 0.997) 1.000 (0.997 – 1.002) 0.992 (0.988 - 0.997) 
Gender    
Women 1 (ref.) - - 
Men 0.86 (0.84 - 0.88) - - 
Age group    
18-44 1 (ref.) 1 (ref.) 1 (ref.) 
45-64 2.56 (2.34 - 2.80) 2.70 (2.44 - 2.98) 2.36 (1.90 - 2.92) 
65-74 2.97 (2.73 - 3.24) 2.57 (2.34 - 2.83) 4.62 (3.77 - 5.64) 
75+ 3.20 (2.93 - 3.50) 2.56 (2.31 - 2.84) 5.11 (4.18 - 6.25) 
Match day    
No 1 (ref.) 1 (ref.) 1 (ref.) 
Yes 1.01 (0.96 - 1.05) 1.03 (0.97 - 1.09) 0.98 (0.92 - 1.04) 
Swiss team plays    
No 1 (ref.) 1 (ref.) 1 (ref.) 
Yes 0.90 (0.75 - 1.07) 0.97 (0.77 - 1.23) 0.80 (0.60 - 1.06) 
Extra time or penalties    
No 1 (ref.) 1 (ref.) 1 (ref.) 
Yes 0.93 (0.82 - 1.05) 0.91 (0.77 - 1.08) 0.95 (0.79 - 1.14) 
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Background: Migrants tend to present higher overweight/obesity levels, but whether this 
relationship applies to all nationalities has seldom been studied. In this study, we assessed the 
prevalence of overweight/obesity according to nationality in Switzerland. 
Methods: data from a five-year nationwide cross-sectional interview survey (Swiss Health Surveys 
- SHS) from 1992 to 2007 (N=63,766) and from local cross-sectional examination survey (CoLaus 
study in Lausanne 2004-2006, N=6,743) were used. Subjects were separated into Swiss, French, 
German, Italian, Portuguese, Spanish, former Republic of Yugoslavia, other European and other 
countries. 
Results: compared to Swiss, German and French nationals presented lower prevalence of 
overweight and obesity, while nationals from Italy, Spain, Portugal and the former Republic of 
Yugoslavia presented higher levels. Adjusting the SHS data for age, gender, education, smoking, 
leisure-time physical activity and survey year, a lower odds for overweight + obesity was found for 
German (Odds ratio=0.80, 95% confidence interval [0.70-0.92]) and French (0.74 [0.61-0.89]) 
nationals, while higher odds were found for participants from Italy (1.45 [1.33-1.58]), Spain 1.36 
[1.15-1.61], Portugal (1.25 [1.06-1.47]) and the former Republic of Yugoslavia (1.98 [1.69-2.32]). 
Similar findings were observed in the CoLaus study for Italian (1.63 [1.29-2.06]), Spanish (1.54 
[1.17-2.04]), Portuguese (1.49 [1.16-1.91]) and former Republic of Yugoslavia (5.34 [3.00-9.50]). 
Conclusion: overweight and obesity are unevenly distributed among migrants in Switzerland. 
Migrants from Southern Europe and former Republic of Yugoslavia present higher prevalence 
rates. This suggests that preventive messages should be tailored to these specific populations. 
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Background: recent data indicate a slight decrease in the prevalence of smoking in Switzerland, 
but little is known regarding the intention and difficulty to quit smoking among current smokers. 
Hence, we aimed to quantify the difficulty and intention to quit smoking among current smokers in 
Switzerland. 
Methods: cross-sectional study including 607 female and 658 male smokers. Difficulty, intention 
and motivation to quit smoking were assessed by questionnaire. 
Results: 90% of women and 85% of men reported being “very difficult” or “difficult” to quit 
smoking. Almost three quarters of smokers (73% of women and 71% of men) intended to quit; 
however, less than 20% of them were in the preparation stage and 40% were in the 
precontemplation stage. On multivariate analysis, difficulty to quit was lower among men (Odds 
ratio and 95% [confidence interval]: 0.51 [0.35-0.74]) and increased with nicotine dependence and 
number of previous quitting attempts (OR=3.14 [1.75 - 5.63] for 6+ attempts compared to none). 
Intention to quit decreased with increasing age (OR=0.48 [0.30-0.75] for ≥65 years compared to 
<45 years) and increased with nicotine dependence, the number of previous quitting attempts 
(OR=4.35 [2.76 - 6.83] for 6+ attempts compared to none) and among subjects with personal 
history of lung disease (OR=1.73 [1.00 - 2.99]). Motivation to quit was inversely related with 
nicotine dependence and positively related with the number of previous quitting attempts and 
personal history of lung disease. 
Conclusion: over two thirds of Swiss smokers want to quit. However, only a small fraction wishes 
to do so in the short term. Nicotine dependence, previous attempts to quit or previous history of 
lung disease are independently related with difficulty and intention to quit. 
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Purpose: Several studies have previously suggested periodical patterns in mortality rates from 
cardiovascular disease (CVD), acute myocardial infarction (AMI) and stroke. The aim of this study 
was to see if there was such a phenomenon and its significance in the Swiss population between 
the years 1969 and 2007.  
Methods: Swiss mortality data from 1969 to 2007 (2’362’430 deaths) were used. Number of 
deaths and mortality rates due to CVD, AMI and stroke were computed for the time of day, day of 
the week, and month. A further stratification on gender or age (<65 and ≥65 years old) was also 
performed.  
Results: There was a clear variability on CVD, AMI and stroke mortality rates according to the 
time of day, day of the week and the month. In general, mortality peaked in the morning 
(8h00-12h00) and also in the late afternoon (14h–18h), while the nadir occurred during the nightly 
hours. Both males and females showed similar hourly patterns, although the trend diminished in 
older patients, particularly regarding death from stroke. Weekly variation of mortality rates was 
also found for the younger (<65 years) subjects, with the lowest mortality rates on Sundays and 
the highest on Mondays. Conversely, seasonal variation according to month was stronger in the 
elder subjects, with the highest mortality rates during the winter and the lowest in the summer 
(July/August).  
Conclusion: There is a timely pattern to death rates for CVD, AMI and stroke in Switzerland 
depending on the age and sex of the patients. Knowing this trend, its triggering factors and 
consequences, measures could put in place to prevent, diagnose and treat the population at 
certain times. 
 
 
 
 
 
Metabolism and Cardiovascular/MCV-61 
 
 
Trends of body image and desire to lose weight in the adult swiss population, 
1997-2007 
 
 
1Marques-Vidal P., 2Melich-Cerveira J., 2Marcelino G., 1Paccaud F.  
 
 
CHUV and University of Lausanne1, Faculdade de Medicina de Lisboa2  
 
 
 
Background/Introduction: Studies have shown that, in the USA, body dissatisfaction has 
decreased among overweight and obese subjects. Knowledge of trends on how current body 
weight relates to both weight satisfaction and desire to change weight among Swiss adults is 
limited. 
Methods: Cross-sectional data from three National health interview surveys conducted in 
representative samples of the Swiss adult population: 1997 (n=12,474), 2002 (n=18,908) and 
2007 (n=17,879). Weight, height, body dissatisfaction and desire to change weight were assessed 
by questionnaire. 
Results: In 1997, 2002 and 2007 the percentages of overweight individuals dissatisfied with their 
weight was 63%, 67% and 63% in women and 41%, 46% and 42% in men respectively. Among 
obese subjects, the percentages were 77%, 82% and 79% in women and 63%, 73% and 67% in 
men. In overweight men, desire to change weight was 62.9% and 69.9% in 1997 and 2007, 
respectively (79.7% and 88.5% in women). Among obese men the percentages were 82.7% and 
86.2% (86.3% and 91.6% in women). Most (>97%) of the desired changes were towards a 
decrease. Still, a significant percentage (36.1% in 2007) of normal weight men reported a desire to 
increase weight (9.1% in normal weight women). Multivariate analysis revealed that female 
gender, younger age, migrant status, high educational level, former smokers and increased BMI 
were independently and positively associated with body dissatisfaction and desire to change 
weight, while no relationship was found for survey year. 
Conclusion: Contrary to the USA, body dissatisfaction and desire to lose weight remained stable 
in Switzerland between 1997 and 2007. 
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Objective: The contribution of atherosclerosis (ATS) in the development of abdominal aortic aneurysm 
(AAA) remains controversial. The aim of this study was to investigate the correlation between the traditional 
cardiovascular risk factors (CVRF), the burden of subclinical ATS, and the diameter of the abdominal aorta 
(AA). 
Patients and methods: 2052 consecutive patients (P) (39% female), mean age 52 ± 13 years, were 
prospectively screened for the burden of subclinical ATS and the diameter of AA. B-mode ultrasonography 
was used to detect the presence of atherosclerotic plaques on carotid and femoral arteries and to evaluate 
the greatest diameter of the AA. 
Results: The mean abdominal aortic diameter (AAD) was 15.2 ± 2.8 mm. We detected atherosclerotic 
plaques in 71 % of P. We found significant correlations between the AAD and the Framingham coronary 
heart disease-risk score (p = 0.001; r = 0.35).  A multiple regression analysis showed that the subclinical 
ATS and only 4 CVRF were significantly correlated with the variability of AAD, namely gender, age, BMI 
and smoking. With this model, all the CVRF accounted for 27% (R² = 0.27) of the variability of AAD. 
The prevalence of enlarged AA and AAA in this population was very low (1% and 0.44% respectively). To 
further analyze our data we used a multivariate logistic analysis to evaluate the impact of the CVRF among 
the P with enlarged AA D as compared to the other P with AAD less than 25 mm. Five CVRF are 
significantly associated with the increased of AAD: age, sub-clinical atherosclerosis, current smoking, 
hypertriglyceridemia and gender. Here again, these results indicate that these CVRF play a role for the risk 
of dilatation of AAD, but that accounting no more than 30 %, as given by the pseudo R² coefficient. Thus 
impact of these CVRF was no greater on the general variability of AAD than on the AA dilatation. 
Conclusion: Our results suggest that CVRF and the burden of subclinical ATS play a role in the increase of 
the AAD and that other major factors should be involved in the development of a dilation of aorta then 
aneurysm. 
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Background: Environmental influences acting early in life predispose to premature cardiovascular 
disease. Assisted reproductive technologies (ART) involve the manipulation of early embryos at a 
time when they may be particularly vulnerable to external disturbances. We recently found that 
vascular function in both children and mice conceived by ART is defective. In mice, this vascular 
dysfunction is transmitted to their progeny, suggesting an epigenetic mechanism.   
Methods: To test this hypothesis, we assessed vascular function and the vascular DNA 
methylation pattern of imprinted genes and the eNOS gene promoter in male ART and control 
mice.  We then tested the effects of a histone deacetylase inhibitor on these variables. 
Results: As expected, ART mice displayed marked mesenteric-artery endothelial dysfunction in 
vitro and arterial hypertension in vivo. Most importantly, the methylation pattern of imprinted genes 
H19 (P<.01, vs. ctrl), Gtl2 (P<.01, vs. ctrl), Peg3 (P=.02, vs. ctrl) and of the eNOS promoter 
(P=.01, vs. ctrl) was altered in the aorta of ART mice. The dysmethylation of the eNOS gene 
promoter in ART mice was of functional importance, since it was associated with decreased eNOS 
expression in carotid arteries and decreased NOx plasma concentration (9.1±10.4 vs. 32.3±9.6 
μM, X±SD, P<.001, ART vs. ctrl). DNA dysmethylation can be reversed by histone deacetylase 
inhibitors. Administration of such an inhibitor (Butyrate, 2 mg/kg/d, i.p. for 2 wks) to male ART mice 
normalized the vascular methylation pattern of imprinted genes H19, Gtl2 and Peg3 (all P<.05 vs. 
vehicle), of the eNOS promoter (P=.04 vs. vehicle) and NOx plasma concentration (29.0±12.4 μM, 
P<.001 vs. vehicle). The normalization of the vascular DNA methylation pattern by Butyrate was 
associated with normalization of the vascular function in ART mice and prevention of the 
transmission of this defect to their progeny.  
Conclusion: ART induces premature systemic vascular dysfunction in mice by an epigenetic 
mechanism. ART mice represent a model organism for the study of epigenetic mechanisms of 
vascular dysfunction. We speculate that epigenetic mechanisms also play a role in ART-induced 
vascular dysfunction and predisposition to premature cardiovascular disease in humans.    
 Grant support: Swiss National Science Foundation 
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Objective: In view of increasing prevalence of obesity worldwide, we examined the associations 
between cardiovascular risk factors (CVRF) and several adiposity markers among young adults in 
the Seychelles. 
Methods: In 549 participants aged 19-20 years from a population-based cohort study (Seychelles 
Child Development Study), we assessed health behaviors through questionnaire and measured 
weight, height, waist, fat mass (bioimpedance), blood pressure (BP), as well as blood lipids and 
glucose and uric acid on fasting blood. Analyses were made separately in males and females. 
Results: The prevalence of several CVRFs was elevated. BMI was strongly associated with 
CVRFs. The standardized regression coefficients ranged between 0.25-0.40 for systolic and 
diastolic BP, triglycerides, uric acid, and blood glucose (females) and between 0.15-0.26 for 
HDL-cholesterol and LDL-cholesterol (males). The odds ratios (contrasting the highest vs. two 
other tertiles for both BMI and the considered CVRFs) ranged between 6-12 for systolic/diastolic 
BP and between 2.5-6 for glucose, triglyceride and uric acid. Overall, associations with the CVRFs 
were not markedly different based on BMI, waist circumference or fat mass but tended to be 
weaker with waist/hip ratio. Estimates were only minimally altered upon adjustment for smoking, 
alcohol intake, physical activity and parents’ socio economic status. 
Conclusion: The elevated prevalence of several main CVRFs in youths emphasizes the 
importance of a life course approach to cardiovascular disease prevention. Our findings show 
strong associations between adiposity and several CVRFs in this population in the African region 
and suggest that BMI and waist circumference are equally useful markers. 
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The cardiovascular connexins (Cx), forming the gap junctions, play a role in the contractility of 
the vessel wall and in the control of blood pressure. To evaluate the role of Cx of the endothelial 
cells (EC; Cx37, Cx40) and smooth muscle cells (SMC; Cx43, Cx45) in the adaptation of the 
vascular wall during chronic hypertension, we investigated how connexins of the aorta change 
during renin-dependent and -independent hypertension. We subjected wild type (WT) mice and 
mice invalidated for the gene encoding Cx40 (Cx40-/- mice representing a genetic model of 
renin-dependent hypertension), to either a 2-kidney, 1 clip procedure or to 
N-nitro-arginine-methyl-ester treatment, which induce renin-dependent and -independent 
hypertension, respectively. All hypertensive mice featured a thickened aortic wall, increased 
levels of Cx37 and Cx45 in SMC, and of Cx40 in EC (except in Cx40-/- mice). Cx43 was only 
upregulated in the SMC of renin-dependent models of hypertension. Blockade of the 
renin-angiotensin system of Cx40-/- mice normalized blood pressure, and prevented both aortic 
thickening and Cx alterations. Ex vivo exposure of WT arteries (aortas, carotids, and mesenteric) 
to angiotensin II (AngII), increased the levels of Cx43, but not of other Cx. In the A7r5 aortic SMC 
line, AngII activated kinase-dependent pathways and induced binding of the Nuclear 
Factor-kappa B (NFKB) to the Cx43 gene promoter, increasing Cx43 expression.  
Using isometric tension measurements in precontracted aortic rings, we demonstrated that 
endothelium-dependent relaxations depend on NO release in both WT and Cx40-/- mice, but are 
markedly weaker in Cx40-/- mice. Consistently, NO production was decreased in the aorta of 
Cx40-/- mice. Altered relaxations and NO release from aorta of Cx40-/- mice were associated with 
lower expression levels of eNOS in the aortic endothelium of Cx40-/- mice, which also exhibit a 
marked decrease of Cx37 in EC. We further showed that eNOS, Cx40 and Cx37 tightly interact 
with each other at intercellular junctions in the aortic endothelium of WT mice, suggesting that the 
absence of Cx40 in association with altered Cx37 levels in EC from Cx40-/- mice participate to the 
decreased levels of eNOS. Altogether, our data demonstrate that 1) Cx37, Cx40 and Cx45 are 
upregulated by the increased mechanical forces impinging on the wall of arteries, whereas Cx43 is 
selectively increased in renin-dependent hypertension, via an AngII activation of the extracellular 
signal-regulated kinase and NFKB pathways and 2) the endothelial connexins participate in the 
control of eNOS expression levels and function. 
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Background: The relative contribution of body weight change at different ages on the level of 
current blood pressure (BP) during childhood and adolescence remains unclear. We assessed the 
association between birth weight, weight change, and current BP across the entire age-span of 
childhood and adolescence in large school-based cohorts in the Seychelles, an Island state in the 
African region.  Method: Three cohorts of children were analyzed: 1606 whose weight was 
measured at age 5.5 and 9.1 years, 2557 at 9.1 and 12.5, and 2065 at 12.5 and 15.5, respectively. 
Birth and one year data were gathered from medical files. The outcome was BP at age 5.5, 9.1, 
12.5 or 15.5 years, respectively.  Results: At all ages, the association between birth weight 
z-score and current BP was either null or weakly positive without adjustment for current weight 
and generally weakly negative upon adjustment for current weight. Current BP was strongly 
associated with current body weight z-score. Conditional linear regression analysis indicated that 
changes in body weight z-score during each successive period of growth since birth contributed 
substantially to current BP at all ages. The strength of the association between weight change and 
current BP increased throughout successive periods of growth.  Conclusion: During childhood 
and adolescence, BP is more responsive to recent than earlier weight changes. 
Key words: blood pressure, birth weight, growth, life course, children 
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The renal site of sodium retention in cirrhosis as well as the transporters involved and the way 
they are activated, although extensively studied in rats and dogs, is still a matter of debate. Our 
previous study using the cholestatic mouse model revealed an aldosterone independent 
stimulation of the basolateral Na+,K+ATPase activity exclusively in the cortical collecting duct 
(CCD). In order to explore the role of the apical amiloride sensitive sodium channel (ENaC) in the 
CCD we took advantage of existing CCD specific αENaC KO (Hoxb7 cre; scnn1aloxlox).  
Control (CTL) and CCD specific αENaC KO (KO) mice underwent bile duct ligation (BDL) or sham 
operation. Urinary sodium and potassium excretion was measured every 3 days in metabolic 
studies over 3-hours period and αENaC expression analyzed by immunofluorescence. 
Two to three weeks after BDL, 30% (CTL and KO) mice displayed ascites (~20 ml, BDL(+)) 
whether the remaining ones did not (BDL(-)). Six groups were distinguished subsequently for 
analysis: CTL and KO; with sham operation, BDL without ascites (BDL(-)) and BDL with ascites 
(BDL(+)). At the time of evident ascites the urinary Na/K ratio (mean±SEM) was as follow: 
CTL-sham 0.9±0.2 (n=6), CTL-BDL(-) 0.8±0.3 (n=7; ns vs CTL-sham), CTL-BDL(+) 0.1±0.1 (n=4; 
p<0.05 vs CTL-sham) and KO-sham 1.3±0.2 (n=6), KO-BDL(-) 1.2±0.3 (n=7; ns vs KO-sham), 
KO-BDL(+) 0.2±0.1 (n=5; p<0.01 vs KO-sham). The differences observed between CTL and KO 
groups were not significant. Macroscopically kidneys of non ascitic mice are more affected by the 
disease. Immunofluorescence confirmed cre-mediated deletion of αENaC in the collecting duct of 
floxed mice. Aside from altered ENaC abundance in CD, no other obvious changes were seen by 
immunofluorescence between CTL and KO mice. 
In conclusion, ENaC activity in the CCD is not required for renal sodium retention in cholestatic 
mice. The urinary Na/K ratio reflects that aldosterone can be involved in the development of Na+ 
retention. 
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AIM: Cardiac PET allows non-invasively assessment of myocardial blood flow (MBF) and 
myocardial flow reserve (MFR). The impact of MBF and MFR in predicting major adverse 
cardiovascular events (MACE) has not been investigated in a prospective study, which was our 
aim. 
MATERIAL AND METHODS: In total, 313 patients (65±11y, 36% women) with known or 
suspected CAD underwent both a rest and adenosine stress cardiac PET/CT with Rubidium-82. 
Dynamic acquisitions were analyzed semi-quantitatively computing the summed difference score 
(SDS) and quantitatively using the FlowQuant 2.1.3 software (MBF, MFR). Patients were stratified 
according to SDS, and allocated into groups of tertiles of stress MBF and MFR. For each group, 
annualized event rates were computed by dividing the number of annualized MACE (cardiac 
death, myocardial infarction, revascularisation or hospitalisation for cardiac-related event) by the 
sum of individual follow-up periods in years. Outcome were analyzed for each group using 
Kaplan-Meier event-free survival curves and compared using the logrank test. Multivariate 
analysis was performed in a stepwise fashion using Cox proportional hazards regression models. 
RESULTS: The median follow-up was 256 days (range 168-494d) during which 42 MACE were 
observed. Ischemia (SDS≥2) was observed in 85 patients for whom annualized MACE rate was 
higher as compared to those without (60% vs. 8%, p<0.0001). The group with the lowest MFR 
tertile (MFR<1.7) had higher MACE rate than the two highest tertiles (44% vs.9% and 12%, 
p<0.0001). Besides, the group with the lowest stress MBF tertile (MBF<1.8mL/min/g) had the 
highest annualized MACE rate as compared to the two others (37% vs. 21% and 3%, p=0.0001). 
On multivariate analysis, the addition of MFR or stress MBF to SDS significantly increased the 
global χ2 (from 60 to 65, p=0.02; and from 60 to 66, p=0.01). The best prognostic power was 
obtained by combining SDS (p<0.0001) and stress MBF (p=0.006). Interestingly, integrating stress 
MBF enhanced risk stratification even in absence of ischemia. 
CONCLUSIONS: Quantification of MBF or MFR in Rb-82 cardiac PET/CT, over semi-quantitative 
assessment, provides independent and incremental prognostic information and is of significant 
value for risk stratification. 
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In response to various pathological stresses, the heart undergoes a remodelling 
process that is associated with cardiomyocyte hypertrophy. Since cardiac 
hypertrophy can progress to heart failure, one of the major cause of lethality 
worldwide, the intracellular signalling pathways that control cardiomyocyte growth 
have been subjected of intensive investigation. We have previously shown that 
AKAP-Lbc, an A-kinase anchoring protein (AKAP) with an intrinsic Rho specific 
guanine nucleotide exchange factor activity, is critical for activating RhoA and 
transducing hypertrophic signals downstream of the α1-adrenergic receptors (ARs). 
During the characterization of the hypertrophic signalling pathways activated by 
AKAP-Lbc, we have discovered that in rat neonatal ventricular cardiomyocytes the 
anchoring protein maintains a signalling complex that is required for the activation of 
the mitogen activated protein kinase (MAPK) p38, which is known to promote 
hypertrophic cardiomyocyte growth.  
It is well established that activated p38 can promote hypertrophic gene transcription 
through the activation of transcription factors such as GATA-4 and MEF2C. In this 
context, we could show that suppression of AKAP-Lbc expression by infecting rat 
neonatal ventricular cardiomyocytes with lentiviruses encoding AKAP-Lbc specific 
short hairpin RNAs strongly reduces α1-AR mediated GATA-4 transcriptional 
activation. 
Altogether these results indicate that in cardiomyocytes AKAP-Lbc assembles a 
transduction complex that includes PKN, MLTK, MKK3 and p38 that is required for 
the activation of p38 and of the hypertrophic transcription factor GATA-4. 
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Circadian rhythms have been described for plasma calcium, parathormone (PTH) and for urinary 
calcium in constant conditions, and may play a role in kidney stone formation and osteoporosis. 
The mechanisms underlying these rhythms remain however largely unknown. Entrainment by 
systemic cues or regulation by the local intracellular molecular clock have been proposed. Here, 
we aimed (i) at describing the physiological circadian rhythms for calcium in the mouse, (ii) at 
measuring the diurnal variations in mRNA levels of the main renal calcium transporters and (iii) at 
assessing the role of the molecular clock in the regulation of calciuria. We first studied the 
variations in plasma calcium, PTH, and in calciuria every 4 hours for 24h in C57/bl6 mice. 
Circadian variations of, respectively, 2.5, 40 and 20% over the 24h mean has been observed 
under light/dark cycles and under constant darkness. Second, the renal mRNA levels for the main 
partners involved in calcium reabsorption have been assessed by qPCR every 4 hours for 24 
hours. TRPV5 and NCX1 mRNA levels were varying by 17 and 12% over the 24 hours mean, 
respectively, while calbindin-D28K and PMCA did not significantly change. NCX1 variations were 
confirmed at the protein level by Western Blot analysis. Third, we studied the effect of the clock 
gene on calciuria. In metabolic cages, Clock-deficient mice displayed higher urine calcium 
excretion (34.7% higher in light/dark conditions and 46.2% in constant darkness) and exhibited a 
disturbed circadian rhythm compared to their wildtype littermates. In clock-deficient mice, plasma 
calcium and PTH levels were not significantly different from wildtype mice. Overall, we 
characterized in detail the plasma calcium, PTH and calciuria circadian rhythms in the mouse and 
we showed that TRPV5 and NCX1 renal mRNAs expression were also varying over 24hours. In 
addition, our data suggest that the clock gene is involved in the regulation of calciuria, as 
clock-deficient mice are hypercalciuric. In order to define the cause of hypercalciuria, 
kidney-specific disruption of the molecular clock is awaited. 
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Introduction 
Diabetes mellitus is a metabolic disease characterised by impaired glucose homeostasis resulting 
from defective function and/or loss of beta-cells. Pregnancy is associated with diminished insulin 
sensitivity of maternal tissues that is compensated by an expansion of the beta-cell mass and an 
increase in insulin release. A better understanding of this physiological process could help 
identifying new possible approaches for the treatment of diabetes. MicroRNAs are small 
non-coding RNAs acting as translational repressors. Some of these gene regulatory molecules are 
known to be involved in the control of beta-cell functions, including insulin secretion and apoptosis. 
The aim of our study is to identify microRNAs that are differentially expressed in pancreatic islets 
of pregnant rats and to assess their involvement in compensatory beta-cell expansion. 
Methods 
We used expression profiling methods to compare the level of microRNAs in the islets of pregnant 
rats at d14 of gestation to non pregnant rats. Differential microRNA expression was verified by 
quantitative real-time PCR. The functional impact of selected microRNAs on insulin secretion, cell 
proliferation and survival was studied by modifying their expression level in the insulin-secreting 
cell lines MIN6 and INS832/13. 
Results 
Microarray and real time PCR analysis identified two down-regulated (miR-218 and -338-3p) and 
two up-regulated microRNAs (miR-144 and -451) in rat islets of pregnant rats. Interestingly, we 
found that miR-338-3p is also down-regulated in the islets of obese db/db mice and in high-fat fed 
mice, two other animal models characterized by compensatory beta-cell mass expansion. 
Reduction of miR-338-3p expression in MIN6 and INS832/13 cells using antisense molecules 
resulted in an increase in proliferation, as evidenced by a rise in Ki67 and BrdU staining, without 
any impairment in glucose-induced insulin secretion. Moreover, anti-miR-338-3p treatment 
protected MIN6 and INS832/13 cells from apoptosis induced by prolonged exposure to 
pro-inflammatory cytokines.  
Conclusions 
We have identified changes in microRNA expression in pancreatic islets of pregnant rats. Our data 
suggest that miR-338-3p might be implicated in beta-cell compensation during pregnancy and in 
the setting of insulin resistance in different animal models. The identification of miR-338-3p 
downstream signalling pathways could provide important information for the design of new 
microRNA-based therapeutic strategies to expand the functional beta-cell mass.
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Type I diabetes develops as a consequence of the autoimmune destruction of most of the 
insulin-producing beta cells composing the endocrine pancreas. Pro-inflammatory cytokines 
including the tumor necrosis factor alpha (TNFα), interleukin-1 beta (IL-1β), and interferon gamma 
(IFNγ) are involved in β-cells apoptosis. Connexin36 (Cx36) contributes to glucose-stimulated 
insulin secretion and has been shown to have anti-apoptotic properties in neuronal cell death 
models.  Herein, we investigated the role of Cx36 in beta cells following exposure to 
pro-inflammatory cytokines. Knocking-down Cx36 using siRNAs increased apoptosis and caspase 
3 cleavage induced by cytokines, indicating that Cx36 protects beta cell against cytotoxic attacks. 
A 24 hours treatment with a combination of IL-1β, TNFα and IFNγ (cytomix) strongly reduced the 
Cx36 mRNA and protein levels in insulin-secreting cell-lines and isolated mouse islets. To a lesser 
extent, IL-1β alone decreased the Cx36 levels in a dose-dependent manner whereas TNFα and 
IFNγ were ineffective. Cytokines have been shown to stimulate the AMP dependent kinase 
(AMPK) activity. Interestingly, the cytomix effects on AMPK phosphorylation and Cx36 expression 
were abolished following AMPK inhibition using both the chemical inhibitor compound C or the 
adenoviral dominant negative form of AMPK.  
Taken together, our results indicate that cytokines down-regulate Cx36 gene expression through 
an AMPK-dependant pathway. The anti-apoptotic properties of Cx36 suggest that the Cx36 
decrease contributes to the pathogenesis of type I diabetes. 
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The heart has been considered for a long time as a terminally differentiated organ with little 
capacity for regeneration. Recent studies, however, have challenged this view by providing 
evidence for a mitotic activity in a population of cardiac precursor cells (CPCs) in the damaged 
heart. Nevertheless, little progress has been made about the molecular mechanisms that control 
the mobilization of CPCs and their proliferation. Notch signaling is a cell-to-cell communication 
system, which plays a crucial role in the development of the cardiovascular system and is 
implicated in adult self-renewing tissues. Notch prevents cardiogenic differentiation in mouse 
embryonic stem cells, favors proliferation of immature rat cardiomyocytes, and promotes 
cardiomyocytes survival. Therefore, the main goal of this study was to evaluate whether the Notch 
pathway could play a role in maintaining human cardiac precursors in an undifferentiated state and 
in stimulating their expansion in vitro. This represents a mandatory step in the production of 
patient-specific CPCs, which could be used in cell therapies for cardiac diseases. Therefore, a 
population of non-myocyte cells containing CPCs was isolated from human right atrial appendages 
obtained in patients undergoing cardiac surgery. CPCs expressed early cardiac markers, such as 
Nkx2.5, but no late cardiac markers expressed in functional cardiomyocytes. Upon induction of 
differentiation, these precursors have the capacity to produce cardiomyocytes and smooth muscle 
cells. The expression of the Notch receptors and ligands was then analyzed in cardiac atrial 
tissues and in CPCs. All ligands (Jagged1, Jagged2, Delta-like1, Delta-like3, Delta-like4) and all 
Notch receptors (Notch1 to 4) were expressed in both biological materials. Delta-like1 was the 
predominant ligand in starting tissues whereas Jagged1 was the most expressed ligand in CPCs. 
The expression of the receptors (Notch1 to 3) was similar in tissues and in CPCs. Notch2 and 3 
demonstrated the highest levels. Notch4 was expressed at low levels in CPCs and was almost 
undetectable in atrial tissues. The activation of Notch signaling in CPCs in vitro was shown by the 
appearance of activated Notch1 and Notch2 intracellular domains in the nucleus, as detected by 
immunostaining, and by the induction of Notch target gene expression. These results suggest that 
the Notch pathway is active in CPCs, and could be used to expand these cells after isolation from 
biopsies. Ongoing experiments aim at taking advantage of immobilized soluble ligands to stimulate 
proliferation of CPCs in vitro in order to produce the numbers of CPCs that would be needed for 
cell replacement therapies in humans. 
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Background: TID ratio indirectly reflects myocardial ischemia and is correlated with cardiac 
prognosis. We aimed at comparing the influence of three different software packages for the 
assessment of TID using Rb-82 cardiac PET/CT. 
Methods: In total, data of 30 patients were used based on normal myocardial perfusion (SSS<3 
and SRS<3) and stress myocardial blood flow (>2mL/min/g) assessed by Rb-82 cardiac PET/CT. 
After reconstruction using 2D OSEM (2 Iterations, 28 subsets, filter butterworth order 10, ρ= 0.5), 
data were automatically processed then manually processed to define identical basal and apical 
limits. Hence, TID ratio were determined with Myometrix®, ECToolbox® and QGS®. Comparisons 
between software results used ANOVA test and Student t-test. 
Results: All of the 90 studies were successfully performed. TID ratio were not statistically different 
between softwares when data were processed automatically (P=0.2) or manually (P=0.17). There 
was a slight but significant relative overestimation of TID with the automatic processing in 
comparison with the manual processing using ECToolbox® (1.07 ± 0.13 vs 1.0 ± 0.13, P=0.001) 
and Myometrix® (1.07 ± 0.15 vs 1.01 ± 0.11, P=0.003) but not using QGS® (1.02 ±0.12 vs 1.05 ± 
0.11, P=0.16). 
Conclusion: Using automatic or manual mode TID estimation was not significantly influenced by 
software type. However, using Myometrix® or ECToolbox® TID was significantly different between 
automatic and manual processing, but not using QGS®. We concluded that the software type 
should be account for to define TID normal values as well as to compare multi-centric studies. 
Moreover QGS® software seemed to be the most operator-independent software package. 
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Aim:  
Myocardial perfusion imaging (MPI) using semi-quantitative analysis of stress/rest 82Rb PET/CT is 
a sensitive tool to detect ischemia/infarct due to epicardial coronary artery disease (CAD). 
However, it is limited to detect microvascular disease or balanced ischemia (3-vessel disease). We 
aimed to determine the impact of quantifying myocardial blood flow (MBF), myocardial flow 
reserve (MFR) and the prevalence of microvascular/3-vessel diseases potentially missed by 
semi-quantitative analysis. 
Material and methods:  
In total, 327 consecutive patients referred for MPI underwent 82Rb cardiac PET/CT for suspicion or 
characterization of CAD. Six-minutes dynamic acquisitions were performed at rest and during 
adenosine stress (140µg/kg/min over 6 minutes) after injection of 1500MBq of 82Rb. Images were 
assessed with ECToolbox software for semi-quantitative analysis (SRS, SSS, SDS and TID) and 
dynamic acquisitions were processed with the FlowQuant software to estimate average left 
ventricular rest-MBF, stress-MBF and MFR (stress/rest-MBF). Statistical analysis used Spearman 
test.  
Results:  
All 327 stress/rest studies were successfully performed. Of them, 132 patients had a normal 
perfusion in the LAD, LCX and RCA territories (SRS<3; SDS<3) on the semi-quantitative analysis. 
Twenty-two out of 132 patients (16.7%) with normal semi -quantitative perfusion scans had both 
decreased stress-MBF (<2mL/min/g) and MFR (<1.8), of whom 3 with known CABG. Of the 19 
patients without known CAD/CABG, 15 patients (15/132=11.4%) had normal TID; only 4 had a 
TID>1.15 leading to suspect microvascular/3-vessel diseases. There was no correlation between 
TID and MFR (P=0.32) or stress MBF (P=0.17). 
Conclusion:  
Our data suggest that up to 1/10 patients referred for MPI with normal semi-quantitative 
myocardial perfusion scans have decrease MFR and stress-MBF due to microvascular or 3-vessel 
diseases that would be undetected without MBF quantification. Further studies are needed to 
investigate the prognosis of patients with low MFR and stress-MBF when quantified by 
82Rb-PET/CT. 
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Introduction: Obstructive sleep apnea (OSA) is associated with an increased risk of 
cardiovascular diseases. Endothelial dysfunction could underly this association. We aimed to 
compare endothelial dependant coronary vasoreactivity in OSA patients and controls by 
quantifying myocardial blood flow (MBF) response to cold pressure testing (CPT) with 82Rb cardiac 
PET/CT. 
 
Methods: On the morning after polysomnography (PSG), twenty-four OSA patients (2W/22M, age 
57±14y, BMI 28.4±4kg/m2) with an apnea-hypopnea index (AHI)≥20/h and 9 controls (AHI<10/h) 
underwent a dynamic 82Rb cardiac PET/CT scan at rest, during CPT and adenosine stress. In 
OSA patients, PSG and PET/CT were repeated 6 weeks after initiating continuous positive airway 
pressure (autoCPAP) treatment. Data were processed with FlowQuant software to estimate 
rest-MBF, CPT-MBF, stress-MBF and MFR. To reflect differences in baseline cardiac work, values 
were normalized according to rate pressure product (RPP). Statistical analyses were performed 
using t-tests and 1-way ANOVA. 
 
Results: All of the 33 patients had normal MFR. At baseline, untreated OSA patients had a AHI of 
48.6±19.5/h and showed a lower MBF response to CPT than controls (1.1±0.2mL/min/g vs. 
1.3±0.4mL/min/g, P=0.048). CPT-MBF was not different between controls and well-treated 
(AHI<10/h, n=11) OSA patients (1.2±0.3mL/min/g vs. 1.3±0.4mL/min/g, P=0.68), but it was 
significantly lower for insufficiently treated (AHI≥10/h, n=10) patients (0.9±0.2mL/min/g vs 
1.3±0.4mL/min/g, P=0.03).  
 
Conclusion: Untreated OSA patients have an impaired coronary endothelial vasomotion as 
measured by MBF response to CPT compared to control subjects. This difference disappears after 
6 weeks of autoCPAP therapy but only in OSA patients showing a good response to CPAP 
therapy (AHI<10/h). Further studies are needed to determine by which mechanism OSA and 
CPAP treatment influence coronary vasoreactivity. 
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Background—Quantification of myocardial blood flow (MBF) with PET during cold pressor test 
(CPT) has been used to assess non-invasively endothelium-dependent coronary vasoreactivity, a 
surrogate marker of cardiovascular events. However, its use remains limited due to cardiac PET 
availability. As multi-detector computed tomography (MDCT) is widely available, we aimed at 
developing measurement of endothelium-dependent coronary vasoreactivity with MDCT with 
similar radiation burden as PET. 
Materials and Methods—Twenty-eight participants without known cardiovascular risk factor 
(18W/10M; aged 59±6y) were enrolled. They underwent within 4 hours a cardiac PET with 82Rb 
and unenhanced ECG-gated MDCT, at rest and during CPT. Changes in absolute MBF by PET 
(ml/min/g) in response to CPT were compared to relative changes in MDCT-measured coronary 
artery surface in the left main or left anterior descending artery using Student’s t-test, linear 
regression analysis and non-parametric Spearman’s correlation. 
Results—MDCT and PET/CT could be analyzed in 18 participants (64%). Main reasons for 
exclusion were patient motion (n=4) and tachycardia during MDCT (n=4) (decision not to 
administrate any beta-blockers in these healthy participants). Hemodynamic conditions during 
CPT at MDCT and PET were similar (P>0.3). Relative changes in coronary artery surface in 
response to CPT (-2.0–21.2%) correlated to changes in MBF (-0.10–0.52mL/min/g) (ρ=0.68, 
P=0.02). Total effective dose was 1.3±0.2mSv for MDCT and 3.1mSv for PET/CT (P=0.01). 
Conclusion—Assessment of endothelium-dependent coronary vasoreactivity using MDCT CPT is 
feasible. Owing to its wider availability, shorter examination times and similar radiation burden, 
MDCT may be attractive in clinical research to complete coronary status assessment in centers 
without access to cardiac PET. 
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Normal TID ratio determination using 82Rb quantitative cardiac PET/CT 
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Aim of the study: 
High transient ischemic dilation ratio (TID) is correlated with poor cardiac prognosis. Our purpose 
was to determine normal value of TID based on normal myocardial blood flow (MBF) and 
myocardial flow reserve (MFR) quantified by 82Rb cardiac PET/CT. 
Methods: 
49 patients (21 M/ 28 F; sex ratio 0.75) with cardiovascular risk factors (smoking, hypertension, 
obesity, dyslipidemia and familial story) underwent a rest/stress cardiac PET/CT using a dynamic 
acquisition over 6 minutes after an intravenous bolus of 82Rb (1600MBq). Stress acquisition was 
performed during infusion of adenosine over 6 minutes. Data were processed with FlowQuant 
using a two-compartment model (tissular+ vascular) (Lortie.EJNMMI2007;34:1765-1774) to 
determine MBF and MFR. Patients were selected based on normal rest/stress uptake images and 
normal stress MBF (> 2 mL/min/g) and MFR (> 2.0). For every patient TID was semi-automatically 
determined using ECToolbox software.  
Results: 
In total, 98 data sets were successfully performed for both quantitative analysis and for 
assessment of TID. All patients had a summed stress and rest score < 4 and a summed difference 
score <2. Mean MFR was 2.7±0.5. Mean TID was 1.01±0.12. TID was not significantly different 
between men and women (1.01±0.12 vs 1.01±0.11, P=0.86) but was between patients smoking or 
not (1.08±0.11 vs 0.99±0.11, P=0.013). 
Conclusion: 
Based on normal MFR, we determined TID upper limit as 1.24 (mean+1.96SD), that was higher 
than TID normal value previously published (Shi.NuclMedCommun2007;28(11):859-63) based on 
a qualitative myocardial perfusion analysis. Moreover TID value was significantly higher for 
smokers but none between genders. 
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Has TID predictive value for MBF and/or MFR abnormality when determined by 
82Rb cardiac PET/CT? 
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Aim of the study: 
Our purpose was to assess the predictive value of transient ischemic dilation (TID) ratio for 
abnormal myocardial blood flow (MBF) and myocardial flow reserve (MFR) detection using 82Rb 
cardiac PET/CT. 
Methods: 
110 patients (66 M/44 F; sex ratio 1.5) underwent a rest/stress 82Rb cardiac PET/CT using a 
dynamic acquisition protocol. Data were processed with FlowQuant to determine MBF at rest, at 
stress and MFR. TID was determined by analyzing uptake images with ECToolbox software. 
Based on previously published study, TID ≤1.15 (1) and MFR >2.0 were defined as normal. 
Comparison between group with or without normal TID were analyzed using Student t test and 
relationship between TID and MFR was determine using regression analysis with robust 
computation of standard deviation. 
Results: 
In total, 220 data were successfully performed. 51 patients had normal MFR and 59 had 
decreased MFR. TID was not significantly different (P= 0.3) between patients with normal MFR 
and patients with decreased MFR. MFR was not statistically different according to TID abnormality 
or not. Therefore, rest MBF and stress MBF were statistically lower for patients with abnormal TID 
compared to patient with normal TID (0.9±0.3 vs 1.1±0.4 mL/min/g, P= 0.02 and 1.8±0.8 vs 
2.2±0.8, P= 0.04). Moreover, there a negative correlation between TID ratio and MBF at rest 
(y= -0.1.x+1.2, P= 0.007) and at stress (y= -0.04.x+1.1, P= 0.021). 
Conclusion: 
TID assessed by 82Rb cardiac PET/CT had no predictive value for decreased MFR detection. 
Therefore, it is inversely correlated with absolute stress MBF. Thus, we conclude that TID may be 
an indicator of stress MBF but cannot replace MFR measurement.  
(1) Shi H, Santana CA, Rivero A et al. Normal values and prospective validation of transient 
ischaemic dilation index in 82Rb PET myocardial perfusion imaging. Emory University School of 
Medicine, Atlanta, GA 30322, USA. Nucl Med Commun. 2007 Nov;28(11):859-63. 
 
 
 
 
 
Metabolism and Cardiovascular/MCV-80 
 
 
Myocardial Blood Flow Quantification with Rubidium-82 Cardiac PET has 
Incremental Prognostic Value in Patients with Known or Suspected Coronary 
Artery Disease 
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AIM: Cardiac PET allows non-invasively assessment of myocardial blood flow (MBF) and 
myocardial flow reserve (MFR). The impact of MBF and MFR in predicting major adverse 
cardiovascular events (MACE) has not been investigated in a prospective study, which was our 
aim. 
MATERIAL AND METHODS: In total, 313 patients (65±11y, 36% women) with known or 
suspected CAD underwent both a rest and adenosine stress cardiac PET/CT with Rubidium-82. 
Dynamic acquisitions were analyzed semi-quantitatively computing the summed difference score 
(SDS) and quantitatively using the FlowQuant 2.1.3 software (MBF, MFR). Patients were stratified 
according to SDS, and allocated into groups of tertiles of stress MBF and MFR. For each group, 
annualized event rates were computed by dividing the number of annualized MACE (cardiac 
death, myocardial infarction, revascularisation or hospitalisation for cardiac-related event) by the 
sum of individual follow-up periods in years. Outcome were analyzed for each group using 
Kaplan-Meier event-free survival curves and compared using the logrank test. Multivariate 
analysis was performed in a stepwise fashion using Cox proportional hazards regression models. 
RESULTS: The median follow-up was 256 days (range 168-494d) during which 42 MACE were 
observed. Ischemia (SDS≥2) was observed in 85 patients for whom annualized MACE rate was 
higher as compared tothose without (60% vs. 8%, p<0.0001). The group with the lowest MFR 
tertile (MFR<1.7) had higher MACE rate than the two highest tertiles (44% vs.9% and 12%, 
p<0.0001). Besides, the group with the lowest stress MBF tertile (MBF<1.8mL/min/g) had the 
highest annualized MACE rate as compared to the two others (37% vs. 21% and 3%, p=0.0001). 
On multivariate analysis, the addition of MFR or stress MBF to SDS significantly increased the 
global χ2 (from 60 to 65, p=0.02; and from 60 to 66, p=0.01). The best prognostic power was 
obtained by combining SDS (p<0.0001) and stress MBF (p=0.006). Interestingly, integrating stress 
MBF enhanced risk stratification even in absence of ischemia. 
CONCLUSIONS: Quantification of MBF or MFR in Rb-82 cardiac PET/CT, over semi-quantitative 
assessment, provides independent and incremental prognostic information and is of significant 
value for risk stratification. 
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Alterations in microRNA expression favour the decline of function and mass 
of pancreatic β-cells in type 2 diabetes 
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Background and aims: 
The mechanisms underlying the development of type 2 diabetes are diverse, all leading to the 
decline of function and/or mass of pancreatic β-cells. MicroRNAs, a recently discovered class of 
non-coding RNAs, are potent regulators of key cellular processes, such as proliferation, 
differentiation and cell death. They are able to regulate gene expression by inhibiting the 
translation of target mRNAs through sequence-specific binding to the 3' untranslated region 
(3'UTR). In this study we evaluated the contribution of microRNAs to the decline of function and 
mass of pancreatic β-cells in db/db mice, a well known type 2 diabetes model. 
Materials and methods: 
Microarray analysis was employed to profile the expression of all known microRNAs in pancreatic 
islets of wild type and diabetic db/db mice. Two microRNAs showing a strong upregulation in the 
islets of diabetic mice were overexpressed in the mouse insulin-secreting β-cell line MIN6B1 to 
test for their impact on insulin secretion and cell survival. The bioinformatic tools TargetScan, 
miRanda and Pictar were used to search for putative targets of these microRNAs. The effect of 
microRNA overexpression on predicted targets was assessed by western blotting. 
Results: 
The expression of two microRNAs, miR-199a-5p and miR-199a-3p, was increased 12- and 9-fold, 
respectively, in pancreatic islets of diabetic db/db mice compared to wild type mice. 
Overexpression of miR-199a-5p in MIN6B1 cells led to defective glucose-induced insulin secretion 
while a rise in miR-199a-3p causes an increase in cell death. Western blot analysis revealed that 
overexpression of miR-199a-5p results in the upregulation of granuphilin a potent inhibitor of 
insulin secretion. On the other side, overexpression of miR-199a-3p reduced the level of mTOR, a 
serine/threonine kinase playing a key role in -cell survival.  
Conclusion: 
Our data suggest that miR-199a-5p and miR-199a-3p, two microRNAs issued from the same 
precursor, may contribute to -cell failure during instauration of type 2 diabetes: with miR-199a-5p 
causing defective insulin secretion, and miR-199a-3p having a negative effect on pancreatic β-cell 
survival. 
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Nitinol Based Artificial Muscle Independent Biventricular External Cardiac 
Assist Device: Bench Test Results  
 
 
1Tozzi P., 1Michalis A., 1Berdajs D., 1vonSegesser L.  
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Background: Ventricular assist devices (VADs) are single-ventricle pulsatile or continuous flow 
pumps that require anticoagulation. Thanks to artificial muscle technology a bi-ventricular assist 
device can restore heart muscle movement with external compression avoiding anticoagulant 
treatment.  
Methods: Electrically driven Nitinol based artificial muscle wires are connected to an external 
carbon fibre scaffold that follows the heart surface at the level of the interventricular septum. This 
reinforced dome wraps both ventricles with a different number of fibres on the right and on the left 
ventricle enabling independent activation. Ejected volume and pressure gradient have been 
measured with afterload ranging from 25 to 150mmHg. 
Results: Bench settings: preload range 5-15mmHg; afterload range 25-150mmHg; telediastolic 
volume 50ml; priming: 100-200ml saline. A single control unit drives both ventricles independently. 
Maximal systolic pressure generated by the left assist is 75mmHg and by the right assist 50mmHg. 
Volume ejected with a heart rate of 60/minute is 330ml/minute on the left side and 264ml/minute 
on the right side corresponding to an ejection fraction of 12% on the left side and 10% on the right 
side. The device requires a power supply of 6V, 250mA for 1.5s. The total power consumption is 
10W. The pressure-volume loop shows that the ejected volume increases when afterload 
increases following the Starling Law. 
Conclusions: External cardiac compression using dedicated artificial muscles is technically 
feasible. The unique design of the device described allows an independent external compression 
of both ventricles. It should be possible to modulate the degree of hemodynamic assistance 
according to the degree of right and/or left cardiac failure. 
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Expression of the Forbidden Gene REST Ensures the Identification of Genes 
Essential to Pancreatic Beta Cells 
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Background: The transcriptional repressor RE-1 Silencing Transcription factor (REST) represses 
a large number of genes that contain the binding motif RE-1. Because REST is ubiquitous, but 
absent from neurons and beta cells, it ensures that this set of genes is specifically restricted to 
neurons and beta cells. However, how these genes participate to beta cell function or survival is 
still unknown. We decided to overexpress REST in beta cells, to identify new RE-1-containing 
genes and assess their role in beta-cells. 
Methods: We used transgenic mice that express REST specifically in pancreatic beta cells under 
the control of the rat insulin promoter (RIP-REST mice). Glucose tolerance test, measurements of 
insulin secretion, quantification of islet cell mass and immunohistochemistry were performed with 
mice. Adenoviral REST transduction, chromatin immuno-precipitation, qPCR, siRNA transduction 
and apoptotic assay were performed with INS-1E cell line. 
Results: One RIP-REST founder line was intolerant to glucose, due to defects in insulin secretion, 
and also displayed a reduced beta cell mass. A second line of RIP-REST mice featured diabetes 
as a consequence of high levels of REST expression, which resulted in a major loss of beta-cell 
mass. Impairment of insulin release affected both phases of the insulin secretion pathway and was 
accounted for by decreased expression of RE-1-containing genes essential to insulin exocytosis, 
such as Snap25, Synaptotagmin IV and VII. Loss of beta cell mass occurred through apoptosis 
and was explained by decreased expression of anti-apoptotic genes containing RE-1, such as 
Irs2, Ib1, Cx36 and Cdk5r2. 
Conclusions: Our work, accredited by the analysis of transgenic mice, have documented the 
need for healthy beta cells to express the whole set of RE-1-containing genes. We provided the 
first evidence that RE-1-containing genes are essential to beta cell life and function, in vivo. 
Especially, we identified crucial REST target genes such as Snap25 and Irs2, and also revealed 
the implication of novel REST target genes in insulin secretion, such as SytIV and VII and in 
beta-cell survival, such as Cdk5r2. We strengthen the need to perform a comprehensive 
identification of all RE-1-containing genes to better understand beta-cell function and life. 
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Critical role of Angiotensin II type 1 receptor on bone marrow-derived cells in 
the development of vulnerable atherosclerotic plaque in 2-Kidney, 1-Clip 
ApoE-/- mice 
 
 
1Pellegrin M., 1Aubert J.-F., 1Bouzourène K., 2Aubry D., 1Nussberger J., 2Duchosal M.,  
1Mazzolai L.  
 
 
Service of Angiology, CHUV1, Service of Hematology, CHUV2  
 
 
 
Background: We have previously shown that the Angiotensin II (Ang II) plays a pivotal role in the 
pathogenesis of atherosclerosis and vulnerable plaque development. Ang II type 1 receptors 
(AT1R) are expressed in a variety of cell types including bone marrow (BM)-derived cells. These 
are mainly constituted of macrophages and T lymphocytes which are key players in atherogenesis 
in general and Ang II-mediated atherosclerosis in particular. Whether Ang II drives atherogenesis 
via direct AT1R signaling on BM-derived cells remains unknown. To clear this issue we generated 
ApoE-/- mice selectively lacking AT1R on BM-derived cells. Methods and results: Irradiated 
ApoE-/- AT1R+/+ mice received BM from AT1R-/- donor mice. AT1R+/+ donor mice were used as 
controls. Four weeks after BM reconstitution, mouse model of Ang II-induced vulnerable plaque 
was generated by clipping the left renal artery (2-Kidney 1-clip renovascular hypertension model). 
Hemodynamic and hormonal parameters were measured 4 weeks later. Atherosclerosis 
characteristics were also assessed at this time point. Mean blood pressure, plasma renin 
concentration and activity were not different between 2K1C ApoE-/- mice receiving either AT1R-/- 
or AT1R+/+ BM. Atherosclerotic lesions size was significantly reduced by 69% in 2K1C ApoE-/- 
mice transplanted with AT1R-/- BM as compared to controls (0.20±0.04% vs 0.98±0.25%, p<0.01). 
Moreover, plaques of mice transplanted with AT1R-/- BM showed a more stable phenotype. 
Fibrous cap was thicker (p<0.0001), lipid core smaller (p<0.0001), layering, adventitia 
inflammation, and macrophage content (8.0±2.0% vs 29.9±3.1%, p<0.0001) were significantly 
decreased while smooth muscle cell content increased (17.3±2.6% vs 32.2±5.7%, p<0.05). Plaque 
staging also differed among the two groups of mice. Only 23% of mice lacking the AT1R in 
BM-derived cells developed advanced lesions (fibrofatty nodule or large necrotic/lipid core with 
multiple layers) compared to the 100% found in control mice (p<0.0001).  
Conclusion: These results indicate that Ang II-mediated atherogenesis, and particularly 
development of vulnerable plaques, requires direct Ang II signaling via the AT1R on BM-derived 
cells.  
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Background: Across species, reproduction and metabolism are tightly linked. In women, energy deficit (i.e. excessive 
exercise, weight loss, eating disorders) can lead to functional inhibition of the reproductive axis termed as 
Hypothalamic Amenorrhea (HA). Whether such a suppression of the reproductive axis exists in men is unclear.  
Methods: We studied 7 men presenting with symptoms and biochemical evidence of hypogonadism in association 
with one or more associated factor known to predispose women to HA (i.e. excessive exercise, low body 
weight/weight loss, and/or psychological stress). Subjects underwent detailed hormonal profiling including an 
overnight frequent sampling study of  LH, and DEXA scan for body composition.  Men received counseling on 
minimizing stressors, and were followed to assess for recovery. A group of 20 age matched healthy adults with normal 
testosterone levels served as controls.  
Results: All 7 hypogonadal men underwent complete pubertal development evidenced by full virilization and normal 
testicular size. The hypogonadal men had significantly lower body weight, BMI, and percent body fat compared to 
controls (see Table).  Biochemically, sex steroids (testosterone [T] and estradiol) were significantly lower than 
controls yet sex hormone binding globulin was comparable.  Interestingly, while LH was lower in the hypogonadal 
men, there were no differences in LH pulse frequency or amplitude.  One hypogonadal subject exhibited a complete 
absence of pulses, while the others had normal pulse patterns or nocturnal entrained pulses -  a pattern typically 
seen in HA women.  Notably, Following amelioration of stressors, 3 subjects demonstrate sustained normal T (>9.4 
nmol/L). 
 
Conclusion: In men, hypogonagonadotropic hypogonadism can occur in the setting of energy deficits and 
psychological stress similar to HA in women.  The absence of compensatory changes in LH pulse frequency or 
amplitude suggest a central defect in these men.  Family history of HA in this cohort points to a possible genetic 
susceptibility to disruption of the reproductive endocrine axis.  Additional follow up evaluations  are underway to 
further assess reversibility.  More of these men will need to be studied to better characterize this entity. 
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STAT3alpha interacts with nuclear GSK3beta and cytoplasmic RISK pathway 
and stabilizes rhythm in the anoxic-reoxygenated embryonic heart.  
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Activation of the Janus Kinase 2 / Signal Transducer and Activator of Transcription 3 
(JAK2/STAT3) pathway is known to play a key role in cardiogenesis and to afford cardioprotection 
against ischemia-reperfusion in the adult. However, involvement of JAK2/STAT3 pathway and its 
interaction with other signalling pathways in developing heart transiently submitted to anoxia 
remain unexplored. 
Hearts isolated from 4-day-old chick embryos were submitted to anoxia (30min) and 
reoxygenation (80min) with or without the antioxidant MPG or the JAK2/STAT3 inhibitor AG490. 
Time course of phosphorylation of STAT3alphatyr705 and Reperfusion Injury Salvage Kinase (RISK) 
proteins (PI3K, Akt, GSK3beta, ERK) was determined in homogenate and in enriched nuclear and 
cytoplasmic fractions of the ventricle. STAT3 DNA-binding was determined by EMSA. The 
chrono-, dromo- and inotropic disturbances were also investigated by ECG and mechanical 
recordings. 
Phosphorylation of STAT3alphatyr705 was increased by reoxygenation and reduced by MPG or 
AG490. STAT3 and GSK3beta were detected both in nuclear and cytoplasmic fractions while 
PI3K, Akt and ERK2 were restricted to cytoplasm. Reoxygenation led to nuclear accumulation of 
STAT3 but unexpectedly without DNA-binding. AG490 decreased the reoxygenation-induced 
phosphorylation of Akt and ERK2 and phosphorylation/inhibition of GSK3beta in the nucleus, 
exclusively. Inhibition of JAK2/STAT3 delayed recovery of atrial rate, worsened RR variability and 
prolonged arrhythmias compared to control hearts. 
In the anoxic-reoxygenated embryonic ventricle the ROS-dependent activation of 
JAK2/STAT3 leads to an increase of STAT3 and inhibition of GSK3beta in the nucleus without 
altering transcriptional activity. Activated STAT3 interacts with cytoplasmic components of RISK 
pathway and in addition stabilizes heart rhythm. 
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Objective: Statin use for the treatment of hypercholesterolemia in women of childbearing age is 
becoming increasingly common. However, published data on pregnancy outcome after exposure 
to statins is scarce and conflicting. This contribution addresses the safety of exposure to statins 
during pregnancy.  
Method: In a multi-center (n = 11) observational, prospective study we compared the outcomes of 
249 women exposed during the 1st trimester of pregnancy to simvastatin (n = 124), atorvastatin (n 
= 67), pravastatin (n = 32), rosuvastatin (n = 18), fluvastatin (n = 7) or cerivastatin (n = 1) with a 
control group exposed to non-teratogenic agents (n = 249). Data were collected by members of 
the European Network of Teratology Information Services (ENTIS) during individual risk 
counseling between 1990 and 2009. Standardized procedures for data collection were used by 
each center.  
Results: There was no statistically significant difference in the rate of major birth defects between 
the statin exposed group and the control group (4.0% versus 2.7% OR 1.53; 95% CI 0.52-4.48, p 
= 0.44). The crude rate of spontaneous abortions (12.8% versus 7.1%, OR 1.90, 95% CI 
1.02-3.57, p = 0.04) was higher in the exposed group. However, after adjustment to maternal age 
and gestational age at initial contact, the difference became statistically insignificant. The rate of 
elective termination-pregnancy (8.8% versus 4.4%, p = 0.05) was higher and the rate of deliveries 
resulting in live births was significantly lower in the statin exposed group (77.9% versus 88.4%, p = 
0.002). Prematurity was more frequent in the exposed group (16.1% versus 8.5%; OR 2.07, 95% 
CI 1.12-3.84, p = 0.02). Nonetheless, gestational age at birth (median 39 weeks, IQR 37-40 versus 
39 weeks, IQR 38-40, p = 0.27) and birth weight (median 3280 g, IQR 2835-3590 versus 3250 g, 
IQR 2880-3600, p = 0.95) did not differ between exposed and non-exposed pregnancies. 
Conclusion: This study did not detect a teratogenic effect of statins. Its statistical power is not 
sufficient to reverse the recommendation of treatment discontinuation during pregnancy. At most, 
the results are reassuring in case of inadvertent exposure. 
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Aim of the study: 
High transient ischemic dilation ratio (TID) is correlated with poor cardiac prognosis. Our purpose 
was to determine normal value of TID based on normal myocardial blood flow (MBF) and 
myocardial flow reserve (MFR) quantified by 82Rb cardiac PET/CT. 
Methods: 
49 patients (21 M/ 28 F; sex ratio 0.75) with cardiovascular risk factors (smoking, hypertension, 
obesity, dyslipidemia and familial story) underwent a rest/stress cardiac PET/CT using a dynamic 
acquisition over 6 minutes after an intravenous bolus of 82Rb (1600MBq). Stress acquisition was 
performed during infusion of adenosine over 6 minutes. Data were processed with FlowQuant 
using a two-compartment model (tissular+ vascular) (Lortie.EJNMMI2007;34:1765-1774) to 
determine MBF and MFR. Patients were selected based on normal rest/stress uptake images and 
normal stress MBF (> 2 mL/min/g) and MFR (> 2.0). For every patient TID was semi-automatically 
determined using ECToolbox software.  
Results: 
In total, 98 data sets were successfully performed for both quantitative analysis and for 
assessment of TID. All patients had a summed stress and rest score < 4 and a summed difference 
score <2. Mean MFR was 2.7±0.5. Mean TID was 1.01±0.12. TID was not significantly different 
between men and women (1.01±0.12 vs 1.01±0.11, P=0.86) but was between patients smoking or 
not (1.08±0.11 vs 0.99±0.11, P=0.013). 
Conclusion: 
Based on normal MFR, we determined TID upper limit as 1.24 (mean+1.96SD), that was higher 
than TID normal value previously published (Shi.NuclMedCommun2007;28(11):859-63) based on 
a qualitative myocardial perfusion analysis. Moreover TID value was significantly higher for 
smokers but none between genders. 
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interval, flattens its kinetics and blunts its rate dependence before sustained 
atrial fibrillation 
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Introduction: We recently observed in an acute ovine model of pacing-induced atrial tachycardia 
(PIAT) that rapid atrial capture and fibrillatory conduction were prevented by 2:1 capture mediated 
by decreased excitability. We hypothesize that long-term intermittent PIAT mimicking pulmonary 
vein tachycardia promotes rapid atrial capture beyond the ERP measured in the baseline state, 
fibrillatory conduction and sustained atrial fibrillation (AF) by decreasing activation recovery 
interval (ARI), a surrogate of action potential duration (APD).  
Methods: We specifically developed a chronic ovine model of PIAT using two pacemakers (PM) 
each with a right atrial (RA) lead separated by ~2cm. The 1st PM (Vitatron T70) was used to 
record a broadband unipolar RA EGM (800 Hz, 0.4 Hz high pass filter). The 2nd was used to 
deliver PIAT during electrophysiological protocols at decremental pacing CL (400 beats, from 400 
to 110ms) and long term intermittent RA burst pacing to promote electro-anatomical remodelling 
(5s of burst followed by 2s of sinus rhythm) until onset of sustained AF. ARIs, defined as the time 
difference between the peaks of the atrial depolarisation and repolarisation waves, were averaged 
over 20 consecutive beats at each pacing CL and their restitution kinetics as a function of the 
pacing CL were compared before (i.e. in the baseline state), during and after remodelling (i.e. the 
week before sustained AF occurred) using multiple-way ANOVA. A p<0.05 was considered 
significant. Logarithmic regression was used to fit the ARI-pacing CL relationship (y=a+b ln(x)). 
Results: Intermittent PIAT induced sustained AF on average after 6.0±3.5 weeks of burst pacing 
(n=8 sheep). The figure shows that ARI measured at 400 ms pacing CL before remodelling 
(122±20 ms) was significantly decreased by intermittent PIAT during and after remodelling (99±16 
ms and 98±20 ms respectively, p<0.05). Moreover, the rate-dependence of ARI was significantly 
altered by intermittent PIAT from a steep kinetics (b=34.1, p<0.01) before remodelling to a nearly 
flat relationship during (b=10.9, p=NS) and after remodelling (b=10.9, p=NS). Importantly, there 
was no difference in atrial structure and fibrosis as assessed by light microscopy between 
remodelled sheep and a set (n=4) of unremodelled control sheep. 
Conclusions: Using standard pacemaker technology, atrial ARIs as a surrogate of APDs were 
successfully measured in vivo during the electrical remodelling process leading to AF. The 
facilitation of AF by pacing-induced atrial tachycardia mimicking salvos from pulmonary veins is 
heralded by a significant shortening of ARI, with loss of rate-dependence in the remodelled as 
compared to the unremodelled state. 
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Excess salt intake is one of the primary risk factors of arterial hypertension. The kidneys play an 
essential role for salt homeostasis and consequently blood pressure. In the proximal tubule the 
bulk of the filtrate is reabsorbed constitutively, whereas in the distal region active Na+ transport is 
finely tuned. This transport is regulated by various hormonal pathways including aldosterone that 
regulates the reabsorption at the level of the ASDN (Aldosterone Sensitive Distal Nephron), 
comprising the late distal convoluted tubule (DCT), the connecting tubule (CNT) and the cortical 
collecting duct (CCD).  In the ASDN, the amiloride-sensitive epithelial Na+ channel (ENaC) plays 
a major role in Na+ homeostasis, as evidenced by gain-of function mutations in the genes 
encoding ENaC, causing Liddle’s syndrome, a severe form of salt-sensitive hypertension. In this 
disease, regulation of ENaC is compromised due to mutations that delete or mutate a PY-motif 
(PPXY) in ENaC. Such mutations interfere with the interaction of the PY-motifs with the 
WW-domains of the Nedd4-2 ubiquitin-protein ligase, leading to reduced ubiquitylation and 
endocytosis of the channel, and consequently to increased channel activity at the cell surface. 
After endocytosis ENaC is targeted to the lysosome and rapidly degraded. The cellular 
mechanisms that are involved in lysosomal targeting are not known. Similarly to other 
ubiquitylated and endocytosed plasma membrane proteins (such as the EGFR), it is likely that the 
multi-protein complex system ESCRT is involved. To investigate the involvement of this system we 
tested the role of one of the ESCRT proteins, Tsg101. Co-immunoprecipitation experiments in 
Hek293 cells showed that Tsg101 interacts with ENaC, and that this primarily involves the 
ubiquitin-binding domain UEV in Tsg101. We then wanted to know if Tsg101 plays a role in ENaC 
degradation in renal epithelial cells and suppressed Tsg101 in mCCDcl1 cells by shRNA. Western 
blots confirmed that Tsg101 was reduced and found, that ENaC subunits were higher expressed. 
These cells were then cultured on collagen-coated permeable filters and equivalent 
amiloride-sensitive currents were measured. Suppression of Tsg101 caused an increase of 
transepithelial currents, which could be further stimulated by aldosterone. Moreover, cell surface 
biotinylation experiments showed also a higher expression of ENaC subunits at the apical 
membrane. Taken together our data imply Tsg101 and likely the ESCRT system in ENaC 
degradation by the endosomal/lysosomal system. 
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In response to various pathological stresses, the heart undergoes a remodeling process that is 
associated with cardiomyocyte hypertrophy and to the progression to heart failure. Our earlier 
work indicates that AKAP-Lbc, an A-kinase anchoring protein (AKAP) with an intrinsic Rho-specific 
guanine nucleotide exchange factor activity, is critical for activating RhoA and transducing 
hypertrophic signals downstream alpha1-adrenergic receptors (α1-ARs). To identify the effector 
proteins linking AKAP-Lbc to the activation of cardiomyocyte hypertrophy, we followed a proteomic 
approach to determine the signaling molecules associated with the AKAP-Lbc signaling complex. 
Analysis of AKAP-Lbc immunoprecipitates using mass spectrometry identified the nuclear 
factor-kappa b (NF-κB) activating kinase IKKβ as an AKAP-Lbc interacting protein. This raises the 
hypothesis that AKAP-Lbc might promote cardiomyocyte growth by maintaining a signaling 
complex that promotes the activation of the pro-hypertrophic transcription factor NF-κB. 
Interestingly, our results indicate that AKAP-Lbc is an important mediator of NF-κB activation as 
shown by the fact that suppression of AKAP-Lbc expression by infecting cells with lentiviruses 
encoding AKAP-Lbc-specific short hairpin RNAs strongly reduces the transcriptional activation of 
NF-κB induced by α1-ARs. Moreover, overexpression of a mutant form of AKAP-Lbc displaying 
constitutive Rho-GEF activity promotes NF-κB activation in HEK-293 cells. Importantly, AKAP-Lbc 
mediated NF-κB stimulation involved RhoA, Rho kinase and IKKβ since it is inhibited by the 
dominant negative T19N mutant of RhoA, Rho kinase inhibitors, and the dominant negative 
mutant K44M of IKKβ. Mapping analysis of the interaction between AKAP-Lbc and IKKβ indicates 
that IKKβ interacts with a region located within the Dbl homology domain of AKAP-Lbc. Altogether 
these results indicate that in HEK cells AKAP-Lbc can organize a transduction pathway including 
RhoA, Rho-Kinase and the IKK complex that is required for the activation of NF-kB. Future 
experiments will assess whether this complex mediates the hypertrophic responses induced by 
α1-ARs. 
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Pathological cardiac remodeling is a multifactorial phenomenon characterized by the hypertrophic 
growth of cardiomyocytes and cardiac fibrosis. During this process, cardiac fibroblasts undergo 
phenotypic changes and become highly proliferative and invasive in response to specific 
hormones, growth factors and pro-inflammatory cytokines. These activated cells increase the 
secretion of extracellular matrix proteins such as collagen. This process leads over the time to an 
increased heart stiffness and diastolic dysfunction. Among the profibrotic factors that are secreted 
in the myocardium in response to stress, GPCR agonist such as angiotensin II has been shown to 
play a major role in mediating the cellular responses that ultimately lead to fibrosis. The small 
GTPase RhoA plays an important role in mediating many of the cellular responses associated with 
cardiac fibrosis that are induced by angiotensin II. However the exchange factors that selectively 
control RhoA activation during these processes are yet to be identified. We have recently shown 
that AKAP-Lbc, a cardiac A-kinase anchoring protein (AKAP) with an intrinsic Rho-specific guanine 
nucleotide exchange factor activity, is critical for activating RhoA and transducing hypertrophic 
signals downstream of  angiotensin II receptor. Expression analysis of the RhoGEF expressed in 
cardiac fibroblasts revealed the presence of AKAP-Lbc as well as other RhoGEFs, including 
p115-RhoGEF, PDZ-RhoGEF and LARG. These findings raise the hypothesis that AKAP-Lbc and 
potentially additional RhoGEFs, might mediate the activation of transduction cascades that 
promote cardiac fibrosis. In order to determine the implication of these signaling molecules in the 
process of cardiac fibrosis, we have initially determined whether angiotensin II stimuli could 
enhance the expression of these different RhoGEFs in primary cultures of rat cardiac fibroblasts. 
We could then show that downregulation of selected RhoGEFs using lentivirus-delivered shRNAs 
could impair RhoA activation induced by profibrotic stimuli. Using a similar strategy, we are 
currently determining whether downregulation of the expression of these RhoGEFs can impair 
fibrotic responses such as fibroblast differentiation, migration and invasiveness in response to 
angiotensin II. 
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Ubiquitylation (i.e. the modification of proteins with ubiquitin) is a covalent post-translational 
modification, comparable to acetylation, glycosylation, methylation, or phosphorylation. Besides its 
well known role in proteasome dependant degradation, a plethora of cellular roles has been 
attributed to ubiquitin, including in DNA repair, protein sorting or signaling. Usually these functions 
depend on the type of ubiquitylation (i.e. mono-, multi- or poly-ubiquitylation). Ubiquitin-dependent 
pathways play also an important role in the regulation of a number of ion channels and transport 
proteins including the epithelial Na+ channel (ENaC), whose activity is under the control of 
aldosterone and the mineralocorticoid receptor. Thereby, this hormone regulates the activity or 
expression of different enzymes such as NEDD4-2, Sgk1 or USP2-45, which all are involved in 
ENaC ubiquitylation and subsequently activity of this channel.  
In this study, using immobilized ubiquitin binding domains, we have identified the mineralocorticoid 
receptor (MR) as an ubiquitylated protein at basal conditions either in M1 cells transfected with the 
MR, or in mCCDcl1 cells derived from the cortical collecting duct. Activation of the receptor by 
aldosterone leads to the rapid deubiquitylation of the receptor. Because Usp2-45 is an 
aldosterone-induced deubiquitylating enzyme, we were interested to know if Usp2-45 is involved in 
the deubiquitylation of the receptor. Surprisingly we found that over-expression of USP2-45 
dramatically decreased the level of MR due to proteasomal degradation, and conversely, RNAi 
dependant cell depletion of USP2-45 lead to stabilization of the receptor. This observation was 
confirmed in vivo in USP2 KO mice, where the expression of MR in the kidney is enhanced. Our 
results suggest a novel role for USP2-45 as a negative regulator of MR pathway that mediates the 
degradation of MR in response to aldosterone. 
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In nuclear medicine, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scan is 
an imaging technique based on the measurement of FDG uptake in tissues. In the heart, FDG 
PET scan allows differentiating viable myocardium from necrotic areas in the left ventricle. This 
method measures the size of the infarcted area to quantify the extent of damage. Moreover, this 
technique, by comparing the infarcted area over time can provide information regarding the 
progression of the damage, which can be useful to determine the effect of treatments aimed at 
improving recovery after infarction. For instance, this method could be very effective to assess the 
potential of transplanted cardiac precursor cells in vivo, and to investigate regenerative 
mechanisms in the adult heart. The quality of the acquired pictures depends on myocardial uptake 
of the glucose analogue FDG, which itself depends on metabolic conditions. Hyperinsulinemic 
euglycemic clamping improves image quality. Premedication with Acipimox, a nicotinic acid 
derivate and hypolipidemic agent, which decreases free fatty acid mobilization, produces quality 
enhancement similar to clamping, and leads to a more homogenous FGD uptake. The goal of this 
study was then to establish the methodology in the mouse, and to evaluate whether infarct size 
can be precisely determined by FDG PET scan. Furthermore, we also evaluated whether 
Acipimox increased image quality. Mice were separated into sham-operated and myocardial 
infarcted groups and underwent cardiac FDG PET scan. FDG was administrated via the tail vein, 
and images were acquired using a microPET machine. Data were analyzed using dedicated 
software for quantitative image processing (PMOD Technologies Ltd) that allows the determination 
of localized FDG standard uptake value (SUV). Results demonstrated that myocardial viability and 
the extent of necrotic area can be precisely measured using FGD PET scan. Preliminary data 
suggested that additional Acipimox administration did not further increase uptake. However, 
further analysis is ongoing to evaluate whether this pharmacological treatment improve 
homogeneity.  All together, this study establishes the conditions for a routine analysis of 
myocardial damage and recovery using FGD PET scan in the mouse. 
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Uric acid is a metabolite of purine degradation and hyperuricemia is strongly associated with gout 
and kidney stones, and has been linked to several other pathological conditions such as 
hypertension, the metabolic syndrome and inflammation. GLUT9 (SLC2A9) is a newly identified 
urate transporter, initially cloned by homology with the glucose transporter family. GLUT9 
mutations in humans have been shown to be causative for the familial renal hypouricemia, a 
condition in which affected patients present hypouricemia, renal uric acid wasting, kidney stone 
and a propensity to acute renal failure during strenuous exercise. 
The in vivo role of GLUT9 has been recently unravelled in the mouse. Mice with whole body 
deletion of Glut9 are hyperuricemic and display severe nephropathy that results from intratubular 
uric acid precipitation. Mice in which GLUT9 has been deleted only in the liver present with 
hyperuricemia, due to the role of GLUT9 in facilitating the entry of uric acid in the hepatocyte for its 
degradation by the enzyme uricase.  
By contrast, the role of GLUT9 in the kidney remains largely unknown. In particular, the exact 
localization of GLUT9 (proximal vs. distal tubules, apical vs. basolateral side of the epithelium), 
and the precise mode of urate transport have not been solved yet.  
In order to address these points, we generated mouse models carrying kidney-specific disruption 
in different parts of the tubules and showed that GLUT9 is essential for proper urate reabsorption 
in the mouse kidney. Indeed, tetracycline-inducible whole nephron deletion of GLUT9 led to 
hyperuricosuria. These results point out GLUT9 as a crucial partner in the renal handling of uric 
acid and designate it as a new target for uricosuric agent. 
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The activity of the heart is modulated by the sympathetic system through the activation of 
β-adrenergic receptors that downstream activate the cyclic AMP-dependent protein kinase, PKA. 
This is a ubiquitous, serine/threonine kinase that after β-adrenergic stimulation phosphorylates a 
set of different substrates within the cardiomyocyte, changing the contractile properties of the cell. 
Due to the broad specificity of PKA, it is needed to target the kinase close to its substrate. 
Evidence collected over the last years demonstrates that compartmentalization of PKA is achieved 
through the association with A-kinase anchoring proteins (AKAPs). These scaffolding proteins 
share the capacity to bind the regulatory subunits of PKA inside cells and thanks to unique 
targeting domains contained within each AKAP, PKA is localized at specific subcellular regions.  
Several AKAPs have been identified in adult cardiac myocytes with roles as important as the 
control of calcium handling, cardiac contractility, the action potential duration or the regulation of 
cardiomyocyte hypertrophy.  
For the purpose of determining the role of new AKAPs in the regulation of the cardiac activity, we 
followed a proteomic approach which allowed us to identify AKAP2 as a very abundant AKAP in 
the heart. AKAP2 also known as AKAP-KL, since it was first characterized in kidney and lung, is a 
broadly expressed protein whose function is still unknown. In order to characterize a possible 
protein complex interacting with AKAP2, we used specific antibodies against AKAP2 to perform 
immunoprecipitations from lysates of adult rat hearts. The immunoprecipitated proteins were then 
analyzed by mass spectrometry for the identification of possible AKAP2 interacting proteins. This 
strategy allowed us to identify the nuclear receptor coactivator 3 (NCoA-3) as protein associated 
with AKAP2. NCoA-3 is a member of the p160 family of steroid receptor coactivators (SRCs), and 
its function within the cell is to potentiate the transcriptional activity of nuclear receptors. We were 
able to confirm the interaction between AKAP2 and NCoA-3 by bi-directional 
co-immunoprecipitations. Current studies are aimed at characterizing the role of AKAP2 in the 
regulation of cardiac gene expression through its interaction with NCoA-3. 
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Background and aims: 
During the initial phases of type I diabetes mellitus, pancreatic β-cells are exposed to 
proinflammatory cytokines, such as IL-1β, TNFα and IFNγ. Chronic exposure to these cytokines 
has a detrimental impact on the regulation of β-cell gene expression leading to impaired insulin 
secretion and apoptosis. AUF1 belongs to a family of proteins that control mRNA stability and 
translation by associating with adenosine- and uridine-rich regions in the 3’UTR of target 
messengers. AU-rich sequences are found in mRNAs encoding for many proteins involved in 
stress and/or inflammation processes. AUF1 can be activated by different signaling cascades and 
translocates from the nucleus to the cytoplasm to accomplish its regulatory functions. In this study, 
we investigated the possible involvement of AUF1 in cytokine-induced β-cell dysfunction. 
Materials and methods: 
The expression of the four AUF1 isoforms (p37, p40, p42, p45) was analyzed by Western blotting. 
AUF1 activation was assessed by following the redistribution of the isoforms from the nucleus to 
the cytoplasm. To test for their potential impact on insulin biosynthesis, insulin secretion and 
apoptosis, each isoform was overexpressed individually in the mouse insulin-secreting cell line 
MIN6. The contribution to cytokine-mediated β-cell dysfunction was evaluated by preventing the 
expression of AUF1 isoforms using specific siRNAs. The effect of AUF1 on the expression of 
potential targets was assessed by Western blotting. 
Results: 
We found that MIN6 cells and human pancreatic islets express the four AUF1 isoforms (p42>p45 
>p37>p40). AUF1 isoforms were mainly localized in the nucleus but partially translocated to the 
cytoplasm upon 24 hours exposure of β-cells to cytokines. Over-expression of each of the 
isoforms did not affect glucose-induced insulin secretion but led to an increase in apoptosis. This 
effect was at least in part mediated by decreasing the expression of the anti-apoptotic protein 
Bcl2. Silencing of AUF1 isoforms restored Bcl2 levels and protected MIN6 cells and human 
pancreatic islet cells from cytokine-induced apoptosis.  
Conclusion: 
Taken together, our findings point to a contribution of AUF1 to the deleterious effects of cytokines 
on β-cell functions and suggest a possible role for this RNA-binding protein in the early phases of 
type I diabetes. 
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Introduction: Type 2 diabetes (T2D) is the most common form of diabetes. The disease manifests 
when islets β-cells from endocrine pancreas fail to release sufficient insulin to compensate for 
insulin resistance in target tissues. Impairment of β-cell activity includes loss of glucose-induced 
insulin secretion and reduction in β-cell mass. It is now accepted that environmental factors as 
hyperglycaemia and hyperlipidemia contribute to β-cell dysfunction. In such diabetic context, β-cell 
has been shown to develop a stress, the endoplasmic reticulum (ER) stress, which participates in 
the alteration of β-cell physiology. The adverse effects of all the stressors rely on activation of the 
c-Jun N-terminal kinase (JNK) pathway. The prolonged JNK activity is achieved by a decrease in 
the contents in the MAPK8 interacting protein 1 also called JNK-interacting protein 1 (JIP-1) or 
Islet Brain 1 (IB1). The function of JIP-1 is to tether the kinases for activation of the JNK pathway. 
Our attempts are done to highlight potential link between the ER stress and JIP-1-dependent JNK 
activation.  
Methods: mRNA expression of diabetic patients has been measured. Mouse and human islets, as 
well as mouse and rat insulin secreting cell lines (MIN6 and INS1E respectively), were treated with 
the ER stress inducers thapsigargin and tunicamycin. The protein and the mRNA contents were 
analysed. To study the promoter activity we used a Luciferase assay. Two proteosomal inhibitors, 
lactacystin and MG132, as well as the lysosomal inhibitor chloroquin, are used to test protein 
degradation. 
Results: Western blotting revealed that thapsigargin induces ER stress in our cell models. By real 
time PCR we have observed that diabetic patients present a significant decrease of JIP-1, and this 
is associated with an increase of the ER stress marker CHOP. Tunicamycin or 
thapsigargin-induced ER stress result in the decrease of JIP-1 expression at protein and mRNA 
levels in MIN6 cells as well as INS1E cells. Similar observations have been done on mouse and 
human islets treated with thapsigargin. Also the promoter activity of JIP-1 was decreased by 
thapsigargin. Blocking the protein degradation by proteosomal and lysosomal inhibitors show that 
JIP-1 protein content is degraded only in the proteasome. 
Conclusion: these data highlight the contribution of the ER stress in the defects of the scaffold 
protein JIP-1 and suggest that the downregulation may be achieved by the binding of a 
transcription factor and by protein degradation via the proteasome. 
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Rationale: Fish Oil (FO) is known to blunt inflammatory responses and to reduce arrhythmias. 
Cardiac surgery patients exhibit a strong inflammatory response and suffer postoperative 
arrhythmias. The aim of the study is to test if short infusion of FO modifies membrane composition 
and n-3/n-6 ratio, and clinical course of patients undergoing elective coronary artery bypass 
surgery. Preliminary 2009 data already showed that 2 preoperative 0.2g/kg intravenous FO 
infusions resulted in a significant incorporation of EPA/DHA in the cardiac tissue and platelet 
membranes 
Methods: Prospective randomized placebo controlled trial in 30 patients, receiving 3 short 
infusions 0.2g/kg of FO (Omegaven, FreseniusKabi) or placebo (P). Infusion timing: evening 
before, at premedication and immediately after surgery. Blood samples: before and after each 
infusion and on day after surgery. Determination of plasma triglycerides (TG) levels, platelet & 
cardiac tissue fatty acid composition. Hemodynamic data: heart rate (HR), mean arterial pressure 
(MAP), Temperature (T°); lactate, glucose, HbCO and Norepinephrine doses (NE) were recorded 
during 24 hours. Stat: t-tests, Wilcoxon signed rank, Area under the curve (AUC). 
Results: 22 patients aged 65±10years were enrolled. Plasma TG peaked after infusion, remaining 
within safe ranges. The EPA membrane composition changes were confirmed. In the FO group, 
HR (89 vs 94 bt/min, p<.000) and T° (36.8 vs 37.2°, p<0.0001) were lower, MAP was higher (88 vs 
81 mmHg, p<.000) with the same NE dose. Glucose, Lactate and HbCO AUC were lower (p< 
0.05) in the FO group. No side effects. Cytokines to come. 
Conclusion: Significant increases in EPA membranes incorporation were confirmed after 2-3 FO 
infusions. Preconditioning with FO significantly blunted clinically observable T°, cardiovascular and 
metabolic responses, resulting in better patient stability. 
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Rationale: Fatty acid cell membranes composition (MC) determines structure, stability, and fluidity 
and related membrane functions. N-3 and N-6 classes of Poly Unsaturated Fatty Acids (PUFA) are 
known to directly modulate the inflammatory response. Literature suggests improvement of clinical 
outcome in patient receiving parenteral nutrition containing FO. While the PUFA dose is known to 
influence the MC, there are no data on the influence of the infusion mode (continuous versus 
intermittent) on MC.  
Methods: Prospective randomized placebo controlled trial in patients admitted to ICU after 
coronary artery bypass grafting (CABG) or acute myocardial infarction (AMI) entering a pre- and 
post-conditioning trial. The subjects received FO (Omegaven®) or placebo (P). The FO patients 
received the same 0.6 g/kg FO dose over 24h: CABG patients received 3 intermittent infusions 
0.2g/kg of FO over 2h each on the evening before, at premedication and immediately after 
surgery; AMI patients received a continuous 24h infusion with a loading dose of 0.2g /kg over 3h 
followed by a 21h continuous 0.4g/kg FO infusion. Blood samples: CABG before and after each 
infusion, AMI at baseline, then after 12h and 24h. The determination of platelet MC were 
performed at baseline (T0) after 12h (+/-2h for CABG) (T12) and at the end of the last infusion 
T24.  
Stat: median and Wilcoxon 
Results: A total of 34 patients were included (CBAG n=23, AMI n=11). PUFA incorporation 
differed between the 2 administration modes. After intermittent infusion EPA MC increased 
significantly more already at T12 (p=.004) than after slow continuous infusion (p=0.46), while DHA 
increased significantly more at T24 with the slow continuous infusion mode (P=.009) versus 
intermittent infusion (P=0.42). 
Conclusion: The FO infusion mode (intermittent versus continuous) appears to be one more 
determinant of the rate of incorporation of the different PUFAs into the cell membranes 
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The epithelial sodium channel (ENaC) plays an important role in sodium balance, blood volume 
and blood pressure. It is composed of three sub-units α, β and γ. Although the role of ENaC in 
sodium reabsorption in kidney and lung is well established, less is known in colon. The aim of this 
project is to investigate the importance of αENaC expression in the distal colon for maintaining 
sodium and potassium balance. It was assessed by creating a double-transgenic mouse in which 
αENaC expression is deleted in the colonic crypt cells. Mice in which αENaC was selectively 
inactivated in colon using the villin promoter (El Marjou et al., 2004) have been generated. 
Quantitative RT-PCR and protein expression analysis revealed that the knockout in distal colon is 
nearly complete. Following standard & low sodium diet, the mice show no difference in body 
weight or length of intestine. Plasma sodium and potassium electrolytes are in the normal range. 
Urine electrolytes show sodium retention under low sodium diet indicating compensatory 
mechanism from the kidney to avoid sodium loss.  In contrary, these mice exhibit a highly 
significant decrease in amiloride-sensitive rectal potential difference that is maintained under 
standard and salt-deficient diets indicating that in colon, electrogenic sodium transport is mainly 
mediated by ENaC. This is also accompanied by a loss in cyclic variation of ENaC activity 
throughout the day. Using this gene targeting approach, we have observed that ENaC-mediated 
sodium reabsorption in colon is relevant for sodium homeostasis, but this loss can be 
compensated by kidney. Ongoing studies will address compensation of sodium reabsorption by 
the kidney.  
This work has been supported by Leducq foundation, TNH & FBM fellowship 
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BACKGROUND: Increasing evidence suggests that serum uric acid (SUA) concentration is 
independently associated with blood pressure (BP) in adults. We examined this association in 
young adults at an age where anti-hypertension treatment, co-morbidity or several other potential 
confounding factors are unlikely to occur.  
METHODS: In 549 participants aged 19-20 years from a population-based cohort study 
(Seychelles Child Development Study), we measured BP, anthropometric variables including 
weight, height, waist circumference (WC) and fat mass (using bioimpedance), lifestyle behaviors 
through a questionnaire, and SUA and blood lipids. 
RESULTS: Mean (SD) SUA was higher in males than females, respectively 0.33 (0.08) mmol/L 
and 0.24 (0.07) mmol/L. BMI was higher in females than males and BP was higher in males than 
females. Systolic and diastolic BP was significantly associated with SUA in males and in females. 
However, the magnitude of the linear regression coefficients relating BP and SUA was attenuated 
by up to 50% upon adjustment for waist circumference (WC) or body fat mass (BFM), while 
virtually unchanged upon adjustment for body mass index (BMI) or waist-to-hip ratio (WHR). The 
attenuating effect of WC or BFM was stronger in females than males. Further adjustment for 
alcohol intake or triglycerides did not alter the association between SUA and BP. In fully adjusted 
models, SUA remained associated with diastolic BP but not with systolic BP. 
CONCLUSION: In young adults, the association between SUA and BP was largely dependent on 
waist circumference or fat mass, but not BMI or WHR, and only diastolic BP remained significantly 
associated with SUA upon full adjustment. These findings suggest a role of abdominal adiposity in 
the link between hyperuricemia and hypertension. 
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Effects of Dietary Protein and Branched Chain Amino Acids on Hepatic 
Steatosis in Mice 
 
 
1Minehira Castelli K., 1Theytaz F., 1Sanno H., 1Seyer P.  
 
 
Department of Physiology1  
 
 
 
Addition of dietary protein into high-fat diet decreases the incidence of hepatic steatosis in 
humans. The mechanism by which dietary protein reduces liver fat accumulation is unknown, 
however. To further understand this, we have been testing whether the protective effect of protein 
is due to increased BCAA content in the diet or not.  
 We fed mice with standard diet (C: fat 10 %, protein 20%), high-fat diet (HF: fat 45%, 
protein 20%), high-fat high-protein diet (HFHP: fat 45%, protein 40%), and high-fat high-BCAA diet 
(HF-BCAA: fat 45%, protein 23%, same BCAA content as HFHP) for 10 weeks.  
 We found that mice fed HF and HF-BCAA became obese/insulin resistant and developed 
severe hepatic steatosis, whereas HFHP diet protected mice from these metabolic derangements. 
We found that reduction in hepatic de novo lipogenesis in HFHP mice explained partly the 
protection. Further pair-feeding studies clearly demonstrated that dietary protein reduced liver fat 
via suppression of appetite. Unexpectedly, these effects were not observed in HF-BCAA groups, 
judged by monitoring food intake and the expression of neuropeptides in hypothalamus. In 
addition to the differential effects on appetite, these mice fed HF-BCAA presented highest tPAI-1 
expression in the liver and the adipose tissue among other groups. These results suggest that the 
addition of BCAA to the HF diet renders mice prone to obesity and increases a risk of 
cardiovascular disease.  
 Our studies clarified that dietary protein reduced liver fat accumulation via reduction in 
hepatic de novo lipogenesis and appetite. Furthermore this was not due to the increased BCAA 
content in the diet. 
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Role of calcineurin/NFAT pathway in lymphatic vascular development 
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The formation of new blood and lymphatic vessels by (lymph)angiogenesis is the hallmark of many 
human cancers, and promotes tumor growth and metastasis. Signaling via vascular endothelial 
growth factors (VEGFs) and their receptor tyrosine kinases expressed on endothelial cells 
(VEGFRs) are essential for vascular growth and remodeling. VEGFR-2 and -3 are both implicated 
in (lymph)angiogenesis. The intracellular signaling pathways following VEGFR-2/3 activation on 
endothelial cells are not well studied in the in vivo context, although a wealth of in vitro studies 
have provided many important insights. In this study we focus on calcineurin/NFAT signaling 
pathway, which is activated by VEGF-A and VEGF-C in blood and lymphatic endothelial cells in 
vitro, and which we have recently shown to contribute to lymphatic development in vivo (ref.1). We 
have now developed several genetic mouse models, which allow tissue- and temporal-specific 
deletion of calcineurin to investigate requirements for calcineurin/NFAT signaling during different 
stages of embryonic development and in adults during tumor progression. 
 
Reference: 
1.  Norrmén C., Ivanov K., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., 
Puolakkainen P., Horsley V., Hu J., Augustin H.G., Ylä-Herttuala S., Alitalo K., and Petrova T.V. 
(2009) FOXC2 controls formation and maturation of lymphatic collecting vessels through 
cooperation with NFATc1. J Cell Biol, 185 (3): 439-457. 
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Control of sodium and potassium transport by ENaC along the aldosterone 
sensitive distal nephron. 
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ENaC plays a critical role in sodium homeostasis as emphasized by gain-of-function mutations in 
patients suffering from Liddle’s syndrome – a severe form of hypertension. Moreover, 
loss-of-function mutations are found in patients with pseudohypoaldosterism type 1 (PHA-1), 
which is a severe and life-threatening salt-wasting syndrome. To study ENaC function, constitutive 
knockout for each of the three subunits of ENaC has been developed. αENaC knockout mice 
display lung clearance failure, hyperkalemia and sodium loss, and β and γ ENaC knockout mice 
hyperkalemia and sodium loss. The aim of the present work is to study the comparative role of α 
and γENaC in control of Na+ and K+ transport in the aldosterone sensitive distal nephron.  
To address this question, we crossed a double transgenic mouse (Pax8/LC1) which expresses the 
reverse tetracycline transactivator under the control of a Pax8 promoter (expressed along along 
the entire nephron) and Cre recombinase under the control of a tetracycline response element 
with the floxed Scnn1a or Scnn1g mouse.  
After six days of doxycycline treatment, under normal salt diet, 4 week -old α and γENaC 
nephron-specific knockout mice kept loosing body weight, whereas wild type mice continued to 
gain weight. Both models develop life threatening hyperkalemia, whereas only αENaC 
nephron-specific knockout mice present a severe hyponatremia. This is associated with an 
increase in daily cumulative Na+ loss in αENaC nephron-specific knockout mice, whereas γENaC 
nephron-specific knockout mice surprisingly develop a significant decreased cumulative urinary K+ 
loss. 
Contrary to nephron-specific Scnn1a-deficient, deletion of Scnn1g is not sufficient to alter Na+ 
reabsorption, but surprisingly K+ excretion is decreased. There is an unexpected dissociation 
between Na+ and K+ transport suggesting that ENaC mediated reabsorption is no longer coupled 
to ROMK mediated secretion. 
This work is supported by Leducq foundation, Transatlantic Network of Hypertension. 
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PPARβ/δ involvement in the control of vascular permeability  
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Endothelial cells form a semi-permeable barrier that participates in exchange of plasma 
fluids, proteins and cells, and helps in maintaining the physiological function of organs as well as 
the circulatory homeostasis. Vascular permeability is increased in acute and chronic inflammation, 
cancer and wound healing. It is mediated by exposure to some vascular permeability increasing 
factors, such as vascular endothelial growth factor (VEGF).  
The peroxisome proliferator-activated receptors (PPAR) belong to the nuclear hormone 
receptor (NHRs) family of ligand-activated transcription factors. Three isotypes, PPARα, PPARβ/δ 
and PPARγ have been identified. They are all expressed in endothelial cells (ECs), and recent 
data have shown that important mechanisms for vasculogenesis and angiogenesis, such as cell 
proliferation/differentiation, directional sensing/migration, and survival, involve PPARs. They were 
reported to modulate the expression of pro-angiogenic soluble factors, such as VEGF-A and may 
also participate in the regulation of the expression of VEGF receptors. What is more, they were 
shown to modulate the PKBα/Akt1 pathway (a pathway activated by most angiogenic factors). 
Furthermore, PPARβ/δ activates the Rho GTPases and actin dynamics, which are also involved in 
cell-cell junction dynamics.  
Using organ culture models of rings of mouse aorta, culture of human dermal microvascular 
endothelial cells (HDMECs) and genetically modified mouse in vivo model, we decided to study  
the consequences of loss or gain in PPARβ/δ activity in endothelial cell functions. We wish to 
know what are the mechanisms underlying PPARβ/δ -dependent adult vessel permeability? As 
well as, if PPARs are pharmaceutical targets able to modulate vessel permeability?  
So far, we have shown that the activation of PPARβ/δ accelerates EC migration in a 
monolayer scraping assay and promotes vessel sprouting in murine aorta explants. In vivo, we 
observed that dermal vessel acute permeability in response to VEGF-A stimulation is strongly 
impaired in PPARβ/δ -/- animals. Additionally, observation of the dermal vessel morphology 
showed a clear enlargement of the wild-type dermal vessels upon VEGF-A injection, whereas the 
vessels of the PPARβ/δ -/- animals showed almost no enlargement.  
Based on the data obtained so far, we suggest that PPARβ/δ may act on intracellular 
signaling cascades in ECs, downstream the VEGF-A receptor. The project will be continued by 
addressing the mechanisms by which PPARβ/δ impact on vessel permeability in endothelial cells. 
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Neurotransmission in the Vasculature, Heart and Kidney  
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The vasculature and circulatory organs have a rich innervation by autonomic sympathetic fibers. 
Their efferent neurotrans-mission is by noradrenaline (NA) released together with neuropeptide 
co-transmitters such as neuropeptide Y (NPY) while afferent fibers release calcitonin-gene related 
peptide or substance P (CGRP, SP). Using a highly specific monoclonal antibody and an 
immunohisto-chemical staining technique with free-floating kryosections, we for the first time 
demonstrate the co-presence of angiotensin II (Ang-II) in autonomous efferent and afferent fibers 
innervating the vasculature, heart and kidney in rat, pig and human tissue samples. Tissue 
co-staining of Ang II with adrenergic markers tyroxine hydroxylase (TH) and 
dopamine-β-hydroxylase or with synaptophysin (SYN), a synaptic vesicular marker, identified (1) 
three subtypes of autonomic fibers depending on the presence or absence of these antigens and 
(2) differentiated efferent from afferent neurons. Ang-II co-localized with SYN in synaptic 
varicosities supporting Ang-II as a new neurotransmitter in sympathetic fibers. Ang-II fibers 
innervated distinct intrarenal targets corresponding to specfic subsets of neurons in the dorsal root 
and coeliac ganglia. There was no detectable ganglionic expression of renin mRNA but of 
angiotensinogen (AGT) and cathepsin D mRNA. AGT exspression co-localized with Ang II 
suggesting that ganglionic neurons operate a renin-free Ang-II generating system with its own 
regulation characteristics. Intra-renal microganglia similarly contained Ang-II positive neurons 
partially co-staining TH. Based on these results, a functional scheme for the angiotensinergic 
sympathetic innervation and its vascular and intrarenal targets is proposed. Abnormal 
angiotensinergic sympathetic neurotransmission may play an independent pathogenetic role in 
arterial dysfunction, hypertension, and cardiovascular target organ pathophysiology that has yet to 
be investigated comprehensively. 
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Zinc finger nucleases as tools for rapid engineering of knockout and knock in 
mice  
 
 
1Ponce de Leon V., 1Hummler E.  
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Generating knockout and knock-in mice and rats is of crucial importance for the understanding of 
cardiovascular and metabolic disorders in humans. 
Zinc fingers are peptides that are extremely common in all cells. They are transcription factors and 
therefore can bind specifically to DNA. By artificially combining three or four zinc fingers that each 
recognizes three base pairs, virtually any DNA sequence can be targeted. Zinc Finger Nucleases 
(ZFN) are made of a binding domain with three or four Zinc finger modules and a FokI nuclease 
domain that is activated upon dimerization. FokI generates double-strand DNA brakes (DSB) in 
the target sequence. DSBs activate endogenous DNA repair system. By providing a DNA “repair 
template”, DSBs induce non-homologous end joining (NHEJ) of the targeted gene sequence. 
DSBs can stimulate recombination efficiency of several thousand folds. Without the “repair 
template”, ZFN are used for direct gene targeting by homologous end-joining (HEJ). 
Each Zinc finger module recognizes specifically three base pairs. However, the efficiency of the 
binding depends on external factors such as DNA folding state, and the tertiary structure of the 
whole protein. Therefore, it is important to generate ZFNs by creating zinc finger arrays of random 
sequences that are adjacent to the peptides that actually bind to the gene sequence. Quantitative 
and qualitative assays allow determining the binding efficiency of the array of ZFN so they can be 
selected for their binding capacity. 
Supported by the NCCR, 2010, Kidney:CH, Kidney control of homeostasis 
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Background Angiotensinogen (Ang-N) is the biosynthetic precursor of the pressor octapeptide 
angiotensin-II (Ang II). Increases in plasma Ang-N by genetic polymorphisms or exogenous stimuli 
like estrogen are associated with a blood pressure (BP) rise, salt sensitivity and cardiovascular 
risk. The pathophysiological links between high Ang-N, the resetting of the renin-angiotensin 
system, and BP still remain unclear.  
Methods and Results A new transgenic rat (TGR) with targeted hepatic overexpression of native 
(rat) Ang-N was established to study the effects of high plasma Ang-N. The transgene harbored a 
mutation producing Val5-Ang-II which was measured separately from native Ile5-Ang-II in plasma 
and renal tissue by HPLC. Heterozygous male TGR and wild-type controls (CTR; n=6/group) were 
treated with lisinopril (0.35 mg/kg) for converting-enzyme (ACE) inhibition or vehicle. Male 
homozygous TGR (n=10) had high systolic BP (sBP, +26 mmHg), plasma Ang-N (~20-fold), renin 
activity (~2-fold), renin activity/concentration (~5-fold), total Ang-II (~2-fold, kidney 1.7-fold), and 
decreased concentrations of renin (-45%, kidney -85%) and Ile5-Ang-I and II (-93%, -94% 
respectively) vs. CTR. Heterozygous TGR had increased plasma Ang-N (~10-fold) and sBP (+17 
mmHg). Lisinopril decreased their sBP (-23 vs. -13 mmHg in CTR), kidney total Ang-II/I (~3-fold) 
and Ile5-Ang-II (-70%). It increased kidney renin and Ile5-Ang-I (≥3-fold). TGR kidney Ang-II 
remained higher, and renin lower vs. treated CTR documenting unequal effects  
Conclusion High plasma Ang-N increases plasma and kidney Ang-II levels and amplifies the 
Ang-II response to changes in renal renin secretion showing increased sensitivity. This 
enzyme-kinetic amplification dominates the Ang-II mediated negative feed-back on renin 
secretion, induces a graded increase in sBP and decreases sensitivity to ACE inhibition. 
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Skeletal muscle mitochondrial content and electron transport chain activity in 
older adults at risk for type 2 diabetes: relationship to insulin sensitivity, 
metabolic flexibility and fatty acid oxidation 
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Purpose: The extent to which skeletal muscle mitochondrial content and function contributes to 
metabolic dysfunction in obesity and aging is not clear. We hypothesized that lower mitochondrial 
content and electron transport chain (ETC) activity in human skeletal muscle are associated with 
reduced fatty acid oxidation and insulin resistance, a.k.a metabolic inflexibility in older overweight 
to obese subjects.   
 
Methods: Fifteen older (60-75 years) obese sedentary subjects were compared to six lean 
physically active age-matched control subjects. Mitochondrial content (MC) was measured in 
muscle biopsies using Western blotting (ETC complexes) and HPLC(cardiolipin). ETC activity was 
determined by NADH-oxidase. Insulin sensitivity (IS) was measured with glucose clamps. Resting, 
insulin-stimulated and exercise-induced substrate oxidation was measured by indirect calorimetry. 
Metabolic flexibility was determined by ∆RQ from fasting to insulin-stimulated conditions.  
 
Results: MC, ETC activity, IS, resting and exercise-induced fat oxidation were lower in Obese. 
ETC activity remained lower in Obese even after adjusting for MC (cardiolipin or ETC complexes).  
When all subjects were combined, MC was related to higher IS (R2=0.36,P<0.01) and 
exercise-induced fat oxidation (R2=0.80,P<0.01). ETC activity was associated with resting fat 
oxidation after an overnight fast (R2=0.40,P<0.01), even after adjusting for MC. The protein 
content of all ETC complexes was associated with greater metabolic flexibility (R2=0.13 to 0.25,all 
P<0.01). 
 
Conclusion: Overweight to obese, physically inactive older adults have a reduced skeletal muscle 
mitochondria content, which is related to their insulin resistance and their metabolic inflexibility. 
Moreover, it appears that their lower fasting-induced fat oxidation is associated with a reduced 
ETC activity, even after accounting for muscle mitochondrial content. 
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Objectifs  
 
Déterminer la contribution du CT "à rotation lente" dans la dose effective (DE) totale délivrée lors 
d’une scintigraphie pulmonaire ventilée/perfusée. 
Matériels et méthodes 
 
96 patients (40H/56F, 73±15 ans (19-98) ont bénéficié d’un SPECT-CT pulmonaire ventilé (V) et 
perfusé (Q) (GE « Infinia Hawkeye 4 », GE Healthcare, Milwaukee, USA). Pour (V) : inhalation 
d’aérosol technétié (Technegas®), préparé à partir de 1850 MBq de pertechnétate dans 0.5ml, 
suivie d’un SPECT. Pour (Q) : injection de 154±16 MBq (100-190) de Tc99m-MAA (Maasol®) 
suivie d’un SPECT-CT (axial, 140kV, 2.5mA, épaisseur 5mm). L’activité réelle inhalée est estimée 
à partir du rapport cps(Q)/cps(V), i.e. 53±31 MBq (4-138). Les DE sont calculées à partir des DLP 
indiqués par l’installation et des coefficients EUR 16262 pour le CT; de l’activité inhalée pour (V) et 
de l’activité injectée pour (Q), selon les coefficients ICRP 80 pour la scintigraphie. 
Résultats 
L'activité inhalée est très variable, difficilement prévisible et dépend du status et de la collaboration 
du patient. 
Doses (mSv) Moyenne DS Min Max 
Ventilation (V) 0.80 0.47 0.07 2.07 
Perfusion (Q) 1.70 0.17 1.10 2.09 
CT 2.72  0.27 1.94 3.31 
Total 5.22  0.64 3.77 6.96 
 
Conclusions 
 
Dans le protocole utilisé, le CT "à rotation lente" double la DE totale délivrée lors d'une 
scintigraphie pulmonaire V/Q. Nous proposons de sélectionner les patients et de ne réaliser le CT 
que pour les résultats SPECT équivoques et/ou lorsque l'examen ventilé est ininterprétable. 
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Obese and/or diabetic patients often concomitantly develop a hepatic steatosis (fatty liver), 
an abnormal fat accumulation in the liver. The hepatic steatosis frequently induces hepatic insulin 
resistance, a main cause of diabetic fasting hyperglycemia. However how exactly hepatic steatosis 
leads insulin resistance has not been clearly defined.  
To study molecular mechanisms of insulin resistance in hepatic steatosis, we have been 
using a mouse model of hepatic steatosis dissociated from insulin resistance. Mice without a gene 
of microsomal triglyceride transfer protein (MttpΔ/Δ) in the liver develop a hepatic steatosis due to a 
defect of very low density lipoprotein secretion. We found that MttpΔ/Δ mouse liver induced series 
of genes coding proteins existing on the surface of lipid droplets such as “Cell-death Inducing 
DFFA-like Effector C (cidec)”, “Lipid Storage Droplet Protein 5 (lsdp5)” and “Bernardinelli-Seip 
Congenital Lipodystrophy 2 Homolog (seipin)”. This is particularly interesting, since these genes 
are normally abundant in adipose tissue and rare function of these genes is known in the liver. In 
this study, we tested our hypothesis that lipid droplets proteins might protect the fatty liver against 
the insulin resistance. 
 We first studied whether these genes were involved in hepatic insulin resistance in Alfa 
Mouse Liver 12 (AML12) hepatocyte cell line. By downregulating cidec or seipin expression by 
siRNA technique, we found a defect in akt phosphorylation under insulin stimulation. It strongly 
suggests that the lack of lipid droplets proteins induces insulin resistance in mouse hepatocytes.  
 We next hypothesized that these genes were also involved in human fatty liver and insulin 
resistance. We analyzed their expression levels in liver biopsies from obese patients with diverse 
degrees of hepatic steatosis. We found that the expression of these genes was significantly 
increased in fatty liver. More interestingly, we found that diabetic patients significantly decreased 
the expression of lsdp5 and seipin compared to the non-diabetic patients with the same degree of 
hepatic steatosis. Our results strongly argue that the lipid droplet proteins are tightly involved in 
human hepatic steatosis and play an important role in the development of insulin resistance. 
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mice 
 
 
1Maurer F., 2Peter B., 2Hersch M., 3Kang H., 3Eskin E., 4Beckmann J., 2Bergmann S.  
 
 
Service of Medical Genetics, CHUV1, Department of Medical Genetics, UNIL and Swiss Institute of Bioinformatics2, 
Department of Computer Science and Department of Human Genetics, UCLA3, Service of Medical Genetics, CHUV 
and Department of Medical Genetics, UNIL4  
 
 
 
The long-term goal of our research is to identify genetic variants associated with differential 
responses to β-adrenergic drugs. Previously, we characterized 27 cardiovascular-related traits in 
23 inbred mouse strains. Mice were phenotyped either in control (ctr) condition, in response to 
chronic administration of a single dose of the β-blocker atenolol (ate), or under a low (iso 1) and a 
high (iso 10) dose of the β-agonist isoproterenol. To identify genetic segments underlying 
differences in trait values, we used Efficient Mixed Model Association (EMMA), which corrects for 
population structure and genetic relatedness in model organism association mapping. These 
analyses were performed on a genome-wide basis, using non-transformed trait values recorded in 
ca 1000 individuals and 100’152 informative SNPs. At first, individual phenotypes were analysed 
separately for each drug condition. The significance of the associations was evaluated with an 
F-test and thresholds of significance were set using the Benjamini-Hochberg correction for multiple 
hypotheses testing. Altogether, these analyses retrieved 6325 significant associations, 1450 of 
which mapped at SNPs with minor allele frequencies above 0.1 in the mouse cohort. Scans for 
body weight gain (iso10) and weight of the cardiac atria (ate, ctr) produced the strongest hits and 
the resulting QTLs were supported by several significant neighbouring SNPs. Signals above 
genome-wide significance were also obtained with the majority of the other traits, yet often as 
single, moderately significant hits. Together with the reduced number of candidate loci mapped in 
each analysis, these results are likely reflecting high trait complexity and limited analytical power. 
We then show that a data-driven pooling of related phenotypes can uncover additional significant 
associations, which could not be detected with a single phenotype. This suggests a new way for 
increasing the analytical power of a dataset of related traits. 
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Introduction 
Many organs from increasingly older brain-dead deceased donors can be successfully 
transplanted. We tested the hypothesis that older patients are more vulnerable to organ 
dysfunction related to brain death (BD), and require more complex critical care management. 
Methods 
We performed a retrospective analysis of the ICU clinical information system of 80 consecutive 
patients admitted to our intensive care unit (ICU) between 2002 and 2009 and evolving toward BD. 
The following variables were determined for each patients: time to BD, diagnosis, mean arterial 
pressure (MAP), heart rate (HR), use of norepinephrine (NE), mean dose of NE, use of 
vasopressin, mean dose of vasopressin, use of vasopressin, and PaO2. In addition, status of 
effective donors and the organs transplanted were analysed. Patients were stratified in quartiles 
according to age. Comparisons between all pairs of groups were performed by Tukey-Kramer 
HSD and chi-square for continuous and categorical variables respectively. p<0.05 was considered 
significant. 
Results.  
The quartiles (Q1 to 4) of age had the following ranges: (Q1: 16.2-36.4; Q2: 39.5-52.9; Q3: 
53.0-63.4 and Q4: 63.6-86.0 years). Traumatic brain injury was more frequent in Q1, while 
intra-cerebral hemorrhage and post-anoxic encephalopathy were more frequent in Q4. Diabetes 
was more frequent in Q3 and Q4, and hypertension in Q2 to Q4. Heart rate was higher in Q1 
throughout ICU stay. Mean dose of norepinephrine was lower in Q3 than in Q1 during the phase 
immediately preceding BD. Mean arterial pressure, doses of norepinephrine during other phases, 
gas exchange, ventilator settings, creatinine and time to brain death were not different between 
quartiles. Less hearts were donated in Q4, while the number of kidneys, livers and lungs donated 
and transplanted were not different between quartiles.  
Conclusions 
Beside minor physiological differences, and surprisingly lower mean norepinephrine doses, 
management of older patients suffering from brain-death was not different to that of younger 
patients. We observed neither a greater severity of illness, nor more complex ICU management in 
older patients developing BD. Old patients can be considered as potentially useful brain dead 
deceased donors. 
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The MEF proposes a vast repertoire of metabolic analyses to assess the phenotype of murine 
models of obesity and diabetes, as well as to test the effectiveness of new therapeutic 
pharmacological agents. For this purpose, the MEF  
• Provides services to researchers from Academia and Industry,  
• Ensures the development of new investigation techniques,  
• Teaches some techniques,  
• Supports internal metabolic research at the Center for Integrative Genomics, thus ensuring a 
constant updating of equipment and expertise.  
 
The MEF, first facility of its kind in Switzerland since 2006, offers a comprehensive and constantly 
evolving panel of analyses in areas of Energy metabolism, Glucose homeostasis, and the 
relationship between brain and periphery. Excerpts of services provided by the MEF include:  
• The non-invasive and accurate analysis of body composition by MRS  
• The analysis of metabolism by indirect calorimetry,  
• The analysis of metabolism during exercise (treadmill) by indirect calorimetry,  
• The measurement of energy content in biological samples by bomb calorimetry,  
• The real-time, online measurement of food intake (cumulative and patterns),  
• The real-time, telemetric measurement of body temperature and locomotor activity,  
• The assessment of glucose homeostasis by insulinemic (eu-, hyper-, hypoglycemic) clamps  
• Intracerebral (ICV/IHP) injections of metabolites / drugs / peptides / viruses.  
• Blood chemistry (Hitachi robot) and multiplex assays of cytokines / hormones (Luminex).  
 
The MEF, which has already been very well received by academic researchers and industrial 
customers alike, strives at provide customized, affordable services to the broader scientific 
community in a constant search for excellence and standardization.  
 
Contacts:  
Director: Prof.. Bernard Thorens, Ph.D. Bernard.Thorens@unil.ch 
Supervisor: Frédéric Preitner, Ph.D. Frederic.Preitner@unil.ch 
Blood analyses: Marianne Carrard Marianne.Carrard@unil.ch 
 
Website: 
http://www.cardiomet.ch/en/cmet_home/cardiomet-chercheurs/cardiomet-chercheurs-plateforme_
metabolique.htmhttp://www.cardiomet.ch/en/cmet_home/cmet-cardiomet-centre_for_cardiovascul
ar_and_metabolic_diseases-researchers/cmet-cardiomet-centre_for_cardiovascular_and_metabol
ic_diseases-researchers-metablolic_evaluation_facility-mef.htm 
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Adverse events in utero are associated with the occurrence of chronic diseases in 
adulthood, like cardiovascular diseases and non-insulin-dependent diabetes mellitus. In particular, 
humans and animals born in hypoxic conditions, or presenting neonatal pulmonary hypertension, 
show later in life an exaggerated pulmonary hypertensive response following a re-exposure to 
hypoxia. 
We previously demonstrated in mice that a transient hypoxic insult in the perinatal period 
resulted in altered regulation of pulmonary vascular tone in adulthood. Adults born in hypoxia 
displayed higher right ventricular pressure compared to controls, suggesting a higher resistance 
state in the pulmonary circulation. Moreover, perinatal hypoxia increased the sensitivity of adult 
pulmonary circulation to acute hypoxia and decreased the relaxation of pulmonary arteries to the 
endothelium-dependent agent acetylcholine. This pulmonary vascular dysfunction was associated 
with permanent alterations in muscarinic receptors and their effectors, in particular 
phosphodiesterases, and with a marked decrease in endothelial nitric oxide synthase (eNOS) 
protein content. 
In humans presenting neonatal pulmonary hypertension, the therapy of choice is inhaled 
nitric oxide (iNO). Long-term effects of neonatal iNO on adult lung vascular reactivity have not yet 
been investigated. 
We investigated whether iNO administered simultaneously to perinatal hypoxia could have 
potential beneficial effects on the adult pulmonary circulation. 
Pregnant mice were placed in hypoxia (13% O2) with simultaneous administration of iNO 
(10 ppm) 5 days before delivery and left in these conditions with their litter for 5 days after birth. 
Pups were then raised in normoxia (21% O2) until adulthood. 
Acetylcholine-induced relaxation is completely restored in isolated pulmonary arteries of 
adults treated with iNO during perinatal hypoxia compared to mice without iNO therapy. Similarly, 
eNOS protein deficiency is completely reversed in pulmonary arteries of adults exposed to 
perinatal iNO and hypoxia compared to hypoxia alone. Therefore, perinatal iNO therapy seems 
to prevent adult pulmonary vascular dysfunction following perinatal hypoxia. 
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Numerous epidemiological studies have linked adverse events occurring in utero or around 
birth to the occurrence of chronic diseases in adulthood. In particular, limitation of nutrients or 
oxygen supply to the fetus, resulting in a small birthweight, is linked to an increased risk to 
develop cardiovascular diseases in adulthood. 
Fetal growth restriction affects approximately 8% of all pregnancies and is associated with 
considerable perinatal mortality and morbidity. The mechanisms implicated in the development of 
intrauterine growth retardation (IUGR) are not yet elucidated, even if some risk factors from 
maternal origin have been identified, like malnutrition, maternal arterial hypertension and tobacco 
consuming.  
We previously demonstrated in a murine model that a transient exposure to hypoxia during 
a critical period of development of the lung vasculature resulted in a definitive imprint leading to 
altered regulation of pulmonary vascular tone in adulthood. We postulate that a reduced oxygen 
supply in utero could influence other vascular beds, like the umbilical circulation, which present 
some similarities with the pulmonary circulation.  
We therefore postulate that reduced delivery of oxygen and/or nutrients to the fetus in case 
of placental insufficiency could be in relation with alterations in regulating pathways of the 
umbilical circulation, contributing further to impairment of materno-fetal exchanges and therefore 
to the development of IUGR. 
We investigated potential modifications induced in the regulation of umbilical vessels tone 
in case of placental insufficiency, in order to identify potential novel therapeutic strategies to limit 
the development of IUGR.  
Umbilical cords were harvested just after birth. The vasoreactivity of umbilical vessels was 
tested in organ chambers: relaxation induced by the nitric oxide donor DEA/NO was investigated 
in vessel rings preconstricted with serotonin (10-5 M) or the thromboxan A2 analog U46619 (10-6 
M). 
Preliminary results show that NO-induced relaxation is reduced in umbilical vessels from 
newborns with IUGR. 
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Background:  We have recently discovered that daily reoxyenation during chronic hypoxia (CH) 
markedly improved recovery of the ventricular performance, attenuated the degree of apoptosis 
and right ventricle pressure without appreciable differences in myocardial hypertrophy. 
Unfortunately, the daily reoxygenation does not apply. Here, we tested the hypothesis that 
Sildenafil administration reverts the negative effects led by CH in the heart and lung. 
Methods: Adult male Sprague-Dawley rats were exposed to CH (10% O2) with no treatment, or 
with sildenafil administration (1.4 mg/kg/day, i.p.)for 2 weeks. Normoxic rats (N) breathing room air 
served as control. Hearts and lung were either subjected to or freeze-clamp for biochemical 
analyses or fixed with formalin for histological analyses. With a catheter inserted in the right 
ventricle and in the carotid artery we measured the right and left ventricle pressures, respectively. 
Apoptosis was assessed using the TUNEL techinique. Data are expressed as mean± SEM. 
Results: The RV systolic pressure was elevated in CH (P<0.001). Administration of sildenafil 
reduced RV systolic pressure (P<0.001). The plasma level of NOx, an index of NO production, 
increased markedly during hypoxia from 4.5±1.0 μmol/L to 8.7±0.9 μmol/L in CH (P<0.001). In vivo 
administration of sildenafil further increased the NOx level to 13.3±1.6 μmol/L (P<0.05). Thus, 
whereas hypoxia increased NO production, sildenafil enabled further increase of this parameter. 
Both RV/LV+S ratio, an index of right hypertrophy, and  lung /body weight, an index of pulmonary 
edema, were increased in CH with respect to normoxic hearts (P<0.001), whereas the treatment 
with sildenafil attenuated the increase of these ratios (P<0.05). CH induced a ∼2 fold increase in 
TUNEL-positive apoptotic cells compared to normoxia (P<0.001) both in heart and lung tissues. 
Sildenafil attenuated such increase (P<0.001). For the Western blot analysis revealed a significant 
increase in the phosphorylation status of extracellular signal regulated kinase ½ (ERK1/2), 
phosphatidylinositol-3-kinase-protein kinase B (Akt) and endothelial NOS with Sildenafil versus 
Normoxia in the heart. In contrast in the lung Sildenafil induced an increase in phosphorylation 
status of ERK1/2 only and unchanged the phosphorylation of Akt and eNOS.  
Conclusion: A marked decline in right ventricle hypertrophy was observed with Sildenafil, which 
paralleled a reduction in pulmonary edema. Sildenafil administration reverts the negative effects 
led by CH in the heart possibly through a nitric oxide-dependent and survival kinases pathways 
(Akt and ERK1/2). In contrast the beneficial effects induced by Sildenafil in the lung could be due 
to activation of ERK1/2 signaling only. 
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In order to better understand the molecular events leading to obesity, we are interested in 
the biology of adipocyte, the major component of adipose tissue and particularly in adipogenesis, 
the process by which new mature adipocytes are created. 
The aim of the initial study was to identify new genes involved in adipose tissue development and 
to place them into the known adipogenic network. We started from a microarray analysis 
comparing lean and obese mice to select genes whose expression in visceral and subcutaneous 
white adipose tissue is correlated with increasing body weight. In the list we obtained, we focus 
our attention on one gene encoding for an enzyme, the β-galactosidase α2,3-sialyltransferase 6 
(St3gal6), involved in sialylation, a post-translational protein modification. As the role of St3gal6 is 
to add a sialic acid to the glycosylated chain of proteins or lipids, we hypothesized that these 
changes in protein structure could have an effect on intracellular signaling or on adipocyte 
interactions and matrix remodeling occurring during differentiation.  
First, we had showed that St3gal6 is expressed at the same level in white and brown adipose 
tissues. Its expression is linked to adipose tissue expansion as it is increased during 
differentiation. Moreover, St3gal6 belongs to a family of 20 enzymes, so we assessed the level of 
expression of these others members in mouse adipose tissue.  It appeared that St3gal6 is the 
sialyltransferase the most highly expressed in white and brown adipose tissue and then it 
suggests a potential role in adipose tissue development.  
To address the issue of the role of St3gal6 in adipocyte differentiation, first we downregulated the 
gene expression in vitro in 2 preadipocyte models that can be induced to differentiate (3T3-L1 and 
3T3-F442A cells). We found that the downregulation of St3gal6 by shRNA strategy decreases 
adipocyte differentiation. We also assessed that the level of expression of others close members 
of the sialyltransferase family is not affected by the knockdown of St3gal6. So, a specific 
knockdown of St3gal6 inhibits adipocyte differentiation in vitro. 
To go further, we are overexpressing in preadipocyte models the wild type form of St3gal6 and 
also mutated forms resistant to shRNA to check the specificity of the knockdown system. These 
mutants were generated by site-directed mutagenesis on cDNA sequences targetted by each 
shRNA. The aim is to prevent gene silencing mediated by shRNA and then to rescue the inhibitory 
effect by co-infecting cells with retrovirus recombined with shRNA and with the corresponding 
mutated cDNA. This rescue will be checked at the mRNA level but also at the protein level using a 
tagged form of the protein. And then, once the silencing specificity confirmed, we will observe the 
effect of overexpression and rescue on adipocyte differentiation by detecting lipid droplets and 
measuring adipogenic markers expression. 
We also plan to study St3gal6 expression in white and brown adipose tissue of mice under high fat 
diet to reinforce the link between St3gal6 increase and adipose tissue expansion. 
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The Notch pathway is a cell-to-cell communication system between two adjacent cells. One cell 
expresses Notch receptors (signal-receiving cell) and one cell expresses membrane-bound 
Notch-receptor ligands (signal-sending cell). Notch signaling is involved in embryonic development 
and adult tissue renewal. The Notch1 receptor and its ligand Jagged1 (Jag1) control also the 
adaptive response of the heart to stress. However, the mechanism by which Notch1 regulates 
cardiac remodeling is unknown. In signal-receiving cells, activation of the Notch receptor induces 
the cleavage of Notch intracellular domain (NICD), which enters the nucleus and upregulates 
target gene expression, in particular of its prototypical target genes: Hes1, Hey1 and Hey2. This is 
thought to represent the canonical Notch pathway. However, it recently appears that a Jag1 
intracellular domain (JICD) fragment is also generated upon receptor-ligand interaction, raising the 
possibility that Jag1-mediated signaling could be activated in signal-sending cells.  
In order to identify Jag1 target genes, we generated different clones of ST2 cells stably 
overexpressing Jag1. Based on Hes and Hey gene expression, Notch signaling was considered 
either highly or minimally activated in these various clones, suggesting that some 
Notch-independent signaling occurs in these cells. Affymetrix microarray analyses were then 
performed, focusing on commonly modulated, and therefore possibly Notch-independent, genes. 
In these cells, Jag1 decreases the expression of cytokines and cytokine receptors such as IL-6, 
LIF, Toll-like receptor. Pathways activated by these factors, including NFkB-, Jak/STAT3- or 
TLR/IRAK4 pathways were also downregulated. Converserly, molecules involved in the regulation 
of cell growth and proliferation such as Cyclin D1, E2F, Elk1 were up-regulated as well as the 
TGFβ/Smad and the Wnt/TCF-LEF pathways. Genes involved in the regulation of the actin 
skeleton were also up-regulated.  
In conclusion, these preliminary results suggest that Jag1 could regulate signaling pathways 
involved in inflammation, cellular growth and cell morphology. Given the importance of these 
processes during cardiac remodeling that follows cardiac injury or heart stress, ongoing 
experiments investigate in vitro and in vivo the relevance of these findings in the adult heart and 
the cardiac response to stress. 
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The number of rodent genetic models of human diseases has increased dramatically over the past 
years. Studying the complex cardiovascular phenotypes in these models requires standardized 
state-of-the-art techniques, and often calls for the development of new methods to investigate the 
cardiovascular system. 
The Cardiovascular Assessment Facility (CAF) is a core facility of the University of Lausanne, 
which was recently established to offer service for researchers in the cardiovascular field. The 
facility aims at providing sophisticated techniques to the scientific community for the physiological 
assessment of the cardiovascular system in rodents. Specifically, the CAF provides investigators 
with the latest equipment for cardiovascular imaging, in particular a high-resolution ultrasound 
system allowing determination of cardiac performance and dimensions. The CAF is also equipped 
for the measurement of blood pressure and heart rate, and for monitoring ECG. In addition, the 
CAF offers a microsurgery service for producing pathophysiological models (transaortic 
constriction, myocardial infarction, renovascular hypertension etc.). Scientific support is provided 
for the design of experimental protocols as well as for the development of new techniques for the 
investigation of the cardiovascular system.  
 
Services: 
ECHOGRAPHY (VEVO770, VISUALSONICS): Left ventricular function and dimensions; Doppler tracing; 
Assessment of organ perfusion; abdominal echography; following of growth of tumor. 
ELECTROCARDIOGRAPHY (EMKA): Detailed analysis of ECG complexes; Arrhythmias 
BLOOD PRESSURE AND HEART RATE MEASUREMENTS (VISITECH, NOTOCORD & DSI): Noninvasive 
method by Tail-cuff recordings; Invasive method by direct arterial measurements, Long term 
measurement by telemetry.  
PATHOPHYSIOLOGICAL MODELS: Myocardial infarction; Transaortic constriction (pressure overload 
model); Goldblatt renovascular hypertension models (1K1C; 2K1C); Carotid balloon injury. 
MICROSURGICAL SERVICES: Vascular catheterization; implantation of osmotic minipump; Myocardial 
cell injection; etc. 
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As the number of interventional procedures is increasing, more effort should be given to the 
patient radiation protection. The technology of X-ray units has improved with the introduction of the 
flat-panel detectors (FPD) and their ability for dose reduction. However, in bibliography it is not 
clear how FPDs influence patient dose. The aim of this study was to examine the differences 
between installations with FPDs. Three radiological units (A, B and C) were characterised with 
respect to entrance dose rate. Units B and C were constructed by the same company. For policy 
reasons, the manufacturer names are not communicated. Four PMMA phantoms with different 
thickness (5 - 20 cm, with a step of 5 cm) were employed. Dose rate was measured by Radcal 
dosimeter connected to an 11 cm3 ion chamber (Monrovia, USA). Source-to-skin distance was set 
at 75 cm. The field size was 16 cm for unit A and 15 cm for units B and C at the level of the 
detector. Dose rate was measured for fluoroscopy (15 and 30 images/sec) and cine mode (15 
images/ sec). Dose rates for the low-dose protocol (fluoroscopy mode) were found to differ 4 to 5 
times between units of different manufacturers. Interestingly, differences up to 12% were 
estimated for units B and C. Dose rate for “paediatric” mode was found slightly lower than that of 
“adult”. It is essential to characterize the X-ray unit in terms of image quality and radiation dose. 
Further optimization is required for the “paediatric” mode as children are more radiation sensitive 
than adults. 
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Purpose: To evaluate the benefits of the adaptive statistical iterative reconstruction (ASIR) [1] 
method on the diagnostic image quality of pediatric cardiac CT examinations and radiation dose 
reduction.  
Materials and Methods: Four pediatric radiologists evaluated ten low-dose pediatric cardiac 
examinations (80 kVp – CTDIvol (4.8-7.9 mGy) – DLP (37.1-178.9 mGy·cm)). The average age of 
the cohort studied was 2.6 years (1 day-7 years). Acquisitions were performed on a 64-MDCT 
scanner. All images were reconstructed at various ASIR percentages (0%-100%). For each 
examination, radiologists scored 19 anatomical structures using the relative visual grading 
analysis method. To estimate the potential for dose reduction, acquisitions were also performed on 
a Catphan phantom and a pediatric phantom. 
Results: The best image quality for all clinical images was obtained with ASIR 20% and 40% 
whereas above ASIR 50%, image quality significantly decreased. With ASIR 100%, a strong 
noise-free appearance of the structures reduced image conspicuity. A potential for dose reduction 
of about 36% is predicted for a 2-3 year-old-child when using an ASIR 40% rather than the 
standard filtered back projection (FBP) method. 
Conclusion: A mixture of 20% to 40% of ASIR slightly improved the conspicuity of various 
pediatric cardiac structures in newborns and children with respect to conventional reconstruction 
(FBP) alone. This result is in good agreement with clinical studies performed in adults [2, 3]. 
References 
[1] J.-B Thibault, K. D. Sauer, C. A. Bouman, and J. Hsieh, “A three-dimensional statistical 
approach to improved image quality for multislice helical CT,” Med. Phys., Vol. 34, No. 11, pp. 
4526-4544, 2007.  
[2] J. Leipsic, T. M. LaBounty, B. Heilbron, J. K. Min, G. B. J. Mancini, F. Y. Lin, C. Taylor, A. 
Dunning, and J. P. Earls, “Adaptive Statistical Iterative Reconstruction: Assessment of Image 
Noise and Image Quality in Coronary CT Angiography” AJR, Vol. 195, No. 3, pp. 649-654, 
2010. 
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Cardiomyocytes derived from differentiated embryonic stem (ES) cells represent an attractive 
source of cells for cell-replacement therapies in cardiac disease. However, cardiogenic 
differentiation of ES cells requires a complete understanding of the complex molecular 
mechanisms controlling the differentiation process.  We demonstrated that differentiation of ES 
cells into cardiomyocytes is favored by inactivation of the Notch1 receptor. In addition some 
components of the Notch pathway in ES cells are under control of miRNAs, which, therefore, play 
an important role in cardiogenesis. So, we aim to investigate whether the increased cardiogenic 
potential in ES cells lacking Notch1 could rely on the expression of particular miRNAs and the 
modulation of their target genes. Alternatively, Notch1 could directly induce the modulation of 
particular target genes independently of miRNAs. As a first approach, we use microarray analysis 
to identify modulated miRNAs in wild-type and Notch1-deleted ES cells. In parallel, we determined 
the transcriptome in both cell lines. We found approximately 20 miRNAs, which were differently 
expressed in Notch1-deleted ES cells as compared to wild-type ES cells. Moreover, 100 genes, 
predicted to be targets of the identified miRNAs using computer assignment, were also modulated 
in the Notch1-deleted ES cells. We confirmed the differential expression of some target genes by 
quantitative methods. Together, these data demonstrate that Notch1 deletion induces specific 
miRNAs and gene expression patterns that could regulate the commitment of ES cells toward the 
cardiac lineage. Ongoing experiments evaluate the importance of these genes in the mesodermal 
and cardiogenic commitment of ES cells. Furthermore, we will also determine whether controlled 
modulation of these genes can be used to force ES cell to adopt a cardiogenic commitment. 
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Background/Introduction: 
Pancreatic β-cells located in the islets of Langerhans secrete insulin but also other signaling 
molecules including several neurotransmitters. Part of these molecules is stored in 
insulin-containing large dense-core vesicles. However, others are located in distinct organelles 
with a diameter of 50-90 nm that closely resemble neuronal secretory vesicles called synaptic-like 
microvesicles (SLMV). The precise content of β-cell SLMVs is still unclear but they are known to 
store at least two major inhibitory neurotransmitters, glycine and GABA. The physiological role of 
these neurotransmitters in the islets is only beginning to unfold but GABA has already been shown 
to inhibit glucagon secretion from pancreatic α-cells and to display autocrine effects on the 
secretory activity and proliferation of β-cells, suggesting an important contribution in the control of 
pancreatic endocrine functions.  
Methods: 
We developed a life imaging technique to selectively monitor SLMV exocytosis in β-cells. Our 
approach is based on the observation that in β-cells the integral membrane protein Synaptophysin 
is specifically targeted to SLMVs. Our strategy consists in transfecting the cells with a fluorescent 
pH sensitive Synaptophysin chimera and to analyze them by Total Internal Reflection 
Fluorescence Microscopy (TIRFM). The pH sensitive moiety of the Synaptophysin construct is 
placed in the interior of the synaptic-like vesicle and undergoes a sharp increase in fluorescence 
when the vesicle fuses with the plasma membrane. This allows a direct detection of exocytosis 
and retrieval of single SLMV. 
Results: 
Using our life imaging approach, we could show that SLMV exocytosis is triggered by glucose and 
other secretagogues with kinetics comparable to those observed for insulin-containing granules. At 
present, the molecular mechanisms underlying SLMV release are investigated in detail using 
various tools including neurotoxins and siRNAs directed against potential components of the 
exocytotic machinery.  
Conclusion: 
The life imaging approach developed in our laboratory will permit to obtain new precious 
information about the mechanisms regulating exocytosis of SLMVs under normal and 
physiopathological conditions. This would help defining the role of these organelles in islet 
physiology and to pinpoint their possible involvement in diabetes mellitus.   
 
Metabolism and Cardiovascular/MCV-126 
 
 
Involvement of the RasGAP-derived fragment N in the resistance of pancreatic 
beta cells towards apoptosis. 
 
 
1Jaccard E., 2Walicki J., Yan J.-Y., 3Dubuis G., 3Widmann C.  
 
 
Departement of Physiology1, UNIGE2, Departement of Physiology - UNIL3  
 
 
 
Our laboratory has previously established in vitro that a caspase-generated RasGAP N-terminal 
moiety, called fragment N, potently protects cells, including insulinomas, from apoptotic stress by 
activating the Ras-PI3K-Akt pathway. We aimed to determine whether fragment N can increase 
the resistance of pancreatic beta cells in a physiological setting and conversely if its absence 
renders them more sensitive to pro-diabetogenic stimuli. 
Two mouse lines have been generated, the first one bearing the rat insulin promoter followed by 
the cDNA encoding fragment N, called RIP-N and the second one bearing a point mutation in the 
caspase recognition site on position 455 on RasGAP and that is unable to generate fragment N, 
called D455A KI. The histology, functionality, and resistance to stress of RIP-N and D455A KI 
islets were then assessed. 
Pancreatic beta cells of RIP-N mice express fragment N, activate Akt and block NFκB activity 
without affecting islet cell proliferation or the morphology and cellular composition of islets. 
Intraperitoneal glucose tolerance tests revealed that RIP-N mice control their glycemia similarly as 
wild-type mice throughout their lifespan. Moreover, islets isolated from RIP-N mice showed normal 
glucose-induced insulin secretory capacities. They however displayed increased resistance to 
apoptosis induced by a series of stresses including inflammatory cytokines, fatty acids, and 
hyperglycemia. RIP-N mice were also protected from multiple low-dose streptozotocin 
injection-induced diabetes and this was associated with reduced in vivo beta cell apoptosis. In 
contrast, mice that cannot generate fragment N were more sensitive to streptozotocin 
injection-induced diabetes, indicating that RasGAP cleavage is a physiological mean of protecting 
beta cells.  
We are now currently investigating whether fragment N can decrease in vivo beta cell apoptosis 
consecutive to high-fat diet feeding.  
In conclusion, fragment N efficiently increases the overall resistance of beta cells to noxious 
stimuli without interfering with the physiological functions of the cells. Fragment N and the pathway 
it regulates represent therefore a potential target for the development of anti-diabetic tools. 
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Heart failure is defined as a deficiency in the capability of the heart to adequately pump blood in response 
to systemic demands. Heart failure is induced by a number of common disease stimuli, including: 
longstanding hypertension; myocardial infarction and oxidative stress. The irreversible end point in heart 
failure is the loss of cardiomyocytes by apoptosis. Doxorubicin (Dox) is an anthracycline antibiotic that has 
been used for the treatment of various types of cancer; doxorubicin induces cardiotoxicity. Resent studies 
suggest that apoptosis plays an important role in Dox-induced cardiotoxicity, which is at least in part 
mediated by the generation of peroxynitrite (PN). PN a reaction product between nitric oxide and 
superoxide is considered as an oxidant and nitrating mediator formed in various pathological situations. 
The myocardium undergoes hypertropy (hypertrophic growth in size without myocyte proliferation) as a 
compensatory mechanism in order to improve the contractile function. Increasing the survival potential of 
cadiomyocytes would be beneficial during episodes of myocardial hypertrophy which ends with loss of 
function. We have determined that the N-terminal fragment of RasGAP (fragment N) can efficiently protect 
a variety of cell types against many different stresses. In the present work we show that the anti-apoptotic 
properties of fragment N protect primary cardiomyocytes from cell death induced by 
peroxynitrite-dependent oxidative stress. In addition, we investigate the heart activity in an in vivo mouse 
model where a mutation renders RasGAP caspase resistant (D455A KI mice); these KI mice are no longer 
able to generate fragment N. Heart parameters in two different experimental models were studied. In the 
first model, pressure overload through Trans aortic constriction (TAC), which induces stress leading to 
hypertrophy, resembles longstanding hypertension over the left ventricle. Heart parameters were measured 
at 2, 4 and 6 weeks post TAC by echocardiography. In the second model mice were injected with a high 
dose of doxorubicin, which induces cardiotoxicity and cardiomyocyte apoptosis, Heart parameters were 
measured 5 days post doxorubicin injection by Millar catheter. Our results show that RasGAP cleavage and 
fragment N generation play a role in preserving the contractile function of the heart upon stress. D455A KI 
mice TAC-stressed showed an increased expression of the hypertrophy gene markers, a marked reduction 
in fractional shortening (%FS) and ejection fraction (%EF), in comparison to their wild type TAC-subjected 
controls. In the same context, doxorubicin induced left ventricular dilation (increase in both end-diastolic 
and end-systolic volume) and reduced left ventricular end-systolic pressure, which tended to be more 
marked in the D455A KI mice. Interestingly the slope of the end-systolic pressure volume relationship, or 
arterial elastance (a load-independent index of contractility) was significantly reduced following doxorubicin, 
this reduction was significantly more pronounced in the KI animals. 
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Heart failure, a condition in which heart does not provide sufficient supply of oxygenated blood, 
constitutes a major health issue in the world. It is the result of reduced contractile capacity, after a 
major loss of cardiomyocytes caused by chronic or acute myocardial injury. In the mammalian 
heart, the dying myocytes are replaced by fibrosis, and the surviving ones become hypertrophic. 
These two features, cardiac hypertrophy and fibrosis, are major hallmarks of heart failure. We 
have previously shown that the Notch pathway, which is essential for development of the 
cardiovascular system, is activated in the stressed adult heart, and that its inhibition exacerbates 
heart failure. The Notch pathway is mediated by transmembrane receptors and ligands, the 
interaction of which leads to the proteolytic release of the receptor intracellular domain. The latter 
translocates to the nucleus where it activates expression of specific target genes. To further 
investigate the role of this pathway in cardiac adaptation to stress, we generated transgenic mice 
overexpressing the ligand Jagged1 in cardiomyocytes (TGJ1 mice). In TGJ1 mice, Notch1 
receptor is activated both in myocytes and non myocyte cells. In newborn mice up to 1 week of 
age, proliferation is increased in TGJ1 mice, relative to their WT counterparts. As a result, the 
adult hearts of TGJ1 mice display increased cellular content both in the LV and RV walls, and the 
RV shows particularly thickened wall and increased chamber diameter, without alteration of the 
cardiac function. When subjected to pressure overload using aortic constriction (TAC), TGJ1 
hearts developed a markedly reduced hypertrophic response both at the organ, cellular and 
molecular level. In addition the Akt-mTOR pathway which is activated to enhance protein 
synthesis in the hypertrophic hearts of WT mice is downregulated under baseline conditions and is 
not activated under stress conditions in hearts of TGJ1. After 1 week of TAC, WT mice developed 
cardiac fibrosis, which is significantly reduced in TGJ1 mice, as indicated by reduced collagen 
expression and deposition and expression of fibrosis regulatory factors CTGF and TGF-beta2. We 
have previously shown that the Notch1 receptor is essential to cardiac adaptation to stress. To 
determine whether Notch1 mediates the effects of Jagged1, we crossed TGJ1 mice to mice with a 
cardiac-specific inducible deletion of Notch1 (TGJ1-cNotch1del/del mice). When subjected to TAC, 
these mice displayed a reduced hypertrophic response, as observed with TGJ1 mice with and 
intact Notch1 gene indicating that Jagged1 exerts its effects independently of Notch1. Taken 
together, the data demonstrate that sustained activation of Notch pathway in the stressed heart, 
via expression of the ligand Jagged1, imparts a beneficial effect to the heart by reducing cardiac 
hypertrophy and fibrosis and further supports the notion that the Notch pathway controls cardiac 
adaptation to stress. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEU 
Neurosciences 
 
Neurosciences/NEU-128 
 
 
Involvement of juxtaparanodal Kv1-channels in diabetic peripheral neuropathy 
 
 
1Zenker J., 1Poirot O., 1dePreuxCharles A.-S., 1Arnaud E., 1Médard J.-J., 1Chrast R.  
 
 
Department for Medical Genetics - Unil1  
 
 
Diabetes mellitus (DM) is a major cause of peripheral neuropathy. However, the underlying 
pathophysiological mechanisms of diabetic peripheral neuropathy (DPN) are still poorly 
understood. 90% of all diabetic patients suffer from type 2 DM, corresponding to more than 220 
million people worldwide.  
To get more insight into DPN associated with type 2 DM, we decided to use the rodent model of 
this form of diabetes, the db/db mice.  
The progression of pathological changes in db/db mice mimics the ones observed in humans. 
Initially, db/db mice exhibit obesity and hyperinsulinaemia. Later they become hyperglycemic, 
and present reduced nerve conduction velocity and small sensory neuropathy (e.g. reduced 
intraepidermal nerve fiber density). After excluding any myelin related deficits in db/db mice, we 
further analyzed the node of Ranvier, a critical region for action potential propagation in 
myelinated fibers.  
We observed a strong reduction of Kv1.2 expression in the juxtaparanodal regions. To detect if 
these changes will lead to any alteration in PNS function we measured compound action 
potentials in isolated sciatic nerves from control and diabetic animals and showed significant 
increase in the afterhyperpolarization phase and in excitability in db/db sciatic nerves. Using 
pharmacological inhibitors we demonstrated that both observations are mostly mediated by the 
decreased activity of Kv1-channels. Corroborating these results, we noticed aberrant action 
potential firing after sciatic nerve stimulation also in vivo, in db/db mice. Interestingly, nerve 
hyperexcitability has been previously described in diabetic patients and was correlated to ectopic 
action potential firing, ataxia, and paresthesiae suggesting that our observations may have a 
clinical significance. 
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Background: Voltage-gated sodium channels (Nav1.x) are important players in chronic pain. A 
particular interest has grown in Nav1.7, expressed in nociceptors, since mutations in its gene are 
associated to two inherited pain syndromes or insensitivity to pain. Rufinamide, a drug used to 
treat refractory epilepsy such as the Lennox-Gastaut syndrome, has been shown to reduce the 
number of action potentials in cortical neurons without completely blocking Na channels. 
Aim: The goal of this study was to investigate the effect of rufinamide on Nav1.7 current. 
Methods and Results: Whole-cell patch clamp experiments were performed using HEK293 cells 
stably expressing Nav1.7. Rufinamide significantly decreased peak sodium current by 28.3, 21.2 
and 12.5% at concentrations of 500, 100 and 50μM respectively (precise EC50 could not be 
calculated since higher rufinamide concentrations could not be achieved in physiological buffer 
solution). No significant difference on the V1/2 of voltage-dependence of activation was seen; 
however a shift in the steady-state inactivation curve was observed (-82.6mV to -88.8mV and 
-81.8 to -87.6mV for 50 and 100μM rufinamide respectively, p<0.005). Frequency-dependent 
inhibition of Nav1.7 was also influenced by the drug. One hundred μM rufinamide reduced the 
peak sodium current (in % of the peak current taken at the first sweep of a train of 50) from 90.8 to 
80.8% (5Hz), 88.7 to 71.8% (10Hz), 69.1 to 49.2% (25Hz) and 22.3 to 9.8% (50Hz) (all p<0.05). 
Onset of fast inactivation was not influenced by the drug since no difference in the time constant of 
current decay was observed. 
Conclusion: In the concentration range of plasma level in human treated for epilepsy, 15μM, 
rufinamide only minimally blocks Nav1.7. However, it stabilizes the inactivated state and exerts 
frequency-dependent inhibition of Nav1.7. These pharmacological properties may be of use in 
reducing ectopic discharges as a causal and symptom-related contributor of neuropathic pain 
syndrome. 
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Variation in stimulus-related behavior and brain responses is commonplace and typically attributed 
to the random variability in neural responses (“internal noise”). Computational models indicate that 
internal noise is sufficient to engender perceptual differences, in turn suggesting that identical 
stimuli can be (mis)perceived as being different. In the case of signal detection theory (SDT), 
internal noise is quantified as the ratio between an observer's discrimination threshold and 
sensitivity (d’). 
The present study investigated the contribution of internal noise to conscious perception and 
discrimination abilities. Participants were instructed to indicate which sound of a pair of identical 
pure tones was of higher pitch, being unaware that sounds were actually physically identical. In 
order to ensure that participants know what pitch differences referred to, they also underwent an 
above-threshold frequency discrimination task. With the aim to determine whether and how 
spontaneous activity can engender different percepts, AEPs to the identical sounds were 
compared as a function of perceived pitch, yielding a “High perceived pitch” vs. “Low perceived 
pitch” design. AEPs modulated topographically 92-115ms post-stimulus onset as a function of 
perceived pitch, indicative of the engagement of distinct intracranial sources; LAURA source 
estimations indicated that it followed from a modulation within the left temporo-parietal areas. 
Activity within this cluster negatively correlated with the participant's sensitivity in pitch 
discrimination measured in the pre-test session. Collectively, our results indicate that the brain’s 
spontaneous internal noise engenders perception and determines sensitivity. 
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Optimal behavior relies on rapid and flexible adaptation to environmental requirements, notably 
based on the detection of errors. The impact of error-detection on subsequent behavior typically 
manifests as a slowing down of response time following errors. This effect has been attributed to 
shifts to more cautious response mode or to distraction induced by the infrequent error trials. 
However, how errors impact the processing of subsequent stimuli and in turn shapes behavior 
remains unresolved. 
To address these questions, we used a speeded auditory spatial Go/NoGo task and contrasted 
auditory evoked potentials (AEPs) to left-lateralized "Go" and right "NoGo" stimuli as a function of 
performance on the preceding Go stimuli, generating a 2x2 design with “Preceding Performance” 
(accurate; inaccurate) and Stimulus type (Go; NoGo) as within-subjects factors. 
Behaviorally, we replicated post-error slowing effects. Electrophysiologically, AEPs modulated 
topographically as a function of preceding performance 80-110ms post-stimulus onset and then as 
a function of stimulus type 110-140ms, indicative of changes in the underlying brain networks. 
Source estimations of these effects revealed a stronger activity of prefrontal regions to stimuli after 
successful than error trials, followed by a stronger response of parietal areas to the NoGo than Go 
stimulus. 
We interpret these results in terms of a shift from a fast-automatic to a slow-controlled form of 
inhibitory control induced by the detection of errors, manifesting during low-level integration of 
subsequent stimuli, which in turn influences response speed. 
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After an ischemic event affecting the brain, glial cells become activated and numerous 
inflammatory cells infiltrate the site of the lesion secreting a large variety of cytokines and 
chemokines. It is less known whether this brain inflammation is detrimental or beneficial for tissue 
recovery. Here, we evaluated if a strong neuroprotective peptide XG-102 (formely D-JNKI1) 
modulates post-ischemic inflammation in animal models of stroke. 
 
XG-102 (0.1mg/kg) or vehicle (saline) was administered intravenously 3 h after transient middle 
cerebral artery occlusion (MCAO) in mice. Lesion size at 48 h was significantly reduced in the 
treated group. Quantification of the average intensity of CD11b positive microglia (infra-red 
emission) within the ischemic tissue showed no significant difference between groups.  
The secretion of inflammatory mediators in the brain and systemic circulation was analysed by 
ELISA at 4 h, 7 h, 24 h, 48 h and 5 days in sham, MCAO and MCAO+XG-102 mice. Our results 
show that in the plasma samples of vehicle mice, Interleukin-6 (IL-6) and Keratinocyte Chemokine 
(KC/CXCL1) were secreted early after ischemia and return to basal level at late time points. 
XG-102 showed a trend towards reducing plasma levels of IL-6 but not KC. Interestingly, we found 
a significant release of IL-6 and KC only at 48 h in the brain of treated mice, compared with 
untreated mice, which decrease 5 days after the occlusion. 
 
These findings suggest that neuroprotection of XG-102 may be linked, at least partly, to the 
inflammatory response. Further experiments will show whether the neuroprotective agent 
infuences downstream events activated by IL-6 (JAK-STAT pathway). 
 
 
 
 
 
 
Neurosciences/NEU-133 
 
 
Tracking dynamic impacts of digestive hormones on brain mechanisms of 
food evaluation following gastric bypass surgery  
 
 
1Lietti C., 2Saugy J., 3Egli L., 3Campos V., 4Murray M., 5Tappy L., 6Giusti V., 7Toepel U.  
 
 
Radiologie1, Neuropsychologie et Neuroréhabilitation, CHUV-UNIL2, Institut de Physiologie, UNIL3, Radiologie, 
Neuropsychologie et Neuroréhabilitation, CHUV-CIBM4, Endocrinologie, diabète et métabolisme, CHUV- Institut de 
Physiologie, UNIL5, Endocrinologie, diabète et métabolisme, CHUV6, Radiologie, Neuropsychologie et 
Neuroréhabilitation, CHUV7  
 
 
Food intake and nutritional behaviour are known to be regulated by several gastro-intestinal 
(ghrelin, GLP-1, PYY) and endocrine (insulin, leptin) factors in animals. In terms of human 
nutritional behaviour, direct links and correlations between gastrointestinal (GI) or endocrine 
signals and reactions of the central nervous system have so far been seldom investigated. In this 
interdisciplinary study, combining methods for the monitoring of gastric hormones linked to 
glucose homeostasis and electrical neuroimaging, we aim to determine the parallels between 
Roux-en-Y gastric bypass (RYGB) - and its associated effects on gastric hormone levels and 
eating behaviour - and brain activity during pre-ingestion discrimination of food images. In 
particular, hormone blood measures are correlated with neural responses as measured by 
electroencephalography (EEG) in healthy normal-weighted and obese controls without surgery, as 
well as in RYGB patients before and after food intake. Preliminary results of this ongoing study will 
be presented. 
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Background: 
In Alzheimer’s disease (AD), synaptic alterations play a major role and are correlated with the 
extension of cognitive changes. Modifications in presynaptic and postsynaptic proteins occur and 
the increase in postsynaptic protein PSD-95 suggests some degree of postsynaptic reorganization 
in AD (Leuba et al., 2008). In order to better understand how synaptic modifications are related to 
cognitive activity, we studied further PSD-95 together with possible alterations in NMDA receptors 
expression, in the entorhinal cortex (EC) and frontal cortex (FC; area 9) from ten patients with AD 
compared to ten age-matched controls. These changes were related to pathological markers such 
as ß-amyloid, including Aß oligomers, AD2 and ubiquitin proteins. 
Methods: 
We used quantitative immunohistochemical methods for synaptic proteins, NMDA receptors R1, 
R2A and R2B, and AD markers. Western blot analysis was also used for some proteins. 
Results: 
In both the entorhinal and frontal cortex, the immunostaining of the NMDAR1 receptors subunit 
was significantly increased in AD, in parallel to that of PSD-95, mainly in the neuropile (puncta). In 
addition, numerous neurons - mostly pyramidal - were also marked, significantly more in AD than 
in controls. This was particularly the case in layer 2 in EC, projecting to the hippocampus, while 
changes in FC were obvious in layers 2-3. The immunostaining of NMDAR2A and R2B receptors 
subunits was mostly not significantly different between AD and controls in puncta, in spite of a 
tendency to increase in AD. But significantly more neurons were stained in controls than in AD 
cases, contrarily to NMDAR1 and PSD-95 staining. Pyramidal neurons positive for NMDAR1 and 
PSD-95 staining were often positive for AD2 and ubiquitin and some degree of colocalization 
between PSD-95 and Aß oligomers was noticeable in positive puncta. 
Conclusions: 
On the whole, these data suggest that the postsynaptic site of glutamatergic synapses is the place 
of significant reorganization in AD cortex, particularly in relation to PSD-95 protein and NMDA 
receptors, and that the NMDA receptor itself could undergo expression changes of its subunits, 
leading to altered synapses and cognitive deficit 
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Auditory spatial functions, including the ability to discriminate between the position of nearby 
sound sources, are subserved by a large temporo-parieto-frontal “where” network. With the aim of 
determining whether and when the right parietal cortex is critical for auditory spatial discrimination, 
we applied single pulse transcranial magnetic stimulation (TMS) on right parietal regions 20, 80, 
90 and 150ms post-sound 1 onset while participants (n= 15 in Exp 1 and n= 13 in Exp 2) 
completed a two-alternative forced choice auditory spatial discrimination task between pairs of 
sounds presented within the left (Exp 1) or right hemispace (Exp 2). Our results reveal that 
transient TMS disruption of right parietal activity impairs spatial discrimination when applied at 20 
ms post-stimulus onset for sounds presented in the left controlateral hemispace and at 80 ms for 
sound presented in the right ipsilateral hemispace. We interpret our finding in terms of a critical 
role for controlateral temporo-parietal networks over initial stages of the building-up of auditory 
spatial representations and for a right hemispheric specialization in integrating the whole auditory 
space over subsequent, higher-order processing stages. 
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Introduction: A large number of parameters have been identified as predictors of early outcome 
in patients with acute ischemic stroke. The present work analyzes a wide range of demographic, 
metabolic, physiological, clinical, laboratory and neuroimaging parameters in a large population of 
consecutive patients with acute ischemic stroke and aims to identify independent predictors of 
early clinical course. 
 
Subjects and methods: We used prospectively collected data from the Acute STroke Registry 
and Analysis of Lausanne (ASTRAL). All consecutive patients between 01/2003 and 12/2008 
admitted to our stroke unit and/or intensive care unit with ischemic stroke within 24 hours after 
onset of symptoms were analyzed. Univariate and multivariate analysis was performed to identify 
significant association with NIHSS score at admission and 24 hours. We also sought for any 
interactions between identified predictors. 
 
Results: 1446 patients were included in the analysis. In multivariate analysis, NIHSS at 24 hours 
was associated with NIHSS at admission (β=1, p<0.001), initial glucose (β=0.05, p<0.002) and 
thrombolytic intervention (β=-2.91, p<0.001). There was a significant interaction between 
thrombolysis and NIHSS at admission (p<0.001), indicating that the latter does not improve early 
clinical course in patients with severe stroke. 
 
Conclusions: Thrombolytic treatment, lower initial glucose and lower initial stroke severity predict 
favourable early clinical course. However, the effect of thrombolysis was limited to minor and  
moderate stroke, and was absent in patients with severe stroke. 
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Introduction: Data on new predictors of outcome include penumbra core or collaterals. 
Objective: To test the predictive value of recanalization, collaterals, penumbra and core of 
ischemia for functional outcome in a large group of patients with MCA occlusion. 
Method:  Consecutive events included prospectively in the Acute Stroke Registry and Analysis of 
Lausanne from April 2002 to April 2009 with an acute stroke due to proximal MCA occlusion (M1) 
were considered for analysis. Acute CTA were reviewed to grade the collaterals (dichotomized in 
poor <= 50% or good >50% compared to the normal side) and localization of M1 occlusion 
(proximal or mid-distal). Acute CTP were reviewed and reconstructed to determine penumbra, 
core and stroke index (penumbra/penumbra+core) of brain ischemia. Good outcome was defined 
by mRS 0-2 at 3 months. 
Results: Among 242 events (115 male, mean NIHSS 18.1, SD 5.8, mean age 66, SD 15), 42% 
were treated with intravenous thrombolysis, and 3% with intraarterial thrombolysis. Collateral 
status was rated as poor in 53% of events and proximal M1 occlusion was present in 64%. 
Recanalization determined at 24 hours with CTA was complete in 26% events and partial/absent 
in 54%.CTP was available for 212 events. Mean penumbra was 88.6 cm3 (median 84.4, SD 53.8), 
mean core was 54.1 cm3 (median 46.2, SD 45.7) and stroke index was 64% (median 68%, SD 
25%). Good outcome was observed in 87 events (36%) and was associated in multivariate logistic 
regression with thrombolysis (p=0.02, OR=2.5, 95% CI 1.2-5.4), recanalization (p<0.001, OR=4.1, 
95% CI 1.9-8.9), lower NIHSS (p<0.001, OR=0.84, 95% CI 0.78-0.91), male gender (p=0.01, 
OR=2.8, 95% CI 1.3-5.9), mRS prior to stroke (p=0.02, OR=0.5, 95% CI 0.28-0.9) and good 
collateral status (p=0.005, OR=3, 95% CI 1.4-6.4). Nor penumbra, nor core, nor stroke index were 
significant in the multivariate model, even if an association was present in the univariate model 
between good functional outcome and penumbra (p=0.004, OR=1.008, 95% CI 1.003-1.01), core 
(p<0.001, OR=0.98, 95% CI 0.976-0.99) and stroke index (p<0.001, OR=16.7, 95% CI 4.6 59.9).  
Conclusion: MCA recanalization is the best predictor for good functional outcome, followed by 
collateral status. CTP data did not predict the functional outcome in our large group of M1 
occlusion. 
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Introduction:  
Severe stroke carries a high short and long term disability and fatality rate. Nevertheless, the 
profile of these patients in the acute phase is poorly defined. The aims of this study are to 
determine the characteristics of patients with severe (“massive”) ischemic stroke at onset 
regarding a large range of clinical and paraclinical parameters. 
Methodology: Using a prospectively constructed acute ischemic stroke databank (Acute STroke 
Registry and Analysis of Lausanne, ASTRAL), we compared all patients with massive stroke 
defined as a NIHSS ≥ 20 at admission with all other patients. The variables included in a 
univariate and then in a multivariate analysis included demographic factors, vascular risk factors, 
clinical presentation, stroke mechanism, previous clinical or silent ischemic events, medication and 
acute radiological and metabolic findings.  
Results:  
Among 1915 acute ischemic patients, 243 (12.7%) had massive strokes. On multivariate analysis 
massive stroke patients had higher prestroke modified Rankin Scale (OR=1.28, 95%CI=1.04/1.56, 
p<0.019), more unknown onset (>1h but less than 24h) (OR=2.35, 95%CI=1.14/4.83, p<0.02), 
more early ischemic CT/MRI findings (OR=2.65, 95%CI=1.79/3.92, p<0.000), less chronic 
radiological infarcts (OR=0.43, 95%CI=0.25/0.71, p<0.001), more arterial occlusions in the 
ischemic territory on admission vascular imaging (OR=0.03, 95%CI=0.01/0.08, p<0.000), lower Hb 
concentration (OR=0.97, 95%CI=0.96/0.98, p<0.000), higher WBC (OR=1.05, 95%CI=1.00/1.11, 
p<0.045), and more cardio-embolic stroke mechanism (OR=1.74, 95%CI=1.19/2.54, p<0.004), 
With this profile, the area under the ROC curve showed a trade-off between sensitivity and 
specificity of 86%. 
Conclusion:   
Stroke severity is predicted by multiple clinical, radiological and laboratory anomalies of which 
several are modifiable. Interestingly, age, admission blood pressure and past history are not 
associated with severe stroke. This study confirms the necessity to consider a broad range of 
clinical and laboratory values in the acute phase of ischemic stroke, including detailed 
neuroimaging. The predictors of poor or good outcome in these patients still need to be studied. 
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INTRODUCTION: Diagnosis, localization and acute treatment of acute ischemic stroke is most 
frequently based on noncontrast cerebral CT (NCCT). CT perfusion (CTP) may improve the 
performance of NCCT. We aim to describe prevalence and predictors of pathological CTP in a 
large series of consecutive stroke patients and to determine its accuracy in predicting infarction on 
follow-up imaging.  
METHODS: All consecutive patients arriving within 24 hours in our hospitals and then admitted to 
the stroke unit and/or intensive care were entered in a prospective registry (Acute STroke Registry 
and Analysis of Lausanne, ASTRAL). All patients with a good quality CTP (usually 4 or 16 slices) 
performed within 24 hours from January 2003 to March 2010 were included in the present 
analysis. Demographic, clinical, radiological and follow-up imaging (CT and/or MRI > 24h after 
initial imaging) were analysed. We used univariate logistic regression analysis to test the 
association of different factors associated with focal hypoperfusion on CTP. Significant predictors 
(at p<20%) were used to fit a multivariable model.  
RESULTS: Of 1296 patients undergoing acute CTP, 455 (35%) had early ischemic changes on 
NCCT, and 943 (73%) had a focal hypoperfusion on CTP. Initial NIHSS, aphasia and neglect, 
cardioembolic stroke mechanism, bilateral carotid territory strokes, other non-lacunar 
supratentorial territories, increased glucose level, quicker time from symptoms onset to CT, early 
ischemic changes on NCCT,  presence of silent infarcts, and presence of significant arterial 
pathology were independently associated with a positive CTP. The calculated sensitivity of CTP 
with regards to an infarction on follow-up imaging was 80.5% and the specificity was 51.3% . 
CONCLUSION: Focal hypoperfusion on CTP is frequent in acute ischemic stroke and is predicted 
by higher NIHSS, earlier imaging, non-lacunar cardiogenic supratentorial infarcts, increased 
glucose levels, and the presence of arterial pathology in the ischemic territory.  Sensitivity for 
subsequent infarct is high, and specificity moderate. Adding CTP to acute CT-based imaging may 
improve recognition of stroke and its localization, interpret arterial pathology, and therefore 
improve stroke management.       
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Background and Purpose: 
Despite the improving imaging techniques, it remains challenging to predict the outcome early 
after transient cerebral ischemia. The aim of this study was thus to identify early metabolic 
biomarkers for outcome prediction. 
 Methods: 
We modeled transient ischemic attacks and strokes in mice. Using high field magnetic resonance 
spectroscopy, we correlated early changes in the neurochemical profile of the ischemic striatum 
with histopathological alterations at a later time-point. 
Results: 
A significant increase in glutamine was measured between 3h and 8h after all ischemic events 
followed by reperfusion independently of the outcome and can thus be considered as an indicator 
of recent transient ischemia. On the other hand, a reduction of the score obtained by summing the 
concentrations of N-acetyl aspartate, glutamate and taurine was a good predictor of an irreversible 
lesion as early as 3h after ischemia.  
Conclusion: 
In conclusion, we identified biomarkers of reversible and irreversible ischemic damage which can 
be used in an early predictive evaluation of stroke outcome. 
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Brain contains glycogen stores, mainly localized in astrocytes. These stores are completely 
depleted during ischemia, but get synthesized again later, even to higher levels, showing an 
overcompensation of glycogen which accumulates around the lesion at 24h and 48h after middle 
cerebral artery occlusion (MCAO) in mice. The aim of this study was to understand the 
mechanisms leading to this overcompensation of glycogen, using an in vivo model of 60 min 
MCAO in mice and an in vitro model of oxygen and glucose deprivation (OGD) on rat organotypic 
hippocampal slices.  
In vivo, western blots analysis on mouse brain extracts after MCAO showed that glycogen 
synthase (GS) is activated (dephosphorylated) in the ischemic hemisphere at early time points 
after MCAO. Using immunohistochemistry on mouse brain slices, we saw an increased expression 
of GS around the lesion and –interestingly- of its inactive form in some cortical neurons. 
Our in vitro model shows the same evolution after ischemia with depletion of glycogen stores 
directly after OGD followed by resynthesis. We observed significantly higher glycogen stores after 
OGD compared to controls at 48h. Addition in the medium of 4 mM L-lactate directly after OGD 
tended to abolish the overcompensation.  
These results open the discussion to establish if the purpose of glycogen overcompensation is to 
prevent further energy depletion or if it does simply reflect a metabolic perturbation. 
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Many fields of biology seek to monitor biological processes over time with a cellular resolution in 
intact organs. Neurosciences pioneered in vivo cellular imaging two decades ago by developing 
the two-photon microscope to allow imaging of fluorescent probes deep inside the brain. These 
microscopes are not easily accessible as the cost of ownership and maintenance is high and 
precludes their widespread use by individual labs. This has led to the installation of shared 
commercial instruments. These shared microscopes are well suited for endpoint measurements; 
however they lack the flexibility and availability to accommodate longer time-lapse imaging 
experiments with living specimens. In addition, they usually offer limited options to monitor 
non-imaging signals synchronously with image acquisition, thus limiting their use for more 
elaborate experimental protocols. 
To overcome these limitations and make the technology more readily available, the Cellular 
Imaging Facility UNIL-CHUV has launched a project, supported by the FBM, to develop a 
custom-made two-photon microscope. This instrument was assembled using off-the-shelf parts 
and without the need of purchasing an actual microscope stand. The software was implemented 
using the LabView programming environment.   
The two-photon microscope we developed is now operational. Extensive imaging testing showed 
that optical properties and robustness of this instrument are comparable to that of commercial 
counterparts. The software offers advanced features and allows making time-series, line-scans 
and z-stacks. Nonetheless, the interface was kept simple and resembles that of typical confocal 
microscope already familiar to our users. This system offers many advantages over a commercial 
microscope: the investment is only a fraction of that of a brand name system, the maintenance is 
done locally at a minimal cost, the modular design allows for easy add-ons, there is ample space 
around the sample to accommodate any kinds of experimental accessories and, last but not least, 
both the hardware and software can be modified at will to fit specific user’s needs. 
We plan to make this instrument accessible to CIF users in a near future. To this purpose, we are 
now seeking input from researchers interested in using it or who would like to evaluate whether 
this kind of technology would benefit their research. Accordingly, we will aim at providing a 
microscope ready for experiments. If the need arises, we might duplicate this microscope. Other 
lines of development will be pursued towards implementation of latest technologies on our 
microscopes, such as fast 3D scanning, second harmonic generation imaging, stimulated 
emission imaging, adaptive optics, or fiber optics microscope for freely-moving animal imaging. 
Finally, we could provide guidance to researchers who wish to duplicate this kind of microscope in 
their own laboratory. 
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Subcortical band heterotopia (SBH) belongs to the spectrum of neuronal migration disorders and is 
characterized by the presence of large clusters of neurone within the white matter underlying a relatively 
normal cortex. In patients, SBH is associated with developmental delay, mental retardation, and epilepsy. 
Despite recent advances, especially in genetics, our understanding of the underlying molecular 
mechanisms of SBH is still insufficient and no curative treatment exists yet, mainly due to the lack of 
appropriate animal models. We described previously the mouse mutant HeCo, a unique mouse model of 
SBH, which shares with its human counterpart the morphology of the heterotopia, developmental delay and 
a lowered epileptic threshold (1). Here we present recent data of on-going electrophysiological and 
neuronal migration/proliferation studies and analysis of the GABA system in the HeCo mouse. 
Analysis of the GABA system by immunostaining for parvalbumin, calretinin and calbindin and the GABA A 
receptor subunits alpha 1, alpha 2, alpha 3, alpha 4 and beta 2 revealed that GABA cell subpopulations 
and GABA A receptors distributions did not differ between cerebral cortex of control mice and the 
homotopic cortex of the mutant HeCo. Furthermore, the labelling intensity within the heterotopia and layer 
II-III of the homotopic cortex was not significantly different for all the antibodies tested.  
Combined EEG/EMG/video recordings in freely moving animals showed trains of 15-20Hz spike activity 
associated with typical behavioural changes including tonic head movement, myoclonic jerks and freezing 
in 5 out of 8 HeCo mice but in none of the 5 control mice. A pilot experiment using 16-epicranial electrodes 
in head restraint animals showed persistent burst suppression pattern under deeper isoflurane anaesthesia 
in the Heco but not in the control mouse.  
Birthdates study and immunochemistry for layer-specific markers revealed that the HeCo formation is due 
to a transit problem in the intermediate zone affecting both radial and tangential migrating neurons. 
Neurons within the heterotopia are generated at relatively late embryonic stages and share their phenotype 
with neurons in superficial layers of the homotopic cortex, which are affected in terms of cell density and 
layer thickness. Pulsed injection (1 hour) of 5-bromo-2-deoxyuridine (BrdU) combined with Tbr1 
immunolabelling (marker of deep cortical layers) as well as GFP plasmids electroporation followed by 
time-lapse microscopy demonstrated an increased neuronal proliferation within the intermediate zone.  
In conclusion, preliminary results of the EEG recordings give further support for the assumption that the 
HeCo mouse has a tendency to spontaneous seizure activity. However, an involvement of the GABA 
system in the seizure activity seems less likely. The formation of the SHB in the HeCo mouse is the result 
of both migration and cell proliferation alterations.  
 
Ref.: 1. Croquelois A, Giuliani F, Savary C, Kielar M, Amiot C, Schenk F, Welker E. Cereb Cortex. 2009 
Mar;19(3):563-75. 
Supported by grants of Swiss National Science (SPUM 33CM30-124089) and Gianni Biaggi de Blasys 
Foundations. 
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Introduction 
 
Lumbar spinal stenosis (LSS) treatment is based primarily on clinical criteria providing that imaging 
confirms radiological stenosis. It has been recently shown that grading stenosis based on the morphology 
of the dural sacs as seen on axial T2 images better reflects severity of stenosis than measurements of 
dural sac cross-sectional area (DSCA). Our aim was to study the variability of surface measurements and 
morphological grading of stenosis for varying degrees of angulation of the T2 axial images relative to the 
disc space as observed in clinical practice. 
Materials and Methods  
Lumbar spine TSE T2 three dimensional (3D) MRI sequences were obtained from 32 consecutive patients 
presenting with either suspected spinal stenosis or low back pain. Axial reconstructions using the OsiriX 
software at 0, 10, 20 and 30 degrees relative to the disc space orientation were obtained. For each image, 
surface area (DSCA) was digitally measured and stenosis was graded according to the recently-published 
4-point (A-D) morphological grading by two observers. Interobserver agreement was analyzed using kappa 
statistics. Statistical analysis of DSCA measurements was performed using t-tests. 
Results 
A good interobserver agreement was found in grade evaluation (kappa = 0.71) of stenosis. 
DSCA varied significantly as the slice orientation increased from 0 to +10, +20 and +30 degrees at each 
level examined (P <0.0001). More specifically DSCA varied from -15.48% to +31.89% (SD 18.40%) at 10 
degrees, -24.00% to +143.82% (SD 20.45%) at 20 degrees and -29.35% to +231.13% (SD 26.52%) at 30 
degrees of slice orientation. At 13 disc levels, DSCA was of less than 100mm2  at 0 degrees slice 
orientation, but changed to values of more than 100mm2 in three cases at 10 degrees orientation, in five 
cases at 20 degrees and in ten cases at 30 degrees orientation. In only two out of 97 levels studied did the 
morphological grading change as the angle increased. 
 
Discussion 
Even though 30 degrees of slice orientation is less frequently encountered, the need to obtain continuous 
slices using the classical 2D MRI acquisition technique entails often at least a 10 degree slice inclination 
relative to one of the studied disc spaces due to physiological lordosis. Such an inclination could have an 
important influence on surface measurements but much less in morphological grading which also better 
reflects nerve tissue impingement and has been shown to be of prognostic value. In conclusion, the axial 
MRI slice angle variation significantly affects DSCA, and thus potentially management decisions. 
Morphological grading seems to offer an alternative means for assessing severity of spinal stenosis that is 
little affected by image acquisition technique. 
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Background and objectives: Decreased level of consciousness (LOC) at ischemic stroke onset 
is infrequent and associated with a poor prognosis. Its causes and mechanisms are insufficiently 
understood. We aimed at finding predictors and topographic correlations for such strokes.  
Methods: In an acute hospital based registry of consecutive acute ischemic strokes admitted 
within 24 hours after last proof of wellbeing(Acute STroke Registry and Analysis of Lausanne, 
ASTRAL), decreased level of consciousness was defined as a value of value ≥ 1 on the 
corresponding NIHSS item on initial neurological assessment. Acute status epilepticus was 
excluded by EEG if suspected. Demographic, clinical, etiological, radiographic, arterial imaging 
and outcome factors were considered. Poor prognosis was defined as a modified Rankin Scale 
score of ≥3 at 3 months. In a first multivariate logistic regression analysis of predictors of 
decreased LOC, we entered all significant variables except initial NIHSS. The second multivariate 
logistic regression analysis considered only significant variables concerning anatomical 
localisation and arterial territories. 
Results: In 1’436 acute ischemic strokes, 139 (9.7 %) had a decreased LOC on admission, of 
whom only one was attributable to early mass effect. These patients showed significantly poorer 
prognosis (OR 7.8, 95% CI 5.09-11.84) and higher mortality rate at three months (OR 4.67, 95% 
CI 3.15-6.92). On multivariate analysis, they had more frequently one or more previous strokes 
(OR 5.1, 95% CI 2.79-9.31), more frequently early ischemic changes on radiology (OR 1.74, 95% 
CI 1.10-2.75) and a higher frequency of arterial stenosis or occlusion in the ischemic territory (OR 
2.87, 95% CI 1.6-4.91). Lacunar mechanism (OR 0.11, 95% CI 0.04-0.36) and stroke with an 
uncertain cause (OR 0.37, 95% CI 0.18-0.71) were less frequent. Regarding localisation, patients 
with pure basilar strokes (OR 1.83, 95% CI 1.15-2.90), bilateral (OR 2.05, 95% CI 1.00-4.19), 
mixed supra- and infratentorial strokes (OR 6.11, 95% CI 3.02-12.35), large hemispheric 
infarction, and involvement of midbrain simultaneous with at least one other posterior circulation 
structure (OR 4.99, 95% CI 2.13-11.65) showed decreased LOC. Limiting the multivariate analysis 
to stroke localization, LOC was more frequently normal in left sided infarctions (OR 0.56, 95% CI 
0.36-0.88) and in supratentorial strokes without cortical involvement (OR 0.23, 95% CI 0.10-0.54). 
Conclusion: Decreased level of consciousness at ischemic stroke onset is related to the 
presence of previous strokes, current stroke mechanism, early ischemic changes on acute 
imaging and acute arterial occlusions. Lesions have to be distributed in specific patterns and 
widespread in infra- and supratentorial structures in order to decrease LOC, suggesting distributed 
networks for its maintenance.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ODE 
Oncology and Development 
 
Oncology and Development/ODE-146 
 
 
Involvement of a RasGAP-derived peptide in cell migration 
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Metastases are the main causes of death in cancer patients. Cells from primary tumor have first to 
escape from the tumor, to travel in the bloodstream, to home to the new location and to promote 
angiogenesis among others. In a therapeutic point of view, it is more relevant to target the first 
step of this sequential process, which is cell adhesion modulation. 
In 2004, our group developed a cell permeable peptide derived from a caspase-cleaved fragment 
of RasGAP (TAT-RasGAP317-326). This peptide was already shown to sensitize, efficiently and 
specifically, cancer cells against chemotherapy-induced cell death. We recently assessed that this 
peptide was also able to inhibit cell migration and to increase cell adherence on cell culture plates. 
Theses observations make us think that the TAT-RasGAP317-326 peptide could be used as a 
potential compound for anti-metastatic therapy.  
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Background: NVP-BEZ235, a PI3K/mTOR inhibitor, reduces the growth of renal cell carcinoma 
(RCC) in vitro and in vivo. However, NVP-BEZ235 has little effect on tumor angiogenesis in renal 
carcinoma xenografts. We therefore hypothesized that the antitumor efficacy of NVP-BEZ235 on 
RCC would be potentiated in combination with anti-angiogenic therapy such as sorafenib. 
Materials and Methods: RCC cell lines 786-0 and Caki-1 were treated with various 
concentrations of NVP-BEZ235 and/or sorafenib, and tumor cell proliferation and apoptosis were 
investigated in vitro. Moreover, treatment efficacy of NVP-BEZ235 alone, or in combination with 
sorafenib, was evaluated on RCC xenografts in athymic nude mice.  
Results: NVP-BEZ235 or sorafenib reduced cell proliferation and increased cell apoptosis in vitro, 
and reduced tumor xenograft growth in vivo. Combination of both drugs in vitro resulted in 
significant RCC growth inhibition and increased apoptosis compared to monotherapy. This 
synergistic effect was also observed on tumor progression in vivo. 
Conclusions: Our findings indicate that the simultaneous use of NVP-BEZ235 and sorafenib 
provides greater antitumor benefit compared to either drug alone and may thus provide a 
treatment strategy in RCC. 
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Background. Epstein-Barr Virus (EBV) infects more than 90% of human adults worldwide. Not 
only EBV causes Infectious Mononucleosis, but it is linked with several kinds of cancers such as 
Hodgkin’s lymphoma. Latent Membrane Protein 1 (LMP1) is the major key player in the 
transformation of cells by EBV. LMP1 activates NF-kappaB transcription factor that, if upregulated, 
is associated with carcinogenesis. We mapped one polymorphism –F144I– on a natural variant of 
LMP1, which allows the protein to activate NF-kappaB at higher levels (3-fold more) than the 
prototype B95-8 LMP1. We further hypothesized that natural LMP1 variants containing this 
polymorphism are able to activate NF-kappaB at higher levels than the prototype LMP1 B95-8. 
 
Methods. To address this question, 31 full length LMP1 variants were isolated from 100 genomic 
DNA samples extracted from PBMC of HIV infected individuals included in the Swiss HIV Cohort 
Study (SHCS). Variants were amplified in a single PCR, fully sequenced and sequences analyzed. 
LMP1 genes were cloned into mammalian expression vector in order to test them by gene reporter 
assay for their levels of NF-kappaB activation. 
 
Results. Among the 31 LMP1 variants characterized, 5 carry the polymorphism of interest. When 
tested by gene reporter assay, all the 5 are able to activate NF-κB at levels higher than the 
prototype B95-8 LMP1. Analysis of phylogenetic tree based on LMP1 sequences revealed a 
second cluster of variants that display a similar phenotype with respect to NF-kappaB activation. 
New candidate determinants based on these results are currently under investigation. 
 
Conclusions. The identification of polymorphisms associated with increased NF-kappaB signaling 
is of crucial importance for evaluating the role of LMP1 gene variation in the development of 
EBV-associated tumors. 
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High stage neuroblastoma is one of the most aggressive solid childhood tumor which is still 
associated to a poor outcome, despite intensive and multimodal treatments. Moreover, children 
represent a population of cancer survivors at high risk to develop late side effects of current 
treatments, for who the development of less toxic therapies is essential. The recent developments 
in cancer nanotechnology offer unique drug delivery systems, showing efficient drug targeting and 
delivery properties. These new options have not yet been developed for neuroblastoma.  
Neuroblastoma cells overexpress molecules such as survivin, which are involved in their 
development and progression, and thus represent potential valuable therapeutic targets. In this 
study chitosan/alginate designed nanogels (HynosphereTM) formulated with a “model siRNA drug” 
have been assayed in vitro as vectors for the delivery of survivin siRNAs in two relevant 
neuroblastoma cell lines (SH-EP and LAN-1). Immunofluorescence-labelled nanogels were shown 
to bind and enter NB cells within 6h with a cell line-dependent efficiency. Survivin siRNA loaded 
nanogels had no significant toxicity, as measured by viability assay. The ability of different 
HynosphereTM formulations to target cells and reduce the cellular level of survivin was measured 
by western blot in cell lines. Survivin levels could be specifically reduced up to by 70 % in different 
cells after exposure to siRNA-loaded nanogels with survivin siRNA concentrations corresponding 
to 80nM. The silencing efficiency was thus comparable to that of classical siRNA transfection 
agents, however not suitable for use in the clinics.  
These preliminary results indicate that chitosan-nanogels represent promising vectors which are 
currently further characterized and developed for the targeted delivery of silencing molecules in 
neuroblastoma.  
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Treatment with antigen-loaded recombinant CD1d proteins leads to sustained 
iNKT cell reactivity, attenuated PD-1 expression and tumor protection 
 
 
1Donda A., 1Corgnac S.  
 
 
Department of Biochemistry1  
 
 
 
Invariant Natural Killer T cells (iNKT) are potent activators of Natural Killer (NK) cells, dendritic 
cells (DC) and T lymphocytes, and their anti-metastatic activity through NK cell transactivation has 
been well demonstrated. iNKT cells can be readily activated by a single injection of the high affinity 
CD1d superagonist ligand alpha-galactosylceramide (αGalCer). However, this activation is only 
short-lived, followed by long-term iNKT cell anergy, limiting the therapeutic use of αGalCer. 
Upregulation of Program Death-1 (PD-1) on iNKT cells was shown to be largely responsible for the 
onset of iNKT cell unresponsiveness, as it could be reversed by PD-1/PD-L1 blockade. As a 
promising alternative, we have demonstrated that when αGalCer is loaded on recombinant soluble 
β2m-CD1d molecules (aGalCer/sCD1d), repeated injections led to sustained iNKT cell activation 
associated with continued cell proliferation and IFNγ secretion. Importantly, the retained reactivity 
of iNKT cells allowed prolonged antitumor activity when the αGalCer/sCD1d was fused to an 
anti-HER2 or anti-CEA scFv antibody fragments. Potent growth inhibition was obtained against 
established tumors expressing the relevant antigen, whereas free αGalCer had no effect. The 
capacity of recombinant CD1d fusion proteins to keep iNKT cells reactive was associated with low 
PD-1 upregulation even after six injections, in contrast to high PD-1 expression reached already 
after one injection of αGalCer alone. These results suggest that activation of NKT cells by soluble 
CD1d fusion proteins does not require iNKT-APC interaction, thus escaping the co-inhibitory 
control of PD-1/PD-L1, PD-L2. Preliminary experiments with human iNKT cells indicate that they 
react similarly to their murine counterparts. Indeed, while free αGalCer requires the presence from 
CD1d-expressing APCs, soluble αGalCer-loaded CD1d proteins are able to directly activate 
human iNKT cell clones. 
Altogether, the proposed innovative strategy of cancer immunotherapy combines two promising 
characteristics, first the targeting of the immune response to the tumor site by CD1d fusion to an 
antitumor scFv and second, the sustained reactivity of iNKT cells by preventing the co-inhibitory 
signal of PD-1/PD-L1. 
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Neuroblastoma (NB) is a devastating childhood neoplasm for which no efficient treatment is 
available for high stage tumours. Chemokines and their receptors, in particular the 
CXCR4/CXCL12 axis, have been involved in tumour progression. We previously reported a 
tumour type-specific and microenvironment-related growth-promoting role for the CXCR4 
receptor. Such growth-promoting effects were highly significant only when NB cells were 
orthotopically injected in the adrenal gland of nude mice. This finding highly suggested a pivotal 
cross-talk between the CXCR4-expressing aggressive tumour cells and the associated 
microenvironment. The recent description of CXCR7 as a second CXCL12 receptor, add to the 
CXCL12/CXCR4 chemokine/receptor axis a new player, which function remains to be 
determined. 
In search for specific microenvironment-related effects, which might cooperate with 
CXCR4-mediated NB tumour growth, we addressed the role and participation of CXCR7. 
Although reported to confer atypical properties to cancer cells, the role of CXCR7 in NB 
development and the cross-talk with the microenvironment is still unknown. A preliminary 
screening of a small panel of NB tissues of different stages and histology types for CXCR7 
expression revealed a selective CXCR7 staining on the more differentiated cells of the tumour 
and on the associated adrenal tissue. In contrast, CXCR7 was only moderately expressed on 
NB cell lines, but was found to increase upon exposition of cells to differentiation agents. 
From these preliminary observations, we propose that CXCR4 and CXCR7 may display two 
distinct and atypical roles in NB. Rather than a metastatic-promoting role identified in several 
other tumour systems, our data favour a tumour type-specific and growth-promoting influence 
for CXCR4, while CXCR7 may be implicated in NB maturation and interactions with the 
environment. These preliminary findings open new research perspectives for the role of the 
CXCL12/CXCR4/CXCR7 axis in the behaviour of NB, that will be further explored in vitro and in 
vivo. 
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The cysteine protease caspase-8 is an essential executioner of the death receptor apoptotic 
pathway. The physiological function of its homologue caspase-10 remains poorly understood, and 
the ability of caspase-10 to substitute for caspase-8 in the death receptor apoptotic pathway is still 
controversial. Here we analysed the particular contribution of caspase-10 isoforms to death 
receptor-mediated apoptosis in neuroblastoma cells characterized by their resistance to death 
receptor signalling.  
Silencing of caspase-8 in TRAIL-sensitive neuroblastoma cells resulted in complete resistance to 
TRAIL, which could be reverted by overexpression of caspase-10A or caspase-10D. 
Overexpression experiments in various caspase-8 expressing tumour cells also demonstrated that 
caspase-10A and caspase-10D isoforms strongly increased TRAIL and FasL sensitivity, whereas 
caspase-10B or caspase-10G had no effect or were weakly anti-apoptotic.  
Further investigations revealed that the unique C-terminal end of caspase-10B was responsible for 
its degradation by the ubiquitin-proteasome pathway and for its lack of pro-apoptotic activity 
compared to caspase-10A and caspase-10D.  
These data highlight in several tumour cell types, a differential pro- or anti-apoptotic role for the 
distinct caspase-10 isoforms in death receptor signalling, which may be relevant for fine tuning of 
apoptosis initiation.  
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Introduction: As imatinib pharmacokinetics are highly variable, plasma levels differ largely 
between patients under the same dosage. Retrospective studies in chronic myeloid leukemia 
(CML) patients showed significant correlations between low levels and suboptimal response, as 
well as between high levels and poor tolerability. Monitoring of trough plasma levels, targeting 
1000µg/L and above, is thus increasingly advised. Our study was launched to assess 
prospectively the clinical usefulness of systematic imatinib TDM in CML patients. This preliminary 
analysis addresses the appropriateness of the dosage adjustment approach applied in this study, 
which targets the recommended trough level and allows an interval of 4-24h after last drug intake 
for blood sampling.  
Methods: Blood samples from the first 15 patients undergoing 1st TDM were obtained 1,5 -25h 
after last dose. Imatinib plasma levels were measured by LC-MS/MS and the concentrations were 
extrapolated to trough based on a Bayesian approach using a population pharmacokinetic model. 
Trough levels were predicted to differ significantly from the target in 12 patients (10 <750µg/L; 2 
>1500µg/L along with poor tolerance) and individual dose adjustments were proposed. 8 patients 
underwent a 2nd TDM cycle. Trough levels of 1st and 2nd TDM were compared, the sample drawn 
1,5h after last dose (during distribution phase) was excluded from the analysis. 
Results: Individual dose adjustments were applied in 6 
patients. Observed concentrations extrapolated to trough 
ranged from 360 to 1832 µg/L (median 725; mean 810, CV 
52%) on 1st TDM and from 720 to 1187 µg/L (median 950; 
mean 940, CV 18%) on 2nd TDM cycle (figure 1).  
Conclusion: These preliminary results suggest that TDM 
of imatinib using a Bayesian interpretation is able to target 
the recommended trough level of 1000µg/L and to reduce 
the considerable differences in trough level exposure 
between patients (with CV decreasing from 52% to 18%). 
While this may simplify blood collection in daily practice, as 
samples do not have to be drawn exactly at trough, the 
largest possible interval to last drug intake yet remains 
preferable to avoid sampling during distribution phase 
leading to biased extrapolation. This encourages the 
evaluation of the clinical benefit of a routine TDM 
intervention in CML patients, which the randomized Swiss 
I-COME trial aims to. 
 
 
 
 
Figure 1:  Comparison of extrapolated trough 
levels on 1st TDM cycle (14 patients, triangles) and 
afterwards on 2nd TDM cycle (8 patients, dots). 
Dashed line: target of 1000 ng/ml. Pattern: 
tolerance interval with lower limit of 750 ng/ml and 
upper limit of 1500 ng/ml (only if accompanied by 
poor tolerability). 
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TRAIP is an E3 ubiquitin ligase which undergoes auto-ubiquitination and is reported to interact 
with TNF-receptor associated factors (TRAF) and two tumor suppressors (CYLD, SYK). TRAIP is 
necessary for mice development since TRAIP knock-out mice die in utero at day 6.5 caused by 
aberrant regulation of cell proliferation and apoptosis. Physiological substrates of TRAIP are not 
known. Over-expression of TRAIP in 293T cells inhibits TNF-α-induced NF-κB activation. We 
showed that TRAIP mRNA expression was strongly down-regulated in cultured primary human 
keratinocytes undergoing differentiation triggered by high cell density or high calcium. Short-term 
phorbol-12-myristate-13-acetate (TPA) treatment or inhibition of phosphatidylinositol-3 kinase 
signaling in proliferative keratinocytes suppressed TRAIP transcription. Inhibition by TPA was 
protein kinase C dependent. Keratinocytes undergoing KD of TRAIP expression by lentiviral 
short-hairpin RNA (shRNA; T4 and T5) strongly reduced proliferation rates compared with control 
shRNA. Furthermore, cell-cycle analysis demonstrated that TRAIP-KD caused growth arrest in the 
G1/S phase. Keratinocytes with TRAIP-KD resembled differentiated cells consistent with the 
augmented expression of differentiation markers keratin 1 and filaggrin. Luciferase-based reporter 
assays showed no increase in NF-κB activity in TRAIP-KD keratinocytes, indicating that NF-κB 
activity in keratinocytes was not regulated by TRAIP. TRAIP mRNA expression was increased by 
~2-fold in basal cell carcinomas compared with normal skin. To understand the mechanisms in 
which TRAIP is implicated, dynamics of TRAIP protein expression and subcellular localization 
during the cell cycle was examined. In HeLa cells and human epidermal keratinocytes transiently 
over-expressing a TRAIP-GFP fusion protein, the fluorescent protein localized mainly to the 
nucleolus. In summary, these results underline the important role of TRAIP in the regulation of cell 
cycle progression and the tight linkage of its expression to keratinocyte proliferation. 
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Leukemic cells are highly prone to become resistant to treatment. Polychimiotherapies, by 
attacking leukemic cells through various pathways are aimed at preventing cell resistance 
development and also at maximizing killing effects. For these reasons, development of new cell 
targeting therapies, i.e. those modifying metabolic pathways is most warranted. In this context, we 
demonstrated the tremendous antitumor activity of a novel agent, APO866: an inhibitor of NAD 
biosynthesis, in numerous leukemic and lymphomatous cells. Treatment with APO866 decreased 
intracellular NAD and adenosine triphosphate (ATP) at 24 hours and 48 to 72 hours, respectively. 
The NAD depletion led to cell death. APO866-mediated cell death occurred in a 
caspase-independent mode, and was associated with mitochondrial dysfunction and autophagy. 
Although, the in-vitro and in-vivo studies demonstrate that most leukemic cells are sensitive to 
APO866-mediated cell death without significant toxicity to normal cells, we recently observed that 
some cells became refractory to this agent. We made a seminal observation that sensitive 
leukemic cells cultured in conditioned medium (CM; supernatant) obtained from APO866 resistant 
malignant cells, become also resistant to APO866 treatment. Interestingly, preliminary results 
confirm that APO866 resistance could be transferred in vivo as it was observed in vitro. These 
findings suggest that drug resistant malignant cells secrete unknown or unidentified factor(s) that 
can promote the tumor resistance and that drug resistance could be transferred in-vivo from 
resistant to sensitive malignant cells. We are currently characterizing the secreted molecule(s) by 
APO866 resistant malignant cells and data from these investigations are presented.  
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Milk fat globule-EGF factor 8 (MFG-E8) is a secreted glycoprotein that is expressed in breast 
carcinomas and is present in the serum of patients with aggressive breast cancer. By performing a 
meta-analysis of publicly available gene expression data of breast cancer biopsies we have found 
that MFG-E8 is highly expressed in breast cancer and its expression is significantly associated 
with low levels of ErbB2 and of Estrogen receptor. We have then confirmed MFG-E8 expression in 
a series of breast cancer biopsies by immunohistochemistry analysis. To investigate the function 
of MFG-E8 we have overexpressed it in non-transformed mouse mammary epithelial cells 
NMuMG. We have observed that MFG-E8 increases in vitro proliferation and 
anchorage-independent growth of NMuMG cells and it promotes their proliferation and branching 
in Collagen I gels. Moreover, overexpression of of MFG-E8 in mouse mammary carcinoma cells 
that have low endogenous levels of the protein promotes their in vivo growth when injected 
orthotopically in immunosuppressed mice. In line with these results, we have also found that 
MFG-E8 downregulation enhances the epithelial phenotype of mammary carcinoma and 
Ras-transformed mammary cells, and decreases the in vivo growth of the latter. In addition, 
expression of a mutated version of MFG-E8 unable to bind integrins decreases in vivo 
tumorigenicity of mammary carcinoma cells. These results demonstrate that MFGE8 promotes 
mammary gland carcinoma growth in vivo and and identify this molecule as a potential therapeutic 
target in breast cancer. 
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Nuclear localization of lactadherin in melanoma cells 
 
 
1Obula R., 1Carrascosa C., 1Mariotti A.  
 
 
CHUV/CePO/UNIL1  
 
 
Lactadherin is a secreted glycoprotein that was shown to promote melanoma progression by 
enhancing cell survival and invasion abilities and by stimulating immune suppression. We have 
analyzed the expression of lactadherin in human melanoma biopsies obtained from tumors at 
different progression stages by immunohistochemistry (IHC). We have observed that while in most 
cells lactadherin is localized in the cytoplasm and at the cell membrane, in some cells it is present 
in the nuclei. To confirm this observation we have then examined lactadherin localization in a 
series of melanoma cell lines by immunofluorescence staining with different anti-lactadherin 
antibodies and we have detected this protein in the nuclei of several melanoma cell lines. We have 
found that the number of cells in which lactadherin is present in the nucleus varies depending on 
the cell line, with some cell lines being highly positive (> 90% of lactadherin-positive nuclei), some 
consisting of a mixture of cells with lactadherin positive and lactadherin-negative nuclei, and 
others  presenting only cytoplasmic and membrane staining. We have observed no correlation 
between lactadherin nuclear localization and the degree of aggressiveness of the analyzed cell 
lines. We have confirmed lactadherin nuclear localization by western blotting of nuclear extracts of 
melanoma cells. This observation suggests that lactadherin function may be more complex than 
what described so far. Ongoing experiments are addressing the biological significance and 
functional role of nuclear lactadherin in the development of melanoma. 
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Lactadherin is a secreted glycoprotein that was shown to promote melanoma progression by 
enhancing cell survival and invasion abilities and by stimulating immune suppression. We have 
analyzed the expression of lactadherin in human melanoma biopsies obtained from tumors at 
different progression stages by immunohistochemistry (IHC). We have observed that while in most 
cells lactadherin is localized in the cytoplasm and at the cell membrane, in some cells it is present 
in the nuclei. To confirm this observation we have then examined lactadherin localization in a 
series of melanoma cell lines by immunofluorescence staining with different anti-lactadherin 
antibodies and we have detected this protein in the nuclei of several melanoma cell lines. We have 
found that the number of cells in which lactadherin is present in the nucleus varies depending on 
the cell line, with some cell lines being highly positive (> 90% of lactadherin-positive nuclei), some 
consisting of a mixture of cells with lactadherin positive and lactadherin-negative nuclei, and 
others  presenting only cytoplasmic and membrane staining. We have observed no correlation 
between lactadherin nuclear localization and the degree of aggressiveness of the analyzed cell 
lines. We have confirmed lactadherin nuclear localization by western blotting of nuclear extracts of 
melanoma cells. This observation suggests that lactadherin function may be more complex than 
what described so far. Ongoing experiments are addressing the biological significance and 
functional role of nuclear lactadherin in the development of melanoma. 
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T-cells specific for foreign (e.g. viral) antigens can give rise to strong protective immune 
responses, whereas self/tumor antigen-specific T-cells are thought to be less powerful. However, 
synthetic T-cell vaccines composed of Melan-A/MART-1 peptide, CpG and IFA can induce high 
frequencies of self/tumor-specific circulating CD8 T-cells in melanoma patients. Here we analyzed 
the functional competence of these T-cells directly ex vivo, by multiparameter flow cytometry. The 
production of multiple cytokines (IFNγ, TNFα, IL-2) and upregulation of LAMP-1 (CD107a) by 
tumor (Melan-A/MART-1) specific T-cells was comparable to virus (EBV-BMLF1) specific CD8 
T-cells. Phosphorylation of STAT1, STAT5 and ERK1/2, and expression of CD3 zeta chain were 
also similar in tumor- and virus-specific T-cells, demonstrating functional activatory signaling 
pathways. Interestingly, high frequencies of functionally competent T-cells were induced 
irrespective of patient’s age or gender. Thus, vaccination with peptide and CpG activated 
multifunctional tumor-specific human CD8 T-cells in vivo, despite that Melan-A is a self-antigen. 
This is strikingly different to tumor-specific T-cell responses arising spontaneously or upon 
vaccination without CpG, which typically show low T-cell frequencies, inefficient cytokine 
production and cytotoxicity, and blunted signaling. Our demonstration of robust T-cell responses 
encourage further development and phase III trials assessing the clinical efficacy of this 
vaccination strategy.  
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TNF-α, a major pro-inflammatory cytokine and the female hormone estrogen have been implicated 
in the pathophysiology of two gynaecological diseases: endometriosis and endometrial 
adenocarcinoma. 
The aim of this study was to examine crosstalk between TNF-α and ER signaling in endometrial 
epithelial cells. 
The action of TNF-α on ER-mediated signaling was compared to the classical ligand estrogen by 
means of an ERE luciferase assay. We demonstrated that TNF-α induced luciferase expression in 
the absence of E2 and augmented the effect of E2 with maximal activation after 3h of exposure. 
TNF-α activity on estrogen signaling appeared to be dependent on the ERK pathway, since E2 
increased TNF-α stimulated phosphorylation of ERK1/2. 
Furthermore, TNF-α increased the expression of c-fos mRNA, an estrogen regulated gene, and 
potentiated the E2 mediated activation. 
Using siRNA againt ERα we also demonstrated that TNF-α activates specifically ER signaling 
through this receptor. 
Our results suggest that a combination of TNF-α and estrogen inhibitors might be useful for the 
treatment of these pathologies. 
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Neurally Adjusted Ventilatory Assist (NAVA) improves patient-ventilator 
synchrony in patients undergoing non invasive ventilation. 
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Rationale 
Neurally adjusted ventilatory assist (NAVA) is an assisted ventilatory mode using electrical activity of the diaphragm or Eadi 
recorded through esophageal electrodes to trigger the ventilator, deliver assistance in proportionality to inspiratory demand and 
cycle off the ventilator. NAVA improves patient‐ventilator synchrony in intubated patients in comparison with pressure support 
(PS). Under non invasive ventilation (NIV), because of the presence of leaks which interfere with the triggering and cycling, 
patient‐ventilator synchrony is difficult to achieve, which can lead to NIV failure and intubation. Using Eadi, a signal independent 
from leaks and respiratory mechanics, could be promising.    The aim of this study is to determine if, compared to PS, NAVA can 
improve patient‐ventilator synchrony in intensive care patients undergoing NIV. 
Methods 
Randomized comparative study during PS with clinician determined ventilator settings and NAVA with gain (proportionality 
factor between Eadi and delivered pressure) set as to obtain the same peak airway pressure as the total pressure obtained in PS. 
A 20 minute continuous recording of airway pressure, flow and Eadi with each ventilatory mode was performed in a randomized 
order allowing determination of Trigger delay (Td), patient neural inspiratory time (Tin), duration of pressurization by the 
ventilator (Tiv), excess duration of pressurization (Ti excess = Tiv‐Tin / Tin X100) and number of asynchrony events by minute. 
Results between both groups were compared by paired T‐test or Wilcoxon test if needed and given as mean ± SD. p was 
considered significant if < 0.05. 
Results 
Preliminary results (mean ± SD): 7 patients (age 64.7 ± 4.9 yr ,1 M/6F, BMI 24.5 ± 6.6 kg/m2, SAPS II 34 ± 9) , 3 patients with 
COPD, 1 with mixed obstructive and restrictive disease.    Ventilator settings: FIO2 32.9 ± 9.1%, PEEP 6.1 ± 1.6 cmH2O, PS 9.3 ± 
2.4 cmH2O, Trigger in PS: 6 flow/ 1 pressure , Cycling off criteria in PS between 30 and 55%. NAVA gain between 0.2 and 1 
µV/cmH2O, trigger NAVA 0.5 µV.   
Under NAVA, 87 ± 8.1% of ventilator cycles were triggered and 96 ± 3.1% were cycled off by the Eadi signal. 
 
  PS NAVA p
Leaks (mean value)    l/min 2.5 ± 2.5 2.2 ±2.0 0.140 
Td      ms  193 ± 62 46 ± 23 < 0.001 
Tiexcess    ms  192 ± 126 131 ± 25 0.275 
Total number of asynchronies   
n/min 
6.8 ± 6.5 2.3 ± 1.6 0.12
Double triggering    n/min 2.5 ± 3.8 0.3 ± 0.3 0.078 
Ineffective effort    n/min  0.7±0.9 0 0.082 
Late cycling    n/min  0.7±1.6 0 0.125 
Premature cycling    n/min 0.8 ± 0.8 0 0.035 
Autotriggering    n/min  2.0± 2.1 1.9 ± 1.5 0.915 
 
Conclusion 
Compared with PS, NAVA  improves patient ventilator synchrony under NIV by reducing Td and premature cycling. With NAVA 
ineffective efforts, late or premature cycling were absent. There is also a strong trend towards reducing total asynchrony events. 
This ongoing trial should provide evidence that NAVA can improve patient‐ventilator synchrony in patients undergoing NIV. 
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Introduction 
Red Blood Cell (RBC) concentrate is the main labile blood product used in transfusion medicine. 
Numerous efforts are made to ensure quality and security of blood products from collection to 
transfusion. Non-physiological cold-storage may provoke RBC alterations, well described in the 
literature as “RBC storage lesions”. Those lesions includes morphological, biomechanical and 
biochemical alterations. How theses lesions affect transfusion efficiency is not yet clearly 
understood. Among the different storage lesions, RBCs are subjected to oxidative stress, which 
leads to the oxidation of part of their protein content. We focus on how oxidative lesions are 
involved in RBC in vitro aging and in-vivo clearance. 
Materials and Methods 
Erythrocyte concentrates are obtained from voluntary blood donation from Lausanne and Bern 
blood transfusion centers. Briefly, whole blood donations are collected into anticoagulant solution. 
Plasma, platelets and leukocytes are removes and RBC concentrates are stored in additive 
solution for up to 49 days at 4°C. Only RBC concentrates stored in SAGM and refused for 
transfusion medicine were used here. 
Cytoplasmic content is extracted by hypotonic lysis with or without previous density-based 
fractionation of RBCs populations through Percoll centrifugation. High-density fraction is thought to 
be enriched in old erythrocytes and low-density fraction in young ones. 
Carbonylation content is here spectrophotometrically investigated. The assay is based on 
carbonylated proteins dérivatisation by 2,4-dinitrophenylhydrazine. This reaction leads to formation 
of protein-hydrazone complexes of which optical density at 375 nm allows quantitaion of protein 
carbonylation. 
Since hemoglobin has absorption peak at the wavelength used for this assay, cytoplasmic extracts 
are previously hemoglobin-depleted by nickel-based IMAC column. 
Results 
Preliminary results show a storage time-related increase of the carbonylated protein content that 
seems to be constant from day one to day 14 (around 2 nmol/mg), then present an important 
increase at day 14 (from 1.7nmol per mg of protein to 3.2nmol/mg), with a maximum at day 22 
(3.7nmol/mg), and seems to stay relatively constant with a little decrease until day 42 
(2.7nmol/mg). 
The age-related fractionation reveals that the supposed old-population enriched fraction presents 
lower protein carbonylation content than the young-population enriched one. It’s however 
interesting to note that the ration between lower-density and higher-density fractions is constant at 
around 1 from day 1 to day 16, then increases until the end of the storage period. 
Conclusions 
RBC cytoplasmic carbonylation content shows an increasing profile from day 14, and a decrease 
in the end of the storage. Contrary to expected, results show that population lower density 
population (supposed to be younger RBCs) have higher carbonylation content. In our hands, it 
appears that number of RBC microparticles increases during storage. A possible explanation 
could be that microparticulation allows harmful components elimination, of which carbonylated 
proteins possibly belong. Further experiments on microparticles and oxidation will be conduct to 
support these results.  
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Introduction: Oseltamivir phosphate (OP), the prodrug of oseltamivir carboxylate (OC; active 
metabolite), is marketed since 10 years for the treatment of seasonal influenza flu. It has recently 
received renewed attention because of the threat of avian flu H5N1 in 2006-7 and 2009-10 
A/H1N1 pandemics. However, relatively few studies have been published on OP and OC clinical 
pharmacokinetics. The disposition of OC and the dosage adaptation of OP in specific populations, 
such as young children or patients undergoing extrarenal epuration, have also received poor 
attention. An analytical method was thus developed to assess OP and OC plasma concentrations 
in patients receiving OP and presenting with comorbidities or requiring intensive care. 
Methods: A high performance liquid chromatography coupled to tandem mass spectrometry 
method (HPLC-MS/MS) requiring 100-µL aliquot of plasma for quantification within 6 min of OP 
and OC was developed. A combination of protein precipitation with acetonitrile, followed by dilution 
of supernant in suitable buffered solvent was used as an extraction procedure. After reverse 
phase chromatographic separation, quantification was performed by electro-spray ionization–triple 
quadrupole mass spectrometry. Deuterated isotopic compounds of OP and OC were used as 
internal standards. 
Results: The method is sensitive (lower limit of quantification: 5 ng/mL for OP and OC), accurate 
(intra-/inter-assay bias for OP and OC: 8.5%/5.5% and 3.7/0.7%, respectively) and precise 
(intra-/inter-assay CV%: 5.2%/6.5% and 6.3%/9.2%, respectively) over the clinically relevant 
concentration range (upper limits of quantification 5000 ng/mL). Of importance, OP, as in other 
previous reports, was found not to be stable ex vivo in plasma on standard anticoagulants (i.e. 
EDTA, heparin or citrate). This poor stability of OP has been prevented by collecting blood 
samples on commercial fluoride/oxalate tubes. 
Conclusions: This new simple, rapid and robust HPLC-MS/MS assay for quantification of OP and 
OC plasma concentrations offers an efficient tool for concentration monitoring of OC. Its exposure 
can probably be controlled with sufficient accuracy by thorough dosage adjustment according to 
patient characteristics (e.g. renal clearance). The usefulness of systematic therapeutic drug 
monitoring in patients appears therefore questionable. However, pharmacokinetic studies are still 
needed to extend knowledge to particular subgroups of patients or dosage regimens. 
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Aim: to assess the role of RG in the evaluation of renal function in live kidney donors.  
Methods: From 2002 to 2008, 109 patients (35M, 74F; 49±12y) were evaluated for kidney 
donation. Creatinine clearance (Ccr) was estimated by Cockroft, and abbreviated modification of 
diet in renal disease (MDRD) equations (n=108), and 24h urine collection (UCcr) (n=100). During 
RG, individual renal function was measured by an accumulation index (AI) defined as the percent 
of injected activity extracted 30-90 sec after heart peak and effective renal plasma flow (ERPF) 
was measured using the single blood sample method at 44 min (Tauxe). Accepted lower limit of 
Ccr is 80ml/min. Normal AI is 11±2 per kidney. 
Results: Of 109 patients, 78 patients have donated a kidney, 19 patients were  excluded, 12 are 
still under investigation. We observed a progressive decrease of ERPF with age, whereas AI 
decreased after 60y only. Cockroft, MDRD and UCcr were higher in donors under 40y, but did not 
vary significantly after 40y.  
Age N AI donated 
kidney 
AI remaining 
kidney 
ERPF 
 
UCcr 
 
Cockroft MDRD 
 
≤40 21 10.2±1.6 10.9±1.9 597±69 115±25 111±25 92±16 
41-60 43 9.7±1.8 10.6±1.6 546±83 101±22 87±23 80±17 
≥60 14 8.8±1.4 9.7±1.6 465±76 102±18 86±15 87±11 
41 donors (53%) had a Cockroft and/or MDRD <80ml/min. In these 41 donors, UCcr was normal in 
35, ERPF in 39, AI of the remaining kidney was ≥9 in 33. The best functioning kidney was left in 
56 donors 
Conclusions: In our population, based on Cockroft and/or MDRD, 53% of potential donors would 
not have been eligible, indicating an additional method is needed to better assess renal function. 
RG (ERPF, AI) and UCcr provided more reliable renal function evaluation. In addition, RG is useful 
to decide on the side of nephrectomy, leaving the best functioning kidney in the donor. 
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Background: Several studies have reported in vitro synergy between beta-lactams and vancomycin (VAN) 
against methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA) isolates. 
Nevertheless, attempts to use such combinations against VISA in animal infection models have yielded 
conflicting results, probably due to the relatively weak affinity of the beta-lactams used for penicillin-binding 
protein 2A (PBP2A). Ceftobiprole (BPR), a novel cephalosporin with improved affinity for PBP2A, showed 
in vitro synergism with VAN against MRSA and VISA (Entenza et al. ECCMID 2010). Here we further 
explored this synergism in vivo against two VISA clinical isolates in the model of experimental endocarditis 
(EE). 
Methods: Rats with aortic vegetations (veg) were inoculated with 106 CFU of VISA strains PC3 or Mu50. 
Infected rats were treated for 3 days with drug dosages simulating the following treatments in humans: (i) 
BPR 750 mg intravenously (i.v.) bid (Cmax: 49 mg/L), (ii) BPR 125 mg i.v. bid (Cmax: 10 mg/L; a low 
dosage purposely used to help detect positive drug interactions), (iii) VAN 1 g i.v. bid and (iv) BPR 125 
combined with VAN.  
Results: MICs (mg/L) of BPR for VISA PC3 and Mu50 were 2 and 1 mg/L, respectively, and MICs of VAN 
were 8 mg/L for both strains. Results of therapy were: 
 VISA PC3 VISA Mu50 
Groups Infected veg/total (%) Infected veg/total (%) 
Control 10/10 (100) 10/10 (100) 
BPR 750 2/14 (14)* 3/13 (23)* 
BPR 125 8/8 (100) 15/15 (100) 
VAN 1 7/7 (100) 8/8 (100) 
BPR 125 + VAN 1 2/9 (22)**   8/14 (57)** 
* P < 0.05 vs control and VAN   
** P < 0.05 vs control, BPR125 and VAN 
 
Conclusions: BPR monotherapy, modeled on approved standard doses, was active against EE caused by 
VISA. Moreover, low-dose BPR strongly synergized with inactive VAN to restore treatment efficacy. 
Combining BPR with VAN merits further study as an option for difficult-to-treat VISA infections especially 
when drug penetration at the infected site is an issue. 
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INTRODUCTION 
Neurally Adjusted Ventilatory Assist (NAVA) (1) is a new spontaneous-assisted ventilatory mode which 
uses the diaphragmatic electrical activity (Eadi) to pilot the ventilator. Eadi is used to initiate the ventilator´s 
pressurization and cycling off. Delivered inspiratory assistance is proportional to Eadi. NAVA can improve 
patient-ventilator synchrony (2) compared to pressure support (PS), but little is known about its effect on 
minute ventilation and oxygenation. 
OBJECTIVES 
To compare the effects of NAVA and PS on minute ventilation and oxygenation and to analyze potential 
determinant factors for oxygenation. 
METHODS 
Comparison between two 20-minute periods under NAVA and PS. NAVA gain (proportionality factor 
between Eadi and delivered pressure) set as to obtain the same peak pressure as in PS. FIO2 and positive 
end-expiratory pressure (PEEP) were the same in NAVA and PS. Blood gas analyses were performed at 
the end of both recording periods. Statistical analysis: groups were compared with paired t-tests or non 
parametric Wilcoxon signed-rank tests. p < 0.05 was considered significant. 
RESULTS (mean ± SD): 
22 patients (age 66 ± 12 yr, 7 M/ 15 F, BMI 23.4± 3.1 kg/m2), 8 patients with COPD. Initial settings: PS 13 ± 
3 cmH2O, PEEP 7 ± 2 cmH2O, NAVA gain 2.2 ± 1.8. Minute ventilation and PaCO2 were the same with both 
modes (p=0.296 and 0.848 respectively). Tidal volume was lower with NAVA (427 ±102 vs.477 ± 102 ml, 
p< 0.001). In contrast respiratory rate was higher with NAVA (25.6 ± 9.5 vs. 22.3 ± 8.9 cycles/min). Arterial 
oxygenation was improved with NAVA (PaO2 85.1 ± 28.9 vs. 75.8 ± 11.9mmHg, p=0.017, PaO2/FIO2 210 ± 
53 vs.195 ± 58 mmHg, p=0.019). Neural inspiratory time (Tin) was comparable between NAVA and PS 
(p=0.566). Among potential determinant factors for oxygenation, mean airway pressure (Pmean) was lower 
with NAVA (10.6 ± 2.6 vs 11.1 ± 2.4 cmH2O, p = 0.006), as was the Pressure time product of the ventilator 
(PTP) (6.8 ± 3.0 vs. 9.2 ± 3.5 cm H2O x sec, p=0.004). There were less asynchrony events with NAVA (2.3 
± 2.0 vs 4.4 ± 3.8, p= 0.009).Tidal volume variability was higher with NAVA (variation coefficient: 30 ± 19.5 
vs. 13.5 ± 8.6, p< 0.001). Inspiratory time in excess (Tiex) was lower with NAVA (56 ± 23 vs. 202 ± 200 ms, 
p= 0.001).  
CONCLUSION 
Despite lower Pmean and PTP of the ventilator in NAVA, arterial oxygenation was improved compared to 
PS. The increase in VT variability with NAVA could be an explanation for improved oxygenation. Further 
studies should now be performed to confirm the potential of NAVA in improving arterial oxygenation and 
explore the underlying mechanisms. 
REFERENCES 
(1) Sinderby et al. Nat Med. 1999 Dec;5(12):1433-6. 
(2) Spahija J et al. Crit Care Med. 2010 Feb;38(2):518-26. 
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INTRODUCTION: Neurally Adjusted Ventilatory Assist (NAVA) is a new ventilatory mode in which ventilator settings 
are adjusted based on the electrical activity of the diaphragm (Eadi). This mode offers significant advantages in 
mechanical ventilation over standard pressure support (PS), since ventilator input is determined directly from patient 
ventilatory demand. Therefore, it is expected that tidal volume (Vt) under NAVA would show better correlation with 
Eadi compared with PS, and exhibit greater variability. 
 
OBJECTIVES: To compare tidal volume variability in PS and NAVA, and it’s correlation with patient ventilatory 
demand (as characterized by Eadi). 
 
METHODS: A comparative study of patient-ventilator interaction was performed for 22 patients during standard PS 
with clinician determined ventilator settings; and NAVA, with gain set to ensure the same peak airway pressure as the 
total pressure obtained in PS. A 20 minute continuous recording was performed in each mode. Respiratory rate, Vt, 
and Eadi were recorded. Tidal volume variance and Pearson correlation coefficient between Vt and Eadi were 
calculated for each patient. A periodogram was plotted for each ventilator mode and each patient, showing spectral 
power as a function of frequency to assess variability.  
 
RESULTS: Median, lower quartile and upper quartile values for Vt variance and Vt/Eadi correlation are shown in Table 
1. The NAVA cohort exhibits substantially greater correlation and variance than the PS cohort. 
 
 
Table 1. Variance and Correlation metrics for PS  
and NAVA 
 
 
Patient 
Cohort 
Variance in Vt  Correlation (Eadi vs 
Vt) 
PS  NAVA  PS  NAVA
Lower 
quartile 
793  5218  0.0405  0.5971
Median  3043  10798  0.2563  0.6618
Upper 
Quartile 
5398  23715  0.3517  0.7618
 
 
Figure 1. Power Spectrum for Vt and Eadi under PS (above) 
and NAVA (below) 
 
 
Power spectrums for Vt and Eadi are shown in Figure 1 (PS and NAVA) for a typical patient. 
 
CONCLUSIONS: There is greater variability in tidal volume and correlation between the tidal volume and the 
diaphragmatic electrical activity with NAVA compared to PS. These results are consistent with the improved 
patient-ventilator synchrony reported in the literature. 
 
 
 
Authors’ Index 
 
Main author in thick 
 
 
ABRIEL HUGUES NEU-129  
ACHTARI CHAHIN IMI-45  
AGALAROV YAN ODE-158  
ALITALO KARI ODE-158  
ALLAGNAT FLORENT MCV-72/MCV-83  
ALLAMAN IGOR NEU-141  
ALLENBACH GILLES MCV-75/MCV-76/ MCV-77/MCV-78/MCV-79/ MCV-80/MCV-88/MCV-111 
ALMEIDA STÉPHANIE ODE-154  
ALONSO FLORIAN MCV-65  
AMATI FRANCESCA MCV-110  
ANDRÉ CYRIL IMI-40  
AOURI MANEL IMI-26  
ARLABOSSE TIPHAINE MCV-64  
ARNAUD ESTELLE NEU-128  
AT AYSE NEU-135  
AUBERSON MURIEL MCV-95  
AUBERT JEAN-FRANÇOIS MCV-84  
AUBRY DOMINIQUE MCV-84/ODE-155  
AUDERSETNARDOU  KATYA  ODE-152  
BACHMANN DANIEL IMI-23  
BACHMANN MARTIN IMI-46  
BADER MICHAEL  MCV-109  
BAECHLER SÉBASTIEN MCV-111  
BAIN MARIANNE IMI-16  
BAITSCH LUKAS ODE-159  
BALLHAUSEN DIANA MCV-48/MCV-49/MCV-50  
BALMAS BOURLOUD KATIA ODE-152  
BARRAS DAVID ODE-146  
BAUMGARTNER PETRA IMI-34/ IMI-46/ODE-159 
BECKMANN JACQUES MCV-113  
BELKHODJA ZALILA CYRINE IMI-35  
BELLINI CRISTINA IMI-19  
BENAKIS CORINNE NEU-132  
BÉNY JEAN-LOUIS  MCV-65  
BERDAJS DENIS MCV-82  
BERGER METTE MCV-51/MCV-100 
BERGERON AURÉLIE MCV-125  
BERGMANN SVEN GEN-11/MCV-113  
BERLIN M. MCV-87  
BERNASCONI ERIC IMI-23  
BERNASCONI FOSCO NEU-130/NEU-131  
BERTHET CAROLE NEU-140/NEU-141 
BERTHET CAROLE   
BERTHONNECHE CORINNE MCV-121/ MCV-169  
BEYSARD NICOLAS MCV-76  
BEZZI PAOLA MCV-125  
BIALAIS EMILIE THE-161/THE-166/THE-167  
BIANCHI NICOLETTA MCV-48 
BIANCIARDI PAOLA  MCV-118  
BICKLE-GRAZ MYRIAM MCV-48  
BICHAT ARNAUD MCV-63  
BILL OLIVIER NEU-138  
BISCHOF-DELALOYE ANGELIKA MCV-75/MCV-77/MCV-111/THE-164  
BIZZINI ALAIN IMI-17/IMI-35  
BOBST MARTINE  IMI-24  
BOCHUD MURIELLE  IMI-33/MCV-102  
BOCHUD PIERRE-YVES IMI-29/IMI-37  
BOHLENDER JÜRGEN MCV-107/MCV-109  
BOILLAT BLANCO NOÉMIE IMI-37/IMI-42  
BOITTIN FRANÇOIS-XAVIER  MCV-65  
BONAFÉ LUISA MCV-48/MCV-49/MCV-50  
BONNEAU JUSTINE EHU-7  
BONNY CHRISTOPHE NEU-132  
BONNY OLIVIER MCV-70/MCV-95  
BONTEMS OLYMPIA IMI-22  
BOUBAKER ARIANE MCV-78/MCV-79/MCV-88/ MCV-111/THE-164  
BOUDUBAN THIERRY MCV-112  
BOURQUIN CÉLINE EHU-1  
BOUZOURÈNE KARIMA MCV-84  
BOVET PASCAL EHU-3/MCV-64/MCV-66/MCV-102  
BRAISSANT OLIVIER  MCV-49/MCV-50 
BRAJKOVIC SASKA MCV-98  
BRAUN MARION IMI-46  
BRUCHEZ F. EHU-168  
BUCLIN THIERRY MCV-87/ODE-153  
BULLIARD JEAN-LUC EHU-7/EHU-168/ENA-10  
BURNIER MICHEL MCV-67  
BÜRGISSER PHILIPPE IMI-40  
CALANDRA THIERRY IMI-16/IMI-18/IMI-20/IMI-21/IMI-29  
CALMET GAUTIER EHU-4  
CAMPOS VANESSA NEU-133  
CAMUS FABRICE MCV-75/MCV-80/MCV-88  
CANELLINI GIORGIA  IMI-40  
CANNY GERALDINE IMI-45/ODE-160  
CARIOLATO LUCA MCV-69  
CARRARD MARIANNE MCV-115  
CARRASCOSA CORALIE ODE-156/ODE-157  
CAVASSINI MATTHIAS IMI-37/IMI-40  
CAVIN SABRINA MCV-92  
CENTENO GABRIEL MCV-70  
CHALANDON YVES ODE-153  
CHAMPENDAL MÉLANIE MCV-88  
CHAPARD CHRISTOPHE ODE-154  
CHAPUIS-TAILLARD CAROLINE IMI-25  
CHASE J. GEOFFREY THE-167  
CHATTON JEAN-YVES NEU-142  
CHERBUIN NICOLAS MCV-74/MCV-111 
CHIOLERO ARNAUD MCV-66  
CHRAST ROMAN NEU-128  
CISSÉ OUSMANE H. EHU-5  
CLARKE STEPHANIE NEU-135  
CLEMENTI M. MCV-87  
COELHO-VELOSO TIAGO RAFAEL THE-165  
CORGNAC STÉPHANIE ODE-150  
CORNUZ JACQUES GEN-11/MCV-59  
COSTE ALIX IMI-29  
COTECCHIA SUSANNA MCV-91  
COULON AURELIE ODE-151/ODE-152 
CRISANTE GIOVANNA IMI-43  
CROQUELOIS ALEXANDRE NEU-143  
CROXATTO ANTONY ENA-9  
CRUCHET STEEVE MCV-169 
CSAJKA CHANTAL ODE-153  
CUPPERS-MAARSCHALKERWEERD B. MCV-87  
D'ANGELO FABRIZIA IMI-23  
DABIRI AMIN MCV-77  
DACOSTA ANABELA MCV-115  
DAMNON FRANÇOISE IMI-45  
DANG THANH IMI-33  
DARIOLI ROGER MCV-62  
DARLING KATHARINE IMI-40  
DAVIN CAROL MCV-56  
DEBONNEVILLE ANNE  MCV-93  
DECOSTERD ISABELLE NEU-129  
DECOSTERD LAURENT A. ODE-153  
DECRAUSAZ LOANE IMI-24  
DEGUEURCE GWENDOLINE GEN-12  
DEKEMP ROBERT MCV-75  
DEL VESCOVO COSMO DAMIANO MCV-91  
DELALOYE ALINE MCV-76  
DELOBEL JULIEN THE-162  
DELODDER FREDERIK MCV-99/MCV-100/MCV-114 
DELORENZI MAURO ODE-156/ODE-158  
DEMARTINES NICOLAS ODE-147  
DEMCIK NATHALIE MCV-5/MCV-73  
DEPAIRON MICHÈLE MCV-62  
DEPREUXCHARLES ANNE-SOPHIE NEU-128  
DERRÉ LAURENT ODE-159  
DESAIVE THOMAS  THE-167  
DESANTIS M. MCV-87  
DESSEN PIERRE MCV-63  
DIACERI GIACOMO MCV-116/MCV-117  
DIVIANI DARIO MCV-69/ MCV-91/MCV-92/MCV-96  
DOMINGOS-PEREIRA SONIA IMI-24  
DONDA ALENA ODE-150  
DORMOND OLIVIER  ODE-147  
DORMOND-MEUWLY ANNE ODE-147  
DUBUIS GILLES MCV-126  
DUCHOSAL MICHEL MCV-84/ODE-153/ODE-155 
DUNET VINCENT MCV-68/MCV-74/MCV-75/MCV-76/MCV-77/MCV-78/MCV-79/MCV-80/MCV-88  
DUPASQUIER RENAUD IMI-30  
DUQUENNE PHILIPPE EHU-2  
DWYER ANDREW MCV-85  
DÉNÉRÉAZ MARIE-LAURE GEN-14  
EGGER MATTHIAS IMI-33  
EGGIMANN PHILIPPE IMI-16/IMI-18/IMI-19/MCV-114  
EGLI DELPHINE MCV-48 
 
EGLI LÉONIE NEU-133  
EL HAKMAOUI FATIMA MCV-74/MCV-88  
ELEFTERIOU J. MCV-87  
ENTENZA JOSÉ MANUEL IMI-36/THE-165  
ESKIN ELEAZAR MCV-113  
FAOUZI MOHAMED NEU-136/NEU-138/NEU-139 
FARESSE NOURDINE MCV-93  
FARHAD HOSHANG MCV-68/MCV-80  
FAVRE DIMITRI MCV-98  
FEIHL FRANÇOIS MCV-51/MCV-77 
FICHE MARYSE  IMI-45  
FIRSOV DMITRI MCV-70  
FLAHAUT MARJORIE ODE-151/ODE-152  
FLUECKIGER URSULA IMI-18  
FRANCIOLI LAURENT ENA-10  
FRANÇOIS PATRICE IMI-21  
FRATTI MARINA IMI-22  
FRITSCHY JEAN-MARC NEU-143  
FROMER MARTIN MCV-89  
FURUSTRAND ULRIKA IMI-27/IMI-28/IMI-42 
GAGNON GHISLAINE MCV-100  
GATTESCO SONIA  MCV-97  
GEDEON JUDE EHU-3  
GIACOBINO ARIANE MCV-63  
GIDDEY MARLYSE IMI-15/IMI-36/THE-165  
GIULIERI STEFANO IMI-37  
GIUSTI VITTORIO NEU-133  
GLAUSER FRÉDÉRIC MCV-62  
GONZALES CHRISTINE MCV-52/MCV-73  
GOODPASTER BRET MCV-110  
GORI ILARIA IMI-45/ODE-160  
GOTTA VERENA ODE-153  
GRAF ROLF IMI-16  
GRANDMAISON GAËL IMI-20  
GREGOR MICHAEL ODE-153  
GREUB GILBERT ENA-9/IMI-32  
GRIVEL JEREMY NEU-131  
GROSS NICOLE ODE-149/ODE-151/ODE-152 
GRUETTER ROLF NEU-140  
GUAL PHILIPPE MCV-112  
GUDINCHET FRANÇOIS MCV-123  
GUESSOUS IDRIS MCV-114  
GUILLAUME PHILIPPE ODE-159  
GUPTA BHAWNA IMI-34/IMI-39  
HAEFLIGER JACQUES-ANTOINE MCV-65/MCV-72/MCV-83  
HANLEY JAMES A. MCV-66  
HAUSER PHILIPPE EHU-5/IMI-18  
HAZAN RONEN IMI-15  
HE JIANXIN IMI-15  
HEBEISEN MICHAEL IMI-41 
HEIM DOMINIK ODE-153  
HEINZER RAPHAEL MCV-76  
HENRY HUGUES MCV-50  
HERSCH MICHA MCV-113  
HIRT LORENZ NEU-132/NEU-140/NEU-141  
HOHL DANIEL IMI-44/ODE-154 
HOTZ PHILIPP EHU-2  
HOUHOU NAWAL ODE-158  
HUBER MARCEL ODE-154  
HUMMLER EDITH GEN-14/MCV-67/MCV-101/MCV-105/MCV-108 
IANCU EMANUELA MARINA IMI-34/IMI-39  
IBBERSON MARK GEN-12  
IMBODEN HANS MCV-107  
IRVING MELITA IMI-41 
IVANOV KONSTANTIN ODE-158  
JACCARD EVRIM MCV-126  
JACOVETTI CÉCILE MCV-71  
JAN CAROLINE ODE-160  
JANDUS CAMILLA ODE-159  
JAQUET MURIEL ODE-158  
JATON KATIA IMI-25/IMI-42 
JAYET PIERRE-YVES MCV-76  
JICHLINSKI PATRICE IMI-24  
JILEK TERRASSE SAMANTHA IMI-30  
JOLLIET PHILIPPE THE-161/THE-166/THE-167  
JOSEPH CHRISTINE IMI-19  
JOSEPH JEAN-MARC ODE-151  
JOUSSET FLORIAN MCV-89  
KAEUPER PETER ODE-149  
KANG HYUN MIN MCV-113  
KASAS SANDOR IMI-17  
KAUFMANN ANNATINA IMI-40  
KENFAK-FOGUENA ALAIN IMI-40  
KESARWANI MEENU IMI-15  
KHALIL HADI MCV-127  
KHOUDI DORRA MCV-99/MCV-100 
KIELAR MICHEL NEU-143  
KLEE PHILIPPE MCV-72  
KLEEBERG JOERG NEU-143  
KLEIN RAIN MCV-75  
KNAUPREYMOND MARLIES IMI-20  
KOESTERS ROBERT MCV-53/MCV-105 
KOSINSKI MAREK MCV-75/MCV-78/MCV-79/MCV-88 
KRAFTSIK RUDOLF  NEU-134  
KULIK GERIT NEU-144  
KUMAR RAJESH IMI-45  
KUTALIK ZOLTAN GEN-11  
LAGOPOULOS LUCIENNE ODE-149  
LAJAUNIAS FREDERIC IMI-16  
LAMBERMONT BERNARD THE-161/THE-167  
LAMOTH FREDERIC IMI-18  
LAMY CHRISTOPHE NEU-142  
LATGÉ JEAN PAUL IMI-29  
LAUE CARSTEN ODE-149  
LAURENT JULIEN IMI-39  
LE CORRE-LALIBERTÉ CELINE NEU-137  
LEHR HANS-ANTON ODE-156  
LEI HONGXIA NEU-140  
LEPORE MARIO MCV-169 
LEROY DIDIER IMI-20/IMI-21/IMI-29  
LEUBA GENEVIÈVE NEU-134  
LEVI F. EHU-168  
LEYVRAZ SERGE IMI-39  
LIAUDET LUCAS IMI-16/MCV-51  
LIBERMAN JULIE ODE-151/ODE-152 
LIENARD JULIA ENA-9  
LIETTI CLAUDIA NEU-133  
LOFFING DOMINIQUE MCV-53  
LOFFING JOHANNES MCV-53/MCV-67 
LOVIS ALBAN MCV-76  
LUCY HENDERSON NEU-144  
LUESCHER IMMANUEL F. ODE-159  
LUGRIN JÉRÔME IMI-20/IMI-21  
LYNGDOH TANICA MCV-64/MCV-102 
LÖVGREN TANJA ODE-159  
MABY-ELHAJJAMI HELENE  ODE-158  
MADELEINE GEORGE MCV-66  
MAEDER PHILIPPE NEU-139 
MAGISTRETTI PIERRE NEU-141  
MAILLARD MARC MCV-67  
MAILLARD MICHEL IMI-23  
MAISON DAMIEN GEN-14  
MAJIC IVANA IMI-28  
MALSURE SUMEDHA MCV-101  
MALTERRE JEROME MCV-74/MCV-78/MCV-79/MCV-88 
MANAKOVA E. MCV-87  
MANEL AOURI THE-163  
MANUEL AURÉLIE NEU-130/NEU-131  
MANUEL ORIOL IMI-25  
MARCELINO GISELA MCV-54/MCV-61  
MARCHETTI OSCAR IMI-18/IMI-25  
MARINO MATHIEU MCV-116/MCV-117  
MARIOTTI AGNESE ODE-156/ODE-157  
MARQUES-VIDAL PEDRO GEN-11/MCV-54/MCV-55/MCV-56/MCV-57/MCV-58/MCV-59/MCV-60/MCV-61  
MARTIN DAVID MCV-83  
MARTINEZ RAQUEL ODE-148  
MASCLAUX FRÉDÉRIC EHU-2  
MATTER MAURICE ODE-159/THE-164  
MAURER FABIENNE MCV-113  
MAZZOLAI LUCIA MCV-62/ MCV-65/MCV-77/MCV-84/MCV-107 
MAZZUCCHELLI LUCA ODE-156  
MEDA PAOLO MCV-65/MCV-72/MCV-83  
MELICH-CERVEIRA JOÃO MCV-54/MCV-59/MCV-61 
MELITA IRVING IMI-41  
MERILLAT ANNE-MARIE GEN-14  
MERLOB P. MCV-87  
METREF SALIMA  MCV-115  
METRICH MELANIE MCV-120/MCV-169  
MEULI RETO NEU-139 
MEYLAN PASCAL IMI-25/IMI-39  
MICHALIK LILIANE GEN-12/MCV-106 
MICHALIS ALEXANDRE MCV-82  
MICHEL PATRIK NEU-136/NEU-137/NEU-138/NEU-139  
MICHETTI PIERRE IMI-23  
MICHIELIN OLIVIER IMI-34/ IMI-39/IMI-41/ODE-159 
MILANO GIUSEPPINA MCV-118  
MILON ANTOINE EHU-7/ENA-10  
MINEHIRA CASTELLI KAORI MCV-10/MCV-112 
MIURA NAOYUKI ODE-158  
MIÉVILLE FRÉDÉRIC MCV-123  
MOCCOZET LAURENT ENA-10  
MOHAMED FAOUZI  NEU-139  
MONOD MICHEL IMI-22/IMI-29  
MOODYCLIFFE ANGUS IMI-44  
MOORHEAD KATE THE-167  
MORADPOUR DARIUS  IMI-40  
MORDASINI DAVID MCV-67  
MOREILLON PHILIPPE IMI-16/IMI-36/THE-165  
MOTTAZ HELENE MCV-106 
MUEHLETHALER VINCENT MCV-116/MCV-117  
MURRAY MICAH  NEU-130/ NEU-131/NEU-133 
MYERS GARY  MCV-64/ MCV-102  
MÉDARD JEAN-JACQUES NEU-128  
MÉNARD JOEL MCV-109  
MÜHLETHALER-MOTTET ANNICK ODE-149/ODE-151/ODE-152  
NAHIMANA AIMABLE  ODE-155  
NARAYAN SANJIV  MCV-89  
NARDELLI-HAEFLIGER DENISE IMI-24  
NEGRO FRANCESCO IMI-33  
NEMIR MOHAMED MCV-120/MCV-169 
NESCA VALERIA MCV-81  
NICOD LALONDE MARIE THE-164  
NICOD PASCAL MCV-63  
NICULITA-HIRZEL HÉLÈNE ENA-8  
NIEDERHÄUSER GUY MCV-98  
NIKOLAEVA SVETLANA MCV-70  
NORRMEN CAMILLA ODE-158  
NTAIOS  GEORGIOS NEU-136  
NUNO INACIO NEU-139 
NUSSBERGER JÜRG MCV-84/MCV-107/MCV-109  
OBULA RAMPRASAD ODE-156/ODE-157  
OPPLIGER ANNE EHU-2/ENA-8  
ORASCH CHRISTINA IMI-18  
PACCAUD FRED GEN-11/MCV-54/MCV-55/MCV-56/MCV-58/MCV-59/MCV-61/MCV-66  
PAGANI JEAN-LUC IMI-19  
PAGNI MARCO EHU-5  
PANCHAUD A. MCV-87  
PANTALEO GIUSEPPE IMI-30  
PAPPON MARTIN MCV-74/MCV-88  
PARADIS GILLES MCV-66  
PASCALE PATRIZIO  MCV-89  
PASQUALI CHRISTIAN NEU-132  
PATIL JASPAL MCV-107  
PEDRAZZINI THIERRY MCV-52/ MCV-73/MCV-120/MCV-121/MCV-169 
PEDRETTI SARAH MCV-86  
PELLEGRIN MAXIME MCV-84  
PELLEGRINI CHIARA  ODE-160  
PELTZE NIEVES GEN-13  
PERRIER ROMAIN MCV-105  
PERRIN LUDOVIC MCV-77  
PERRUCHOUD STÉPHANIE MCV-52/MCV-94  
PETER BASTIAN MCV-113  
PEYTER ANNE-CHRISTINE MCV-116/MCV-117  
PEZZUTO IOLE MCV-124  
PHILIPPE MAEDER NEU-139  
PIAZZA YVO NEU-141  
PIERRE-YVES BOCHUD IMI-33  
PILON NATHALIE MCV-114  
PIQUILLOUD LISE THE-161/THE-166/THE-167  
PISTELLI A. MCV-87  
PITTELOUD NELLY MCV-85  
PLAISANCE ISABELLE MCV-52/MCV-73/ MCV-169  
PLUMETTAZ CHLOÉ EHU-3  
POIROT OLIVIER  NEU-128  
PONCE DE LEON VERONICA MCV-108  
PREITNER FREDERIC MCV-115  
PREITNER MARIA  MCV-119  
PRIOR JOHN MCV-68/ MCV-74/MCV-75/MCV-76/MCV-77/MCV-78/MCV-79/MCV-80/MCV-88  
PROBST ARNOLD IMI-33/IMI-37  
PRUVOT ETIENNE MCV-89  
PURICEL SERBAN-GEORGE NEU-145  
PYTHOUD CATHERINE IMI-23  
PYTHOUD CHRISTELLE IMI-38  
PÉREZ LÓPEZ IRENE MCV-96  
QANADLI SALAH DINE MCV-77  
QUAIRIAUX CHARLES NEU-143  
QUE YOK AI IMI-15/ IMI-16/IMI-36  
RADDATZ ERIC MCV-86  
RAFFOUL WASSIN MCV-51  
RAHME LAURENCE G. IMI-15  
REAVEY MICHELLE MCV-60  
REGAZZI ROMANO MCV-81/MCV-97/MCV-125 
REICHMUTH PHILIPP MCV-114  
RENAUD JENNIFER MCV-75  
RETO MEULI NEU-139  
REVELLY JEAN-PIERRE IMI-19/MCV-114  
REXHAJ EMRUSH MCV-63  
REY-BATAILLARD VINCIANNE MCV-76  
RICHARME DELPHINE NEU-144  
RIEDERER BÉAT NEU-134  
RIEDERER IRÈNE NEU-134  
RIGNAULT STEPHANIE MCV-51  
RIMOLDI STEFANO MCV-63  
RIVALS JEAN-PAUL ODE-159  
ROCHEMONT VIVIANE MCV-118  
ROESELER JEAN THE-161/THE-166/THE-167 
ROGER THIERRY IMI-16/IMI-20/IMI-21/IMI-29  
ROGGLI ELODIE MCV-97  
ROMERO PEDRO IMI-34/IMI-39/IMI-46  
RONZAUD CAROLINE MCV-53  
ROSENBLATT-VELIN NATHALIE MCV-51  
ROSSI NATHANAEL ODE-149  
ROSSIER BERNARD MCV-101/MCV-105  
ROTHENBERGER SYLVIA ODE-148  
ROTHUIZEN L. MCV-87  
ROULIN DIDIER ODE-147  
RUBINO IVANA IMI-29  
RUCHAT PATRICK MCV-52/ MCV-73/MCV-89  
RUFER NATHALIE IMI-34/IMI-39/IMI-41/ODE-159  
RUSCONI BRIGIDA IMI-32  
RUSSELL RONAN ODE-160  
RYSER STEPHAN IMI-44  
RÜEGG CURZIO ODE-156  
SABINE AMÉLIE MCV-104  
SAMAJA MICHELE MCV-118  
SAMARA ELENI-THEANO MCV-122  
SAMBEAT AUDREY MCV-119  
SAMUILOVA OLGA ODE-158  
SANNO HITOMI MCV-103  
SARRE ALEXANDRE MCV-121/ MCV-169  
SARTORI CLAUDIO MCV-63  
SAUGY JEREMY NEU-133  
SAVIOZ ARMAND  NEU-134  
SCHAEFER STEPHAN MCV-89  
SCHERRER URS MCV-63  
SCHIZAS CONSTANTIN NEU-144  
SCHLUEP MYRIAM IMI-30  
SCHMID DAPHNE IMI-41  
SCHRENZEL JACQUES IMI-21  
SCHWARZ KATRIN IMI-46  
SCHÜTZ FRÉDÉRIC GEN-12  
SEYER PASCAL MCV-103  
SHAMLAYE CONRAD EHU-3  
SIEGEMUND MARTIN IMI-18  
SINGY PASCAL EHU-1/EHU-6  
SOTTIAUX THIERRY THE-161  
SOUBEYRAN VINCENT MCV-80  
SPEISER DANIEL IMI-34/IMI-39/IMI-41/IMI-46/ODE-159 
SPIERER LUCAS NEU-130/NEU-131/NEU-135  
STAEDLER DAVIDE  ODE-160  
STAUB OLIVIER MCV-53/MCV-90/MCV-93 
STAUFER JEAN-CHRISTOPHE MCV-122  
STEPHENS S. MCV-87  
STIEFEL FRIEDRICH EHU-1  
STUBER MATTHIAS MCV-47  
STOKES JOHN B  MCV-53  
STUBER MATTHIAS MCV-47  
SUAREZ PHILIPPE IMI-31  
SULSTAROVA BRIKELA EHU-6  
SURBECK ISABELLE IMI-45  
SUTER MARC NEU-129  
TAPPY LUC MCV-99/ MCV-100/NEU-133  
TASSAUX DIDIER THE-161/THE- 166/THE-167 
TELENTI AMALIO ODE-148  
TENKORANG JOANNA MCV-89  
THEUMANN NICOLAS NEU-144  
THEYTAZ FANNY MCV-103  
THOME MARGOT  ODE-152  
THORENS BERNARD MCV-95/MCV-115/MCV-119 
THÉVENIN MARIE-JOSÉPHINE IMI-19  
TISSOT FREDERIC IMI-18  
TOEPEL ULRIKE NEU-133  
TOLSA JEAN-FRANÇOIS MCV-116/MCV-117  
TOZZI PIERGIORGIO MCV-82/MCV-99/MCV-100 
TRAMPUZ ANDREJ IMI-17/IMI-27/IMI-28/IMI-35/IMI-42  
ULLRICH NINA  MCV-52  
V.PETROVA TATIANA ODE-158  
VALMU LEENA ODE-158  
VASLIN ANNE NEU-132  
VELIN DOMINIQUE IMI-23  
VELOSO TIAGO IMI-36  
VENETZ JEAN-PIERRE THE-164  
VERDUN FRANCIS MCV-75/MCV-78/MCV-79/MCV-111/MCV-123/MCV-122 
VERNAY ANDRÉ NEU-134  
VERNEZ DAVID EHU-7/ENA-10  
VERRIER JULIE IMI-22  
VESIN JEAN-MARC MCV-89  
VIAL T.  MCV-87  
VIAL YVAN MCV-117  
VICARI MANUELA IMI-45  
VIGNAUX LAURENCE THE-161/ THE-166/THE-167  
VINCENT ZOETE IMI-41  
VISWANATHAN BHARATHI  EHU-3/MCV-64/MCV-102 
VITAGLIANO JEAN-JACQUES MCV-90  
VOGT BRUNO MCV-67  
VOIROL PIERRE IMI-19  
VOLLENWEIDER PETER GEN-11/MCV-55/MCV-56/MCV-58/MCV-59  
VON SEGESSER LUDWIG K MCV-82/MCV-118 
VOUILLAMOZ JACQUES IMI-36/THE-165  
VUILLEUMIER LAURENT ENA-10  
WAEBER BERNARD MCV-51/MCV-77  
WAEBER GÉRARD GEN-11/MCV-55/MCV-56/MCV-58/MCV-59/MCV-65/MCV-72/MCV-83  
WAELTIDACOSTA VRENELI IMI-37  
WAHLI WALTER GEN-12  
WALICKI JOEL MCV-126  
WANG QING MCV-67  
WASELLE LAURENT ODE-147  
WAWRZYNIAK MARTA MCV-106  
WELKER EGBERT NEU-143  
WIDMANN CHRISTIAN MCV-126  
WIDMER NICOLAS ODE-153  
WIECKOWSKI SÉBASTIEN IMI-34/IMI-39  
WINTERFELD URSULA MCV-87 
WINTERMARK M. NEU-139  
XENARIOS IOANNIS GEN-12  
YAN JIANG-YAN  MCV-126  
YANG BAOLI MCV-53  
YLA-HERTTUALA SEPPO ODE-158  
ZANETTI GIORGIO IMI-19  
ZAVADOVA VLASTA MCV-70  
ZENKER JENNIFER NEU-128  
ZHANG JIANGWEN IMI-15  
ZIMMERLI STEFAN IMI-18  
ZIMMERLI WERNER IMI-28  
ZOETE VINCENT IMI-43  
ZUERCHER EMILIE ODE-148  
ZUFFEREY PHILIPPE NEU-138  
